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Dissertation Abstract 
 
 
Bone tissue engineering has progressively emerged as a response to the 
current limited replacement therapies for damaged or lost bone tissue. Ideally, the 
implanted construct should aid in complete bone regeneration in a reasonably short 
time, without causing significant inconvenience to the patient. General tissue 
engineering approaches are based on three different bioactive factors: scaffolding, a 
cellular component, and a molecular component. These factors are closely conjoined 
to create successful constructs and fit into a bone tissue engineering paradigm that 
includes the extraction of a cellular biopsy from a healthy site of the patient. Cells are 
then expanded in vitro and seeded onto the scaffold. The cell-scaffold construct is 
cultured under mechanical and/or chemical stimuli for a certain amount of time so as 
to allow the in vitro secretion of a bone-like extracellular matrix (ECM). This 
construct, which now possesses an osteoinductive nature due to the secreted ECM, is 
implanted in the defective site for bone regeneration. The main objective of the 
present research project was to create an integral tissue engineering approach that 
combines both mechanical and chemical stimulation by. To fulfill this goal, four 
major steps were successfully carried out. First, a dynamic scaffold seeding technique 
based on oscillatory flow perfusion that improved initial cellular distribution 
throughout the scaffold surface, and cell-matrix interactions was developed. Secondly, 
a biomimetic poly(L-lactic acid scaffold) with improved cell adhesion using RGD 
peptides that could additionally allow the evaluation of the effect of different 
modification levels on cell adhesion, proliferation and differentiation was created. 
Thirdly, the oscillatory flow perfusion seeding of these RGD-modified scaffolds was 
characterized. And lastly, the effect of the level of RGD scaffold modification on the 
osteoblastic differentiation of mesenchymal stem cells when cultured under 
xvi 
conditions of flow perfusion was evaluated. What makes this approach unique is the 
combination of mechanical and chemical stimulation of mesenchymal stem cells to 
direct them towards an osteoblastic path. This combinatorial approach resulted more 
successful than those based on chemical or mechanical stimulation alone. 
 
 
 
 
1 
Chapter 1 
 
Overview and Research Objectives 
 
 
Over the past two decades, bone tissue engineering has progressively emerged 
as a response to the current limited replacement therapies for damaged or lost bone 
tissue. Ideally, the implanted construct should aid in complete bone regeneration in a 
reasonably short time, without causing significant inconvenience to the patient. The 
optimum alternative would be the use of autografts, in which a bone biopsy is 
extracted from a healthy site of the patient and implanted into the injured site. 
Nevertheless, donor site morbidity and lack of graft availability pose major limitations 
on the application of this therapy. Other choices are allografts extracted from a 
different individual of the same species, and xenografts, which come from an 
individual of a different species. These last two therapies have shown a certain degree 
of success, but they may result in strong immune responses and disease transmission. 
1-3
 Tissue engineering creatively combines biology and engineering principles to 
create constructs capable of replacing damaged or lost tissue and overcoming the 
aforementioned obstacles 4. 
 
General tissue engineering approaches are based on three different bioactive 
factors: scaffolding, a cellular component, and a molecular component. These factors 
are closely conjoined to create successful constructs that can induce the efficient 
regeneration of the damaged tissue once implanted 4. In the case of bone, the 
scaffolding is usually a porous matrix that can support cell adhesion, migration and 
proliferation 5,6. Scaffolds are made out of natural or synthetic materials. Collagen, 
poly(ethylene glycol), ceramics, titanium and poly-α- hydroxyl esters are among 
2 
some of the most popular choices 7-11. A wide variety of cell types; but progenitor 
cells, such as mesenchymal stem cells (MSC) have grown in popularity and will 
continue to do so due to their great osteogenic potential 12-15. The molecular 
component consists of growth and differentiation factors, which are basically proteins 
or other molecules that are capable of eliciting specific cellular responses. In many 
instances growth factors are incorporated into scaffolding technologies to create a 
biomimetic scaffold. As the name suggests, biomimetic scaffolds are matrices 
designed to mimic a certain feature correspondent to the native extracellular matrix 
(ECM) and have the purpose of inducing a desired cellular response, such as the 
differentiation of MSCs towards the osteoblastic phenotype 16-21.  
 
All these components fit into a bone tissue engineering paradigm, on which 
this project is based, that includes the extraction of a cellular biopsy from a healthy 
site of the patient. Cells are then expanded in vitro and seeded onto the scaffold. The 
cell-scaffold construct is cultured for a certain amount of time so as to allow the in 
vitro secretion of a bone-like extracellular matrix (ECM). This construct, which now 
possesses an osteoinductive nature due to the secreted ECM, is implanted in the 
defective site for bone regeneration 4. Conditions of culture prior to implantation are 
crucial in the development of an efficient construct. Furthermore, researches have 
realized that mimicking the in vivo mechano-chemical conditions in which the tissue 
operates dramatically enhances the secretion and rearrangement of the ECM that more 
closely resembles the morphology of the native tissue 22-28. Bioreactors effectively 
modulate the desired mechanical conditions. Additionally, they enhance the 
transportation of nutrients to the interior of the scaffolds and yield homogenous 
distribution of cells and ECM 23,29. 
3 
 
This study ultimately focuses on a novel approach that employs both chemical 
and mechanical stimulation to enhance MSC osteogenesis. This innovative concept 
can therefore yield more efficient constructs than those produced through individual 
stimulation. Mechanical stimulation was exerted by the application of shear forces on 
the cells in a flow perfusion bioreactor that has been shown to induce higher degrees 
of MSC osteoblastic differentiation than those achieved by static cultures 23,30-32. 
Moreover, in order to amplify the effect of flow perfusion on the development of bone 
constructs, the system was not only used for long term cultures but also in scaffold 
seeding. Traditional static seeding techniques, in which the cell suspension is added in 
a drop-wise manner on top of the scaffolds, yield rather low number of cells on the 
scaffolds and poor cellular distributions throughout the scaffold surface. Flow 
perfusion is capable of overcoming external and internal diffusion limitations and 
thereby could potentially yield a more homogenous initial cellular distribution 23.  
 
Chemical stimulation was based on enhancing the cell interactions with the 
scaffolding material, poly (L- lactic acid) (PLLA). Cell-matrix interactions play an 
important role in bone tissue engineering since they affect the proper cell growth, 
migration and differentiation towards the osteoblastic phenotype 33-35. The interaction 
of cells with PLLA is very limited due to the inert nature of the polymer; thus, it is 
desired to incorporate bioactive molecules that support cell adhesion. This was done 
by the linkage of adhesion peptides, most specifically Arginine-Glycine-Aspartic 
Acid (RGD), to an amine-functionalized PLLA surface.  
 
4 
In the present project, it was hypothesized that the combination of this novel 
biomimetic scaffold with flow perfusion cultures would result in improved MSC 
osteoblastic differentiation, when compared to their sole effects. MSCs were seeded 
on the scaffold using the newly developed technique and cultured under mechano-
chemical conditions beneficial to their osteoblastic differentiation. Therefore, the 
main objective of the present research project (shown in Figure 1.1) was to create an 
integral tissue engineering approach that combines both mechanical and chemical 
stimulation by utilizing the three different bioactive components (scaffold, cells and 
growth factors).  
 
 
Figure 1.1. An integral bone tissue engineering approach that includes biomimetic scaffolds and 
bioreactor technologies to produce efficient constructs with a bone-like matrix secreted by 
mesenchymal stem cells. The biomimetic scaffold is produced by incorporating growth factors in the 
scaffold making process 
 
The proposed approach can result in enhanced MSC osteoblastic 
differentiation when compared to those achieved by the stimulatory mechanisms 
individually. In order to fulfill the main objective, four specific aims were proposed: 
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1) To develop a dynamic scaffold seeding technique based on oscillatory 
flow perfusion and evaluate its effects on seeding efficiency, initial 
cellular distribution throughout the scaffold surface, and cell-matrix 
interactions. 
2) To create a biomimetic poly(L-lactic acid scaffold) with improved cell 
adhesion using RGD peptides that can additionally allow the 
evaluation of the effect of different modification levels on cell 
adhesion, proliferation and differentiation.  
3) To characterize the newly developed oscillatory flow perfusion seeding 
of mesenchymal stem cells on the modified scaffolds based on cell 
spatial distribution, seeding efficiency and strength of cell attachment 
at different modification levels and flow conditions. 
4) To evaluate the effect of the level of RGD scaffold modification on the 
osteoblastic differentiation of mesenchymal stem cells when cultured 
under conditions of flow perfusion.  
 
In order to better understand the reasons behind the main objective of this 
project, Chapter 2 provides a more detailed background on bone tissue engineering, 
the bioactive components involved in it, and an overview on biomimetic scaffolds and 
bioreactor technologies. Chapter 3 describes the development of a new oscillatory 
flow perfusion seeding technique that resulted in improved seeding efficiency and 
distribution of osteoblastic cells onto fibrous matrices and porous foams. The creation 
of a functionally flexible, biomimetic scaffold with improved cell adhesion is 
presented in Chapter 4, while the characterization of the seeding of MSCs on these 
scaffolds is highlighted in Chapter 5. In Chapter 6, the effect of different extents of 
6 
RGD incorporation into PLLA foams on the osteogenic differentiation of MSCs under 
conditions of flow perfusion at different flow rates is presented. Finally, Chapter 7 
provides general conclusions addressing the general research objective and specific 
aims. This chapter also provides ideas for future projects that aim at answering new 
questions that arose during the development of the present project. 
7 
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Chapter 2 
Bone Tissue Engineering: An Introduction 
 
Chapter Abstract 
An increasing number of bone-related injuries has propelled the quest for 
finding efficient therapies, particularly in the cases where the body cannot regenerate 
the lost tissue by itself. Current techniques have limited success, driving researchers 
towards developing tissue engineering approaches. In bone tissue engineering, it is 
desirable to create an implant that can induce and conduct new tissue formation 
without compromising the mechanical and other functional properties of the tissue. 
The main bone tissue engineering components consist of a scaffolding material, 
osteoblastic and/or osteoprogenitor cells, and growth and differentiation factors. An 
interaction between these three elements is desired. A recent growing application is 
the use of bioreactors that can mimic the physiomechanical conditions in which the 
tissue operates. This chapter gives an insight into the main aspects of bone structure 
and function, the fundamentals of bone tissue engineering, as well as some of the 
common, existent technologies on tissue engineering scaffolds and bioreactor 
cultures. 
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2.1 Overview of Bone 
Bone, the major component of the skeletal system, is a hard, calcified, 
connective tissue that protects vital organs, provides support for body motion, and 
serves as storage of calcium and other ions. Bone is viscoelastic, porous and semi 
rigid. The major components of this tissue are: cells, extracellular matrix, and an 
inorganic mineral phase, with weight percentages of about 8%, 25% and 67% 
respectively 1,2. 
 
2.1.1. Cellular component 
The most relevant cell types related to bone formation and modeling are the 
osteoblasts, osteocytes and osteoclasts. Osteoblasts and osteocytes are responsible for 
the bone-making process and reside along with the bone-lining cells, which are 
immediate osteoblast precursors 3,4. Osteoblasts also derive from local pluripotent 
progenitor cells, such as mesenchymal stem cells (MSC). In their last stage of 
differentiation, osteoblasts synthesize alkaline phosphatase, and secrete calcium and 
other extracellular matrix proteins, such as osteopontin, osteocalcin, and bone 
sialoprotein 3. Once they have secreted sufficient calcified ECM, osteoblasts are 
entrapped and become osteocytes. They communicate among themselves and other 
cells on the bone surface through gap-junction-coupled cell processes that take place 
in the extracellular matrix via channels called canaliculi 5-7. However, bone is a 
dynamic tissue that is undergoing a constant process of remodeling; thus, as there is a 
process of bone formation, a process of bone digestion must also exist in order to 
maintain the integrity of the tissue. The resorption of bone matrix is carried out by 
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osteoclasts, which are multinucleated cells of hematopoietic origin formed by the 
fusion of mononucleated cells of the monocyte/macrophage family 5,8. 
 
2.1.2. Organic extracellular matrix (ECM)  
The extracellular matrix of bone is mainly composed of approximately 90% 
collagen type I, and a series of non-collagenous proteins and proteoglycans in smaller 
quantities 5. It is important to point out that osteoblasts secrete, on a mole basis, one 
non-collagenous protein molecule per one collagen molecule, and that the difference 
in quantity is due mainly to molecular weights 8,9. Collagen fibers in bone present 
many intra and intermolecular crosslinks, diminishing their solubility. Their structure 
and degree of crosslinking affect the strength and general function of bone. Some of 
the non-collagenous molecules found in bone ECM are osteopontin, osteonectin, 
glycosaminoglycans (chondroitin sulfate, dermatan sulfate, keratan sulfate, and 
hyaluronic acid), fibronectin, and some growth factors from the morphogenetic 
protein (BMP) family entrapped in the matrix during bone formation 5,8-10.  
 
2.1.3. Mineral phase 
The mineral phase of bone is based on calcium compounds. This is the main 
feature that differentiates the composition of bone from that of other musculoskeletal 
tissues and is a major player in bone strength. The mineral component of bone is 
comprised of a crystalline analog of hydroxyapatite [Ca10(PO4)6(OH)2]. This structure 
is often called dahllite. It is deficient in calcium and less crystalline when compared to 
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hydroxyapatite, in addition to containing carbonate 5. The mineral crystals are 
arranged in a parallel fashion within the bone collagenous matrix and appear as plate-
shaped crystals that are hundreds of angstroms in length and 20-30 angstroms thick 
1,2,5,8
. 
 
2.1.4. Bone structure 
Macroscopically, there are different types of bone in the skeleton and different 
ways to classify them. The macroscopic classification of bone can be based on its 
function; it can be weight bearing, protecting, articulating, etc. Another categorization 
is based on the shape, long, short or flat. The most used macroscopic cataloguing of 
bone is based on its mechanism of formation: endochondral bone formation or 
intramembraneous ossification. 
 
However, in long bones there are two different types of tissue: cortical or 
compact bone, found mostly in the diaphyses, and cancellous or trabecular (also 
called spongy bone) found mainly in the metaphyses and epiphyses (see Figure 2.1). 
Cancellous bone is spongy in appearance, formed by thin trabeculae and arranged in a 
3D lattice, and is located in the extremities of the bone. Cortical bone, on the other 
hand, is a compact, continuous mass usually located at the cortices of mature bone. 
Thus, the main difference between cancellous and trabecular bone is their porosity. 
The diaphysis of a long bone can withstand bending and torsional loads imposed on 
its shaft due to its tubular design, basically a thick cylinder with bone marrow in the 
cavity. The metaphysis and epiphysis however, are designed to withstand mostly 
compression forces 5,11-13. 
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Figure 2.1. Macroscopic bone structure. The different areas of a long femur are shown, as well as the 
different types of bone in each area: cancellous or spongy, and cortical or compact 14.  
 
 On a microscopic level, there are two different types of bone: woven and 
lamellar. Woven bone is generally immature tissue that is generated for rapid bone 
formation such as in the repair of fractures and other injuries. Collagen fibers are 
arranged in a random fashion and give the tissue an isotropic behavior. Lamellar bone 
presents a more organized structure that consists of parallel sheets and bundles1,5.  
 Cortical bone is made up in two thirds by osteons and the remaining is 
composed of interstitial bone derived from previous generations of osteons. Osteons 
are branching cylindrical columns with a diameter in the order of 150 µm and a 
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central vasculature canal called the Harvesian canal 11. These canals connect with one 
another and with the marrow cavity via Volkmann’s canals whose blood vessels are in 
fact larger than those of the Harvesian canal. In lamellar bone, osteons are oriented in 
a parallel fashion along the axis of the tubular bone section. They are surrounded by a 
cement line that is a region of reduced mineral and collagen content. Osteons of 
woven bone have a different shape, a more random orientation and are bound to the 
bone marrow on one side and an irregular cement line on the other side 11,15,16. 
 
2.1.5. Mechanisms of bone formation 
After injury, bone can be replaced through two distinct mechanisms of bone 
formation (osteogenesis): intramembranous ossification and endochondral 
ossification. Intramembranous ossification is the process in which precursor cells, 
mesenchymal stem cells (MSC), differentiate directly into osteoblasts and begin 
secreting bone matrix. What appears as thin and disorganized trabeculae soon 
mineralizes, entrapping osteoblasts to form osteocytes. MSCs continue to differentiate 
to form woven bone. This woven bone also has the potential to become a primitive 
cortical bone if the mineral matrix grows at the expense of connective tissue. 
Intramembranous ossification is commonly found in the regeneration of certain bones 
of the skull 1,15,17,18. 
 Endochondral ossification represents a different mechanism from that of the 
intramembranous. As the name suggests this process starts by the deposition of a 
primitive cartilaginous tissue. Endochondral ossification usually takes place when 
there is a need for rapid growth. When the neocartilage is formed, new cells can be 
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easily incorporated into the tissue, expanding both its volume and length rapidly. This 
mechanism is also observed in embryonic bone formation, where an avascular 
cartilaginous model is created with the shape of the bone. Ossification follows with 
three processes occurring simultaneously 11,18,19: 
1. Formation of a collagen type I rich osteon outside the cartilage core, 
which later mineralizes to create a periosteal collar 
2. Hypertrophy of chondrocytes in the center with enlargement of their 
lacunae and calcification of the remaining tissue 
3. The cartilage core is penetrated by new blood vessels coming from the 
periosteum, bringing along hematopoietic and osteoprogenitor cells 
that eventually calcify the entire cartilage volume 
Once the bone is formed, it undergoes a process of modeling and remodeling 
by which the skeleton is continuously renewed so as to maintain its mechanical 
properties, prevent the accumulation of fatigue, and minimize micro fractures, among 
other things. Remodeling is a surface process that begins by osteoclastic resorption of 
the existing organic and mineral components, forming a cavity. After reaching a 
certain depth, osteoclast activity ceases and they are replaced by macrophage-like 
cells that deposit an early, immature tissue. Osteoblasts later start forming a new 
osteon within the cavity 1,11,16,20.  
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2.2 The need for bone tissue engineering 
Every year there are more than 8.6 million procedures related to bone injury 
worldwide, a great portion of these require the use of an implant in order to recuperate 
bone functionally in the affected area. In 2001, expenditures related to bone implants 
surpassed $1 billion 21. Cases where implants are necessary are usually related to the 
destruction of a large portion of the bone, infections, or in any other circumstance 
where the body can not regenerate the damaged osseous tissue, causing the disability 
of the patient. This type of therapy is needed in any part of the skeleton; however, 
usually the most affected areas are long bones, spinal cord, and maxillofacial bones. 
The estimated expenditures due to bone grafts needed for these surgeries is about 
$500 million with over 605,000 procedures a year in the United States alone 21,22. 
Traditional tissue replacement therapies consist of implants made out of 
synthetic materials such as titanium and ceramics that can meet the mechanical 
demands of the injury site, enabling temporal recovery of the functionality. 
Nonetheless, these implants, which to a certain degree are successful in reestablishing 
functionality, generally exert considerable stress on the surrounding tissue resulting in 
significant wear over time 23-26. Thus, further surgeries on a regular basis become 
necessary, increasing not only the cost of the therapy but also the patient’s discomfort. 
The use of constructs that can interact with the body, induce the formation of new 
tissue and be fully incorporated is the most desirable solution to this problem. Natural 
grafts would be ideal for this application because they possess part of the chemical 
and mechanical environment necessary for the optimal performance of the tissue. 
There are different kinds of natural grafts used to regenerate tissue in vivo 27-31. 
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 Autografts: in this therapy, a piece of tissue is harvested from a healthy site 
of the same patient’s skeleton and implanted at the area of injury. This therapy does 
not pose any problems of host acceptance; nevertheless, the surgical procedure would 
be considerably invasive and painful for the patient and morbidity of the site of 
harvesting is a major concern. Additionally, the amount of harvested tissue is limited 
and thereby off-the-shelf availability is very challenging 28,29,32,33.  
 Allografts: these grafts are harvested from another individual of the same 
species, usually a cadaver. The limitations in terms of the amount of tissue being 
harvested still remain, and host acceptance may arise, causing undesired immune 
reactions and potential disease transmission 29,34. 
 Xenografts: these grafts are harvested from a member of a different species. 
For human tissue regeneration, this therapy mitigates the problems of availability 
encountered with the autografts and allografts. Nevertheless, in addition to the risk of 
a strong immune reaction, there exists a great possibility of transmission of animal 
viruses 30,35. 
All the limitations encountered with these different technologies have led 
researchers to the development of new approaches based on the combination of 
different bioactive components. The goal of tissue engineering is then to create 
artificial constructs that induce the formation of new tissue at the site of injury by 
activating a cascade of events related to wound healing and the process bone 
formation. Tissue engineering is based on the principle that new tissue formation can 
be guided through the use of cells, biomaterials and bioactive molecules 36. 
Ultimately, recovery of total functionality is the ultimate goal of this field. The most 
common strategy employed in tissue engineering consists on the extraction of a 
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biopsy of autologous tissue without compromising the functionality of the harvesting 
site (Figure 2.2). Cells extracted from this piece of tissue are then cultured and 
expanded in a three dimensional scaffold that supports their growth and 
differentiation 36. Furthermore, the in vitro creation of an efficient construct can be 
accelerated by applying certain stimuli, chemical or mechanical, that can elicit 
specific responses to the cells.  
 
Culture in 
3D scaffold
Chemical and/or mechanical 
stimulation (bioreactor)
Cell harvesting
from Patient
Tissue
Regeneration
and Transplantation
Culture on
3D scaffold
 
Figure 2.2. The tissue engineering paradigm. Cells are harvested from the patient for expansion in a 
three dimensional scaffold; they are later mechanically stimulated in a bioreactor for implantation and 
regeneration of the damaged or lost tissue 37 
 
2.3. Cell Source for Bone Tissue Engineering 
The type of cells utilized in a specific tissue engineering application is of 
extreme importance. Cells cultured in vitro will generate an initial, immature tissue by 
depositing an extracellular matrix (ECM) rich in tissue-specific proteins and growth 
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factors. These cells will strongly interact with the scaffolding material and respond to 
any environmental stimulus both in vitro and early after implantation in the body. 
Consequently, choosing the right cell type will affect the development of the in vitro 
culture and the efficient tissue regeneration both early and later after implantation. 
One of the first cell-based approaches for bone tissue engineering was the use of 
fresh, unfractioned bone marrow, which is rich on osteogenic precursors 38-40. The 
bone marrow is usually extracted from a healthy site of the patient, i.e. the iliac crest, 
and implanted in the defect site thereby preventing immune rejection. However, the 
greatest limitation to this approach is the lack of availability of sufficient marrow 
aspirate for transplantation 41. Stem cells, such as mesenchymal stem cells (MSC), are 
pluripotent cells found in the bone marrow. They have the potential for differentiation 
into different lineages (Figure 2.3) in addition to the ability of being cultured and 
greatly expanded in vitro without differentiation and without loosing the potential for 
differentiation. Their potential for clinical application has been shown in different in 
vivo studies, where regeneration of bone has been observed 42-46.  
 
Figure 2.3. Differentiation potential of adult bone marrow mesenchymal stem cells. Several steps are 
involved in the mesengenic process as stem cells differentiate into tissue specific cells 47. 
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Specific stem cell differentiation can be achieved through the use of growth 
and differentiation factors or by the application of certain mechanical stimuli that will 
be discussed later in this chapter 16,48-52. MSC harvested from the bone marrow can be 
differentiated into the osteoblastic lineage by being cultured in the presence of β-
glycerophosphate, dexamethasone and ascorbic acid 48. When cultured under these 
conditions, MSCs undergo a cascade of morphological and functional changes that 
lead up to their transformation into osteoblasts. Usually, MSC which are fibroblastic 
in appearance, assume a cuboidal shape and tend to form communities that will 
eventually form hydroxyapatite- mineralized nodules late in the differentiation 
cascade. Other events that take place during osteogenic differentiation include the 
transient up-regulation of alkaline phosphatase (AP) activity, while at the late states 
collagen type I is down-regulated, and the production of ECM proteins such as 
osteopontin, osteocalcin and bone sialoprotein are up-regulated 47,48,53. 
 
2.4. Scaffold Technologies in Bone Tissue Engineering 
The biochemical and physical interactions of the cells with the scaffold are of 
crucial importance in the process of tissue regeneration. The deposition of 
extracellular matrix by the osteoblastic cells on the surface of the scaffolds improves 
the osteoinductive potential of the construct once implanted in vivo. Thus, strong cell-
matrix interactions between the cultured cells and the scaffold will result in greater 
expression of extracellular matrix components. The scaffold has to thereby support 
the adhesion of the cells, as wells as their growth, migration and differentiation 
towards a specific phenotype, in this case, osteoblasts 54,55. 
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Certain mechanical and morphological requirements must be met by the 
scaffold in order to achieve a more efficient regeneration process 56. The scaffolding 
material needs to have mechanical properties that can meet the demands of the defect 
site, especially when the injury occurs in a load-bearing zone. Sufficient porosity, an 
optimum pore size and pore interconnectivity are necessary for the nutrition of the 
cells. It is important to achieve the formation of neotissue and a vascular network that 
will guarantee the survival of the newly formed tissue. Ideally, the scaffold should be 
biodegradable so as to permit further formation of tissue as it degrades. However, this 
process needs to occur without compromising the mechanical demands at the site of 
implantation. 29,56-58  
Scaffolds for tissue engineering have been created using a wide variety of 
techniques and materials, both synthetic and natural. Collagen is the most widely used 
material for the creation of scaffolds in numerous tissue engineering applications 
ranging from cardiovascular tissue to bone 59-68. Other important natural materials 
include glycosaminoglycans, which are traditionally used for cartilage reconstruction; 
however, crosslinked heparin and hyaluronic acid have been found to support the 
deposition of mineral matrix 69-73. Some popular choices for synthetic materials 
include ceramics, metals such as titanium, poly-ethylene glycol and biodegradable 
polymers 74,75. Poly(α-hydroxy esters) are widely used biodegradable polymers for 
bone and other tissue engineering therapies due to their well known degradation 
characteristics and the fact that they are approved by the Food and Drug 
Administration, particularly poly(lactic acid), poly(glycolic acid) and their 
copolymers. Both types of materials present advantages and disadvantages. Generally 
being part of the ECMs of different tissues, natural materials can be chosen to possess 
the right chemical composition to allow strong cell-matrix interactions and thereby 
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provide the appropriate environment for the cells to attach, migrate and proliferate. 
Nonetheless, most of these materials present poor mechanical properties, posing a 
limitation for the regeneration of certain tissues such as bone in load bearing zones. 
Greater mechanical properties can be acquired through the right modulation of 
synthetic materials in terms of their chemistries and morphologies. The disadvantage 
of synthetic materials is often due to the lack of functional groups that the cells are 
known to interact with.  
Scaffolds for tissue engineering can be injectable or preformed. Injectable 
materials are in situ polymerizable and generally come in the form of hydrogels and 
ceramic pastes, which can be made of different synthetic and natural materials. 
Poly(ethylene glycol) and modifications of it are some of the most widely used 
hydrogels. Injectable scaffolds are able to fit injuries with odd shapes and they also 
require implantation procedures with a minimal level of invasiveness 76,77. They also 
have drawbacks such as potentially poor mechanical properties and inability to work 
for large defects, but most importantly, they may result in high levels of cytotoxicity 
negatively affecting the surrounding tissue. Preformed scaffolds, as the name 
suggests, are scaffolds formed in vitro prior to implantation. Many different 
techniques have been used to create them: fiber bonding, solvent-casting, particulate 
leaching, micro-printing, melt molding, etc 78-83. All these techniques are capable of 
producing porous scaffolds that can sustain cell attachment and growth, and provide 
open spaces for nutrient transport. Most of these scaffolds minimize risks of 
cytotoxicity and have better mechanical properties than preformed scaffolds, but their 
implantation can be rather invasive. 
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Most biodegradable polymers used in preformed scaffolds are able to support 
cell adhesion and growth to a certain extent, yet they possess a hydrophobic and inert 
nature that limits cell-matrix interactions 84. Consequently, the creation of a construct 
that can mimic the in vivo molecular environment and enhance cell-matrix 
interactions is imperative in the process of creating efficient constructs 60,85. The 
development of these biomimetic scaffolds involves the bulk or surface modification 
of the base biomaterial with growth and differentiation factors that can improve cell 
attachment, proliferation, and migration, as well as eliciting other specific cellular 
responses and biological signals to the surrounding extra cellular matrix (ECM) of the 
tissue in vivo such as development of angiogenesis 36,60. 
The most common way to modify biodegradable polymers is by chemically 
grafting them with a bioactive molecule 60,86-88. Shan-hui H et al improved cell 
attachment by cross linking poly (lactic-co glycolic acid) (PLGA) with collagen type 
II 89. Cook et al also increased the number of cells attached to the surface and 
improved cell spreading by covalently attaching arginine-glycine-aspartic acid (RGD) 
peptides to PLGA 90.  
Physisorption is another technique that has been utilized for surface 
modification of tissue engineering scaffolds 91,92. Yang et al induced adsorption 
poly(L-lysine)-GRGDS conjugates to the surface of poly(L-lactic acid) (PLLA) films 
and porous scaffolds, affecting the osteoblasts’ response not only in terms of cell 
adhesion but also on differentiation and the long term deposition of extracellular 
matrix 88. However, this methodology poses the risk of desorbing the incorporated 
bioactive molecules. Cui et al entrapped gelatin in the surface of PLLA films and 
enhanced the attachment of chondrocytes, overcoming, at the same time, the problem 
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of desorption of the bioactive molecule 93. In our studies we have used partial 
dissolution and entrapment of bioactive molecules for the creation of biomimetic 
scaffolds that can be further functionalized for specific applications. 
 
2.5. Bioreactors in Bone Tissue Engineering 
A bioreactor is described as a simulator, a device in which biological and/or 
biochemical processes can be carried out 57. In tissue engineering, bioreactors are used 
to impart certain forces that imitate different mechanical stimuli that simulate those 
occurring in the body. However, these devices are not limited to the sole application 
of mechanical stimuli; they must meet other requirements in order to create grafts 
that, when implanted, will lead to the regeneration of damaged organs. A bioreactor 
must efficiently transport nutrients and oxygen to the construct, maintaining an 
appropriate concentration in solution. In most tissue engineering applications, a 
scaffold is seeded with cells that supports the formation of extracellular matrix 
(ECM). Consequently, the bioreactor has to induce a homogeneous cell distribution 
throughout these structures in order to generate a uniformly distributed ECM. Tissue 
engineering bioreactors can be used for cell seeding and/or long term cultures. 
 
2.5.1. Common Bioreactors Designs in Tissue Engineering 
The choice of a bioreactor to cultivate three dimensional constructs depends 
upon the tissue to be engineered and its functional biomechanical environment. 
Emulation of physiological conditions is the main objective when developing these 
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kinds of systems, and this issue has been addressed in different ways. The 
incorporation of convective forces has become a common characteristic among most 
bioreactors. Some bioreactors that meet some these characteristics and are often used 
in many different applications are: 
Spinner Flask: The spinner flask (Figure 2.4b) represents one of the simplest 
bioreactor models. It was first designed with the idea to use convection in order to 
maintain a well mixed system. The scaffolds are threaded into needles connected to 
the cover of the flask, and submerged in the culture medium. Convection is generated 
through the usage of a magnetic stir bar or a shaft that continuously mixes the media 
surrounding the scaffolds, providing a practically homogenous distribution of oxygen 
and nutrients 52,94. The fluid dynamic environment at the external surface of the 
scaffolds is turbulent and characterized by the existence of eddies that may enhance 
the transport of nutrients into the porosity, and locally expose cells residing at the 
exterior of the construct to relatively high shear forces. The magnitude of the shear 
stresses can vary significantly between different locations; therefore, not all the cells 
are exposed to the same shear stresses. The presence of convective forces external to 
the scaffolds may not suppress concentration gradients appearing deep inside large 
three dimensional constructs, where diffusion is the controlling mechanism of nutrient 
transport 95,96. 
Rotating-Wall Vessels: Initially designed by NASA as a microgravity 
environment for cell culture, the rotating wall bioreactor (Figure 2.4c) is now widely 
used in the formation of engineered bone, cartilage, and other tissues 52,94,97,98. This 
device consists of two concentric cylinders whose annular space contains the cell 
culture medium 99. The inner cylinder is static and permeable to allow gas exchange 
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for oxygen supply. The outer cylinder, on the other hand, is impermeable and 
horizontally rotates at a speed that causes centrifugal forces that can balance, if tuned 
properly, the gravitational forces; thus, generating a pseudo microgravity environment 
52,99,100
. Unlike the spinner flask, in the rotating wall vessel the fluid flow is mostly 
laminar and the range of shear forces experienced by the cells at the outer surface is 
relatively narrow, with the existence of a stagnation zone at the upstream edge. As 
reported by Williams et al, shear stresses decrease in the direction of flow, and no 
significant variations from scaffold to scaffold are observed 101. Medium can be 
recirculated between the annular space and an external gas membrane. A modification 
of the original design, called rotating-wall perfused-vessel bioreactor, includes the 
rotation of the inner cylinder. In this model, media is perfused from the vessel’s end 
cap to the pores of the inner cylinder 100.  
 
(b)
(a)
(e)
(c) (d)
 
Figure 2.4. Common bioreactors used in tissue engineering. (a) Static culture (b) Spinner flask (c) 
Rotating wall (d) Perfusion system (e) Perfused column 37 
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Perfusion Chambers and Flow Perfusion Systems: Flow perfusion 
bioreactors provide continuous flow through chambers where the scaffolds are 
located. The perfusion column (Figure 2.4e) was one of the first designs of this kind 
of bioreactors. Culture medium is continuously recirculated through the chamber, thus 
improving the transport of nutrients and oxygen to the constructs 62,102,103. 
Nevertheless, the flow of medium in these chambers is distributed between the inner 
network of the construct and its surroundings, minimizing convective flow through 
the scaffold 79,104,105. To ensure that the flow of medium occurs exclusively through 
the porosity of the material, new designs of flow perfusion bioreactors include the 
confining of the construct in chambers (figure 2.4d). In this way, a more controllable 
flow is achieved and nutrient transport limitations are virtually eliminated. Internal 
flow can also expose the cells inside the scaffold to fluid shear forces that have been 
known to be stimulatory for some cell types such as osteoblasts and endothelial cells 
51,105,106
. A standard design of this kind of reactors does not exist, but all of them are 
based on the same principle. A more detailed description of a perfusion system will be 
given later in this chapter. 
 
2.5.2. Cell Seeding in Bioreactors 
The first step to culturing cells in a three dimensional environment is the 
seeding of scaffolds 107. Along with the characteristics of the material, this process 
plays a crucial role in the development of efficient constructs for tissue engineering. 
Seeding of scaffolds determines the initial number of cells in the construct, as well as 
their spatial distribution throughout the matrix. Consequently, proliferation, migration 
and the specific phenotypic expression of the engineered tissue will be affected by the 
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seeding technique utilized 102. In the case of tissues that require a fibrous or porous 
material, static seeding has been the most widely used method of cell seeding (see 
Figure 2.4a).  Burg et al., compared different seeding techniques using rat aortic cells 
in poly(glycolide) fibrous meshes. Static seeding produced the poorest cellular 
distribution 108. In addition to preventing a homogeneous spatial distribution of the 
cells, static seeding also produces a low yield 57,108.  Holy et al., reported a 25% 
efficiency of attac hment after seeding 0.5 to 10x106 cells on porous PLGA 75/25 
scaffolds 57. A low yield diminishes the development of specific functions related to 
cell-cell interactions and increases the amount of cells necessary; therefore, the usage 
of new seeding techniques becomes imperative. 
 
In order to address these issues, researchers have incorporated convection into 
the process of cell seeding, suppressing some of the mass transfer limitations 
encountered in the static procedure. Spinner flask bioreactors (figure 2b) have been 
implemented to create convection and, thereby, hydrodynamic forces that could help 
increase mass transport. Poly(glycolic acid) (PGA) scaffolds were threaded onto 
needles, and chondrocytes suspensions with a total number of cells between 2x106 
and 10x106 were used. A yield of 60% was obtained after 2 hours of seeding. A more 
uniform distribution of the cells in the scaffold was seen (compared to the static 
seeding); nonetheless, the concentration of cells in the outer layer of the construct was 
60-70% higher than that in the bulk 109. This behavior may be due to the poor 
convection to the interior of the scaffold, making migration the only way for cells to 
reach the interior of the scaffold. 
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It has been reported that, in the spinner flask, the shear forces at the external 
surface of the scaffold are highly non-uniform. Such variability may influence the 
homogeneity of the seeded cells even when considering only the external surface area 
96
. However, despite the high efficiency of seeding achieved with the spinner-flask 
bioreactor, a more homogeneous distribution of the cells throughout the construct 
volume is still desired. 
 
One way to guarantee mass transfer to the interior of the scaffold and a better 
distribution of cells is by applying perfusion 79,108,110. In this technique, the construct 
is press fitted into a chamber, and the cell suspension is flowed through it (figure 2c). 
Li et al., used a depth filtration system to seed poly(ethylene terephthalate) matrices at 
a rate of 1ml/min. The cell suspension was recycled to increase the yield. Cell density 
increased along with the inoculation cell number, with an efficiency of about 65%, 
while with the static seeding, the yield stayed constant and lower than that achieved 
with perfusion 102. Similarly, Kim et al seeded hepatocytes on polymeric matrices 
using a flow perfusion system. A suspension of rat hepatocytes at a density of 5x106 
cells/ml was pumped through bone matrices at a flow rate of 1.5 ml/min for 4 h. A 
total of approximately 4.4x106 cells were attached to the matrix, which was 
considered successful. Furthermore, scanning electron microscopy and histology 
confirmed a uniform distribution of hepatocytes throughout the scaffold. 
Wendt et al., monitored seeding efficiency and uniformity of static, spinner 
flask and perfusion systems 110. Using the same inoculation concentrations, there was 
not statistical significance among the efficiencies of the static and perfused 
techniques, both producing a larger yield than the spinner flask. Uniformity, however, 
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was optimized by the perfusion apparatus, while the static and the spinner flask 
generated cell-scaffold constructs with low spatial uniformity 110.  
 
2.5.3. Development of Bone-Like Extracellular Matrix in Bioreactor Systems 
Bone is a hard connective tissue that provides mechanical support to the 
human body and is a frame for locomotion. Bone grafts have been generated under a 
wide variety of culturing conditions, including static and dynamic systems. Among 
the most popular dynamic systems are spinner flasks, rotating wall vessels and 
perfusion systems 106,109,111. Like for every tissue engineering approach, before 
deciding upon the kind of bioreactor to be used, considerations concerning the carrier 
matrix, cells (osteoblasts, mesenchymal stem cells, etc.) and growth factors must be 
taken into account. In the case of bone, the matrix to be used must be 
osteoconductive, provide mechanical support, deliver cells and allow their attachment, 
growth, migration and osteoblastic differentiation. Synthetic and natural polymers 
have been implemented. Among the synthetic polymers poly(α-hydroxy esters), 
poly(ε-caprolactone), poly(propylene fumarate), poly(sebacic acid) and their 
copolymers have been widely used. Materials such as ceramics and titanium have 
been also used for bone replacement 74,75. Cell number and calcium deposition are 
good markers to evaluate the evolution of bone matrix. Furthermore, alkaline 
phosphatase activity (ALP) is used to assess early differentiation activity of 
osteoblastic cells. Production of extracellular matrix proteins such as osteocalcin, 
osteopontin and bone sialoprotein is also taken into consideration 112.  
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As mentioned earlier, static culture was one the first attempts to produce bone 
matrix. Ishaug et al., seeded marrow stromal cells on top of poly (DL-lactic-co-
glycolic acid) foams of different pore sizes at different densities. Cell proliferation 
was supported by the scaffold, and high level of ALP activity and calcium matrix 
deposition were observed. It was found that the depth of mineralized tissue increased 
over time, but the maximum penetration was only around 240µm, resulting in a non 
homogeneous cell and matrix distribution 84.  
Improvement in the development of bone matrix in vitro has been achieved 
with the addition of convection in the in vitro culture stage, which ultimately 
translates in a better transport of nutrients and gases. After statically seeding 1x106 
marrow stromal  cells on PLGA scaffolds, Sikavitsas et al., cultured these constructs 
under three different conditions: statically, in a spinner flask and in a rotating-wall 
vessel 52. The culture was carried out for 21 days, and samples were analyzed at 7, 14 
and 21 days. Scaffolds cultured in the spinner flask bioreactor showed the largest 
number of cells at all time points, followed by the static culture. At the end of the 
culture period, constructs in the spinner flask presented higher calcium contents than 
those encountered in the static and rotating wall vessel 52. 
Shea et al., also utilized a spinner flask to culture poly(lactic acid) foams 
seeded with MC3T3-E1 pre-osteoblasts and evaluated their differentiation 59. Cells 
were seeded statically and cultured for 12 weeks. Proliferation was observed over 
time; however, their distribution throughout the scaffold lacked homogeneity. Cells 
were densely located only at a thin layer of 200µm near the scaffold’s surface. The 
density dramatically decreased deeper into the construct. The same behavior was seen 
for the formation of extracellular matrix and calcium deposition. 
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It has been shown that mechanical stimulation augments the production of 
alkaline phosphatase, osteoblast proliferation, and mineral deposition in osteoblastic 
cells seeded on different scaffolding materials 113. Osteoblastic cells have been shown 
to be responsive to shear stress induced by fluid flow. The stimulatory effect of shear 
stresses has shown to induce an increase in the release of important regulatory factors 
such as nitric oxide and prostaglandin E2 16,114. Interestingly, osteoblasts have been 
found to be more responsive to fluid shear forces than mechanical strain 115. A 
question arises then, what is the physiological relevance of the stimulatory effect of 
fluid flow on bone cells? It has been hypothesized that mechanical strains on bone 
tissue cause fluid flow in the lacunar-canalicular porosity of bone 116-118. 
Consequently, the incorporation of fluid flow through the porous network is desired in 
order to stimulate a faster and more efficient formation of bone matrix. This goal has 
been reached with the implementation of flow perfusion bioreactors 92,106,119.  
Bancroft et al., developed a perfusion system (figure 2.4) where medium is 
pumped through the scaffold, thereby maintaining mechanical stimulation and 
transport of nutrients through the pores 94. The scaffolds are tightly fit into cassettes in 
order to ensure fluid flow exclusively through the porous network. Constructs are 
later placed in flow chambers that are capped and secured with o-rings to restrict the 
flow around them (figure 2.5a). The medium is pumped from a flask to the top of the 
chamber and sent to another reservoir from the bottom. This direction of flow helps 
avoiding the entrance of air bubbles into the flow chamber. Both flasks are connected 
so that the medium is in continuous recirculation. The main body of the reactor 
consists of a total of six chambers and is made out of Plexiglas to allow the 
visualization and monitoring of the flow inside the chambers. Each chamber 
corresponds to an independent circuit using one of the heads of a peristaltic pump that 
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produces flow rates from 0.1 to 10 ml/min (Figure 2.5b). The tubing permits the 
exchange of carbon dioxide and oxygen with the atmosphere in the incubator. A 
complete change of medium can be done due to the two-reservoir set up 51,104. 
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Figure 2.5. Schematics of a flow perfusion bioreactor (a) Close up of the perfusion chamber where the 
scaffold is press fitted (b) Lateral view of the main body of the bioreactor (c) Schematics of the system 
 
To study how the shear rate affects the growth of bone matrix in vitro, 
Bancroft et al., varied the flow rate when culturing titanium fiber meshes seeded with 
rat marrow stromal cells for 16 days 51,105. Controls had been cultured under static 
conditions, and the flow rates used in the perfusion culture were 0.3, 1.0 and 3.0 
ml/min. It was found that the deposition of calcium was greatly increased in the flow 
perfusion culture as compared with the static conditions. It was also observed that 
increased medium flow improves the distribution of extracellular matrix throughout 
the construct volume 51,105.  The increased calcium deposition could have been due to 
the increased shear forces or increased chemotransport in the porosity of the scaffolds 
when higher flow rates were employed. To isolate the effects of shear forces from the 
mass transport effects, the shear forces were changed by varying the viscosity of the 
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culture medium under constant flow rate 51. An increase in viscosity, which translates 
into greater shear forces, was found to enhance the deposition of mineral matrix and 
the ECM distribution throughout the construct, demonstrating the importance of fluid 
flow induced shear forces on the creation of bone tissue-engineered grafts. 
Mainel et al., cultured human mesenchymal stem cells on silk scaffolds for 
five weeks in a flow perfusion chamber (at 0.2 ml/min) and a spinner flask. Scaffolds 
cultured under flow perfusion showed a more homogenous distribution of the 
mineralized matrix throughout the construct although those cultured in the spinner 
flask produced a greater amount of deposited calcium 119. 
The use of flow perfusion greatly enhances the formation of bone matrix, 
activating mechanisms related to the differentiation of osteoblastic cells. Great 
challenges are still encountered however. What are the actual mechanisms that 
transduce the external shear forces and influence the cellular behavior? Currently, 
only estimates of the shear rates at the interior of three dimensional scaffolds have 
been provided, and detailed mathematical modeling needs to be conducted. Using 
larger scaffolds can represent another problem; is it possible to achieve a completely 
homogeneous distribution of matrix in larger constructs? What would be the 
necessary culturing conditions to achieve this? And how long and under what 
conditions must the cells be pre-cultured prior to the application of mechanical forces 
to avoid their detachment? By answering these questions, the field of tissue 
engineering could be enriched and take a more feasible route towards achieving 
practical applications.  
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In bone tissue, cells experience a degree of shear stress due to interstitial fluid 
flow. The shear stress was estimated by Weinbaum et al assuming peak physiological 
loading regimes, with values of 8-30 dynes/cm2. This effect is mimicked in the flow 
perfusion bioreactor; therefore, it is important to estimate the values of average shear 
stresses experienced by the cells due to perfused flow.120 
 
The mechanotransduction mechanisms by which the activity of bone cells is 
increased are still being investigated. However, it has been shown that different 
osteoblast and osteocytes receptors, such as integrins and CD44, that are located on 
their membrane, are stimulated by shear forces and convert the mechanical stimuli 
into different intracellular signaling pathways. Prostaglandins have also been shown 
to be involved in osteoblastic behavior in the presence of shear stress. Moreover, 
nitric oxide (NO) production increases in the presence fluid flow. NO is a mediator of 
many intracellular processes, and it is suggested that it maybe one of the major 
mediators of the response of osteoblasts to stress.6 
 
The characterization of shear forces on the surface of tissue engineering 
scaffolds in the presence of perfusion has proven very challenging. Scaffolds 
generally possess non-uniform pore distribution. In the present work, the scaffolds 
used were prepared through two different techniques:  
1. Porous foams by particulate leaching 
2. Fibrous matrices by melt blowing 
 
In the first case, foams made by particulate leaching, the pores represent a 
tortuous path with very irregular structures generated by the initial presence of sodium 
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chloride crystals (refer to Chapter 3 for more details on slat leaching). Thus, the 
estimation of shear stresses at different points of the scaffold’s surface can be made 
by three dimensional computational modeling, usually based on the Lattice-Boltzman 
method. For the fibrous matrices prepared by melt blowing, the scenario is very 
similar since the fibers are randomly oriented.121,122  
 
In the field of tissue engineering, the need for characterizing the distribution of 
shear stresses throughout the scaffold has been recognized. This analysis would allow 
for a detailed study of cell-matrix interactions due to fluid flow. Nevertheless, for the 
studies comprising the present doctoral research project, it was important to at least 
know the magnitude of the shear stresses. Models for the estimation of shear stress on 
scaffolds in the presence of flow perfusion are based on Newton’s Law of Viscosity. 
Figure 2.6 shows a fluid placed between two parallel, infinite plates. At a certain time 
(t = 0) the lower plate is set in motion in the x direction at a constant velocity v. After 
some time, the linear steady state velocity profile is reached. It is assumed here that 
the flow is laminar, moving in parallel layers. Newton’s law of viscosity establishes 
that the constant force, F, required to maintain the steady state motion is proportional 
to the area, A, and velocity, and inversely proportional to the distance, y. This is 
summarized in equation 2.1: 
dy
dv
A
F xµτ −==                   (2.1) 
 
where τ is the shear stress, defined as the applied force per unit area necessary to 
deform the fluid. The symbol µ is the viscosity, and it is the proportionality constant 
between the shear stress and the shear rate (dvx/dy). 123 
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Figure 2.6. Steady state linear velocity profile of a Newtonian fluid between two plates. 
 
For porous foams, it is assumed that the flow is uniformly distributed across a 
foam surface of diameter, D. The mean velocity, Vm, through the porous media is then 
calculated as 95: 
2)2/(D
QVm φπ=                   (2.2) 
 
where Q is the flow rate, and φ is the porosity of the scaffold. The shear stress, τ, at 
the pore walls can be estimated by assuming flow through parallel cylindrical pores of 
diameter d. 95 
d
Vmµτ 8=                    (2.3) 
 
For the fibrous matrices, the Stokes-Olsen model for flow around a cylinder 
can be applied 124. This model was developed for creeping flow around a single 
cylinder. In the scaffolds used for the study presented in Chapter 3, fibers were 
separated by at least 150µm, which is considerably greater than the fiber size (20-50 
µm). In addition to that, Reynolds numbers were very small at the conditions of flow 
used (Re < 1). Thus, this model was appropriate for estimating the magnitude of the 
shear stresses experienced by the cells under those conditions of flow perfusion. 
According to this model, the drag coefficient is expressed as follows 124: 
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( )Re4.7logRe*
8
2
π
ρ
==
rU
DCD                 (2.4) 
 
where D is the drag force per unit length, ρ is the density of the fluid, U is the 
velocity, r is the radius of the cylinder, and Re is the Reynolds number. Shear stress is 
defined as: 
A
D
=τ                     (2.5) 
where A is the area of the cylinder, which is defined as A= 2πrL. Then considering 
the area per unit length, and knowing that the Reynolds number for flow around a 
cylinder is: 
µ
ρUr2Re =                    (2.6) 
where µ is the fluid’s viscosity, equations 2.4, 2.5 and 2.6 are combined to obtain an 
expression for shear stress on the walls of the cylinder 124: 
 
( )Re4.7log*
2
r
Uµ
τ =                   (2.7) 
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Chapter 3 
 
Oscillating Flow perfusion improves seeding of different 
tissue engineering scaffolds 
 
Chapter Abstract 
Scaffold seeding determines initial cellularity and cell spatial distribution 
throughout the scaffold, and affects cell-matrix interactions. Static seeding often 
yields low seeding efficiencies and poor cell distributions; thus creating a need for 
techniques that can improve these parameters. We have evaluated the effect of 
oscillating flow perfusion on seeding efficiency and spatial distribution of MC3T3-E1 
pre-osteoblastic cells in fibrous polystyrene matrices (20, 35 and 50-µm fibers) and 
foams prepared by salt leaching, using as controls statically seeded scaffolds. An 
additional control was investigated where static seeding was followed by 
unidirectional perfusion. Oscillating perfusion resulted in the most efficient technique 
yielding higher seeding efficiencies, more homogeneous distribution and stronger 
cell-matrix interactions. Cell surface density increased with inoculation cell number 
and then reached a maximum, but significant detachment occurred at greater flow 
rates. Oxygen plasma treatment of the fibers greatly improved seeding efficiency. 
Having similar porosity and dimensions, fibrous matrices yielded higher cell surface 
densities than foams. Perfusion seeding produced more homogeneous cell 
distribution, with fibrous matrices presenting greater uniformity than the foams. 
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3.1 Introduction 
The main goal of bone tissue engineering is to create artificial constructs that 
could repair or simply replace lost or damaged osseous tissue. Common tissue 
engineering strategies involve the extraction of cells from a small biopsy of tissue for 
in vitro expansion. This culture can be carried out in a three dimensional scaffold that 
allows and induces the formation of new tissue after implantation 1-4. Most 
approaches in this field are based on common bioactive factors, consisting of cells 
(generally stem or tissue specific cells), a scaffolding material and growth and 
differentiation factors 5. Furthermore, the in vitro creation of an efficient construct can 
be improved by applying certain stimuli that can elicit specific responses to the cells. 
Stimulation can be done in two major ways: chemically and mechanically 6-9.  
 
The need for in vitro mechanical stimulation in tissue engineering is drawn 
from the fact that most tissues function under specific biomechanical environments in 
vivo that play a key role in tissue remodeling and regeneration 10,11. These mechanical 
stimuli can be classified into different kinds of forces that range from load bearing to 
hydrodynamic forces due to fluid flow 9,11. Thus, the mechanochemical 
microenvironment that progenitor cells grow into is expected to control the fate of 
these cells and influence their differentiation.  
 
In many tissue engineering applications, bioreactors are used to impart certain 
forces that imitate different mechanical stimuli occurring in the body, thereby 
enhancing the formation of an extracellular matrix (ECM) similar to the in vivo matrix 
12-19
. However, these devices are not limited to the sole application of mechanical 
stimuli; they must meet other requirements in order to create grafts that, when 
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implanted, will lead to the regeneration of damaged organs. A bioreactor must 
efficiently transport nutrients and oxygen to the construct. In most tissue engineering 
approaches, a scaffold is seeded with cells and supports the formation of extracellular 
matrix (ECM). Consequently, the bioreactor has to induce a cell distribution 
throughout these structures that is as homogeneous as possible in order to generate a 
uniformly distributed ECM. Tissue engineering bioreactors can be used for cell 
seeding and/or long term cultures 19-29. 
 
The first step to culturing cells in a three dimensional environment is the 
seeding of scaffolds with cells appropriate for the desired application 20. Scaffold 
seeding determines the initial number of cells in the construct, as well as their spatial 
distribution throughout the matrix. Therefore, proliferation, migration and the specific 
phenotypic expression of the engineered tissue will be affected by the utilized seeding 
technique 30. In the case of tissues that require fibrous or porous materials, static 
seeding has been the most widely used method of cell seeding; however, poor cellular 
distribution and a low seeding efficiency are obtained with this technique 26,31.  A low 
seeding efficiency diminishes the development of specific functions related to cell-
cell interactions and requires a greater amount of cells suspended prior to seeding; 
therefore, the usage of new and improved seeding techniques becomes imperative 32. 
 
In order to address these issues, researchers have incorporated convection into 
the process of cell seeding to overcome some of the limitations encountered in the 
static procedure. Spinner flask bioreactors have been utilized to create convective 
flow and deliver hydrodynamic forces that may help increase mass transport into the 
scaffold. In these systems, higher seeding efficiencies are obtained, and the cells are 
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more uniformly distributed when compared with static seeding; however, a more 
homogeneous cell distribution is still desired 19,33. This behavior may be due to the 
poor convection through the interior of the scaffold, making migration the only way 
for cells to reach the interior. 
 
One way to improve cell penetration into the interior of the scaffold and a 
better distribution of cells is by applying perfusion 14,24,34-36. In this technique, the 
construct is press fit into a chamber, and the cell suspension is perfused through it. 
Different systems that operate based on the concept of flow perfusion have been 
utilized to seed polymeric scaffolds. Dramatic increases in the seeding efficiency have 
been found in all these systems, and more homogeneous cell distributions throughout 
the scaffolds have been achieved, compared with static and other dynamic systems 
30,34,37
. 
 
Therefore, it can be hypothesized that scaffolds seeded in a flow perfusion 
system, using oscillatory flow, will present higher seeding efficiencies and more 
homogeneous cell distributions than scaffolds seeded statically.  In this study, we 
evaluate the effect of flow perfusion on seeding efficiency and cell spatial distribution 
on fibrous polystyrene matrices and foams using MC3T3-E1 pre-osteoblastic cells, 
using a flow perfusion system also suitable for long-term cultures. To asses the 
potential applicability of this seeding technique as a first step for long term cultures or 
as the last step prior to implantation of cell/scaffold constructs, oscillatory flow was 
followed by unidirectional flow and the scaffold cellularity (total number of cells 
attached per scaffold) was determined afterwards. The effects of fiber size and surface 
modification by oxygen plasma on polystyrene fibers were also evaluated, as well as 
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the assessment of cell distribution on poly(L-lactic acid) (PLLA) foams in order to 
demonstrate that the employed methodology is not material dependant. The results 
yielded by oscillatory flow perfusion seeding are compared to those achieved with 
static seeding and static seeding followed by unidirectional flow perfusion. 
 
3.2 Materials and Methods 
 
3.2.1 Scaffolds 
Fibrous meshes and porous foams are among the most popular scaffold architectures 
employed in the regeneration of bone and other tissues 13,38-45. These two different 
morphologies were utilized in this study and seeded with MC3T3-E1 pre-osteoblastic 
cells under static and dynamic conditions in a flow perfusion bioreactor14. Scaffolds 
were prepared as follows: 
 
a) Fibrous meshes. Non-woven polystyrene fibrous matrices were produced by 
spunbonding 46,47. The apparatus consisted of a Brabender™ single screw extruder, a 
spin pack equipped with a gear pump, and a spinneret. The extruder barrel was 19.0 
mm (0.75 in.) in diameter and 381 mm (15 in) in length and had a compression ratio 
of 3:1. The spin pack contained a Zenith™ gear pump that metered and pressurized 
the molten polymer. A single-hole spinneret was used for the production of fibers. 
The single-hole spinneret had a diameter of 0.407 mm (0.016 in) and a length 2.97 
mm (0.1169 in). The Brabender extruder was kept at 265oC, the spin pack was kept at 
275oC, and the spinneret was kept at 280oC. Fiber diameters were 20, 35 and 50µm. 
The fibers were used as produced and also treated with oxygen-plasma in order to 
incorporate hydroxyl groups on the surface of the fibers and; both, plain and treated 
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surfaces were compared. Oxygen-plasma treatment was carried out for 1 min at 
medium intensity and a pressure of 200mmHg in a plasma cleaner/sterilizer (Model 
PDC-32G, Harrick). Fibrous scaffolds were punched from the resulting mesh. These 
fibrous matrices had an approximate porosity of 95%, and dimensions of 8 mm in 
diameter and 3 mm in thickness. The porosity was determined as the percentage ratio 
of the weight of the scaffold to the weight of a solid polystyrene disc with the same 
dimensions. 
 
b) Porous foams. Polystyrene foams were prepared by particulate leaching, using 
sodium chloride (NaCl) as the porogen 48-50. The grain size of the NaCl was between 
300-450µm. Briefly, polystyrene (average MW 100,000) was dissolved in chloroform 
at a concentration of 5% w/v. The solution was then poured on a sodium chloride bed, 
and the solvent was allowed to evaporate for 24 h. The solid salt-polymer composite, 
which was 95 wt% NaCl, was pressed in a cylindrical mold with an inner diameter of 
8 mm at 500 psig, using a hydraulic press, with simultaneous heating at 130oC for 30 
min. The resulting pellet was cut into discs of 3 mm in thickness using a low speed 
diamond wheel saw (Model 650, South Bay Technology, Inc). Salt leaching was 
carried out using deionized water for 3 days while the water was changed at least 
twice a day. The scaffolds had a porosity of 95% determined as the percentage ratio of 
the weight of the scaffold to the weight of a solid polystyrene disc with the same 
dimensions. 
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3.2.2. Cell Source  
Preosteoblastic MC3T3-E1 cells were cultured in T-75 flasks (Corning) using 
Dulbeco’s modified essential medium (D-MEM, 10% fetal bovine serum) (Atlanta 
Biologicals), in a humid atmosphere at 37ºC and 5% CO2. Media was changed every 
other day. Prior to seeding, cell cultures were rinsed with PBS (Atlanta Biologicals) 
and lifted from the culture flask using 0.25% trypsin/EDTA (Gibco). Cells were 
centrifuged at 400g for 5 min and re-suspended in fresh D-MEM. Seeding densities 
were 1.25x105, 2.50x105, 5x105 and 1x106 cells in 250µl of D-MEM.  
 
3.2.3. Seeding Techniques 
Three different seeding techniques were compared to evaluate scaffold initial 
cellularity, seeding efficiency and cell spatial distribution. 
 
Static Seeding: Scaffolds were pre-wet with 200-proof alcohol by applying 
manual vacuum, rinsed in a series of solutions of decreasing concentrations of alcohol 
in phosphate buffered saline (PBS), press fit into cassettes designed for static seeding 
and placed in a low-attachment 6-well plate prior to seeding. Cells suspended in 
250µl of D-MEM were slowly distributed on top of the scaffolds and allowed to 
attach for 4h. The wells were then filled with medium and cells were allowed to 
condition for 8h, in an incubator at 37oC and under 5% CO2. 
 
Oscillatory perfusion (Dynamic) seeding: a modified flow perfusion system 
utilized in other studies was used in this set of experiments 14. Briefly, scaffolds were 
confined in cassettes so as to force the flow throughout the porous network and 
restrict it from going around the scaffold. The cassettes were placed into the perfusion 
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chambers of the main body of the bioreactor, which consists of a total of six 
chambers. Culture media was pumped to the top of the chambers using a peristaltic 
pump (Cole-Parmer) from a media reservoir and returned to a second reservoir, 
allowing media recirculation.  
 
Prior to seeding, the flow system was cured with D-MEM for 2 h. Pre-wet 
scaffolds were press-fit into cassettes and placed in the flow perfusion chambers of 
the bioreactor. Cell suspensions (in 250µl of D-MEM) were poured on top of the 
scaffolds, and the chambers were filled up with fresh media to avoid the presence of 
air bubbles. Oscillating flow was then applied for 2 h at 0.15 ml/min by manually 
changing the direction of the pump every 5 min.  Cell conditioning, without flow, was 
allowed for a period of 2h, after which unidirectional flow was incorporated at 0.15 
ml/min for 8h.  
 
Statically seeding followed by shearing: Scaffolds were seeded statically for 
4h, using flow perfusion cassettes as described earlier in this chapter. After that, the 
cassettes with the statically seeded scaffolds were placed in the bioreactor chambers, 
and unidirectional flow was applied at 0.15 ml/min for 8h. 
 
3.2.4. Cell detachment 
Scaffolds were seeded statically or dynamically for 2h as explained 
previously. After the additional 2h conditioning period (absence of any type of flow), 
unidirectional flow was applied for 8h at rates of 0.15, 0.5 and 1 ml/min, using the 
flow perfusion bioreactor. 
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3.2.5 Cell number quantification  
After completing of the seeding process that lasted 12h for all groups, the 
constructs were quickly rinsed in PBS, suspended in 3 ml of water, and broken down 
into small pieces. Samples were later submitted to three cycles of freezing and 
thawing in order to lyse the cells. A picogreen® DNA quantification assay 
(Invitrogen) was carried out to obtain the number of cells attached to the scaffolds. A 
standard curve was made using known-concentration solutions of λ-DNA. Sample 
and standard aliquots of 43µl were accommodated in a 96-well plate, along with 
107µl of reaction buffer (20mM Tris-HCl, 1 mM EDTA, pH 7.5) and 150µl of the 
Picogreen® Dye. Fluorescence was measured at 490 nm in excitation and 520 nm in 
emission, using a Synergy HT plate reader (Bio-Tek). The number of cells was 
calculated using the total amount of DNA determined in the sample divided by the 
amount of DNA contained in one cell, which was estimated in our laboratory to be 3 
pg/cell. 
 
The data were reported in two ways: total scaffold cellularity, which is the 
total number of cells attached to the scaffold; and cell surface density, which is 
defined as the cellularity divided by the total surface area available for cell 
attachment. Surface area in the foams was estimated using mercury porosimetry. The 
surface area of the fibrous matrices was calculated as follows51: 
 
First, the total volume of the fibers (V) was computed by:  
 
2LD
4
π
ρ
mV ==                    (3.1) 
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Where L is the total length of the fibers, D is the fiber diameter, m is the mass of the 
fibrous matrix, and ρ is the polystyrene density. Then, the total surface area of the 
fibers is given by: 
 πDLA =                    (3.2) 
By combining equations 3.1 and 3.2, the surface area available for attachment in a 
fibrous matrix is estimated by the following expression: 
 
 
ρD
4mA =                    (3.3) 
 
3.2.6. Assessment of cell spatial distribution throughout the scaffold surface 
 
3.2.6.a. Fluorescence microscopy 
After seeding with all of the methodologies previously described, cells were 
fluorescently tagged with BODIPY® FL phallacidin (Invitrogen), a high affinity 
probe for F-actin. Briefly, seeded scaffolds were fixed in 3.7% formalin for 10 min. 
Rinsing with 0.1% Triton-X and PBS followed. Constructs were then incubated for 20 
min in the dye solution, with a concentration of 200units/ml. They were finally rinsed 
with 0.1% Triton-X and PBS. Top and bottom sections were analyzed for cell 
distribution, with the top section corresponding to the surface on which the cell 
suspension was originally placed. In fibrous matrices, the middle portion of the 
construct was also assessed for cellularity by manually sectioning the matrices along 
the axial direction. Fluorescence microscopy was performed using a Nikon 
Epifluorescence microscope, and image analysis was carried out with MetaMorph 6.2 
(Universal Imaging Corporation). The excitation and emission wavelengths were 
558nm and 569nm respectively. 
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3.2.6.b. Histological Analyses 
Histology of 20-µm plasma treated fibers seeded both statically and 
dynamically with MC3T3-E1 pre-osteoblastic cells was carried out. Seeded scaffolds 
were fixed in 3.7% formalin overnight, dehydrated using a series of ethanol solutions 
of increasing concentration, and embedded in paraffin. Embedded samples were 
sectioned using an MT 6000 microtome (RMC). Sections were mounted on glass 
slides and stained with Safranin-O (Electron Microscopy Sciences). 
 
Histology of porous foams seeded both statically and dynamically was also 
carried out. The material used in this section of the study was poly(L-lactic acid) 
(PLLA) (Birmigham polymers, average MW: 100,000). Foams were prepared by 
particulate leaching, using sodium chloride as the porogen (as previously explained 
for polystyrene foams). Seeded scaffolds were fixed in 3.7% formalin overnight, 
dehydrated, and embedded using a low viscosity embedding media Spurr’s kit 
(Electron Microscopy Sciences, RT 14300). Infiltration of the samples with the 
embedding medium was done by starting with and ethanol-PBS solution (1:1), 
followed by a 1:3 mixture, and finally pure PBS. Each infiltration step lasted 2h. 
Fresh embedding media was aggregated and allowed to polymerize overnight at 60oC. 
Embedded samples were sectioned in the direction of the flow, mounted on glass 
slides and stained with toluidine blue (Electron Microscopy Sciences). Microscopy 
was performed using a Nikon Epifluorescence microscope. Eight images were taken 
per each cross-section with a 10X objective.  
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The images were segmented in three different areas: an upper zone close to the 
surface on which the cell suspension was placed (0-1mm), a middle zone (1-2 mm), 
and a lower zone (2-3 mm). Cell nuclei were counted per zone. The distribution of 
cell coverage along the direction of the flow was determined by calculating cell 
coverage fractions. The cell coverage fraction was defined as the ratio of the number 
of cells counted in one zone to the total number of cells in the entire cross section.  
 
To obtain a quantitative measurement of cell uniformity, we utilized the 
method proposed by Zhao et. al. and Wendt et. al.56,65. Six histological sections were 
obtained for each scaffold. Each cross section was divided into five areas in the 
direction of the flow starting from the top. Each area was imaged and the number of 
cells per image was quantified. The average number of cells for a cross section ( x ) 
along with the standard deviation (s) were determined. Percent uniformity for a cross 
section was calculated by the following equation 56,52: 
 










−=
x
sUniformity 1*100%                 (3.4) 
 
3.2.7. Statistical analysis 
For all the experiments, three to five samples were used (n = 3-5) in all the 
experiments, unless otherwise specified. Values were reported as the average of all 
the samples, and the error was reported as the standard error of the mean. The data 
were analyzed by using ANOVA, and multiple pair-wise comparisons were carried 
out using the Tukey-HSD method at a confidence level of 95%. 
69 
3.3. Results 
 
3.3.1 Effect of the seeding technique and fiber diameter on initial scaffold 
cellularity and seeding efficiency in fibrous scaffolds 
In Figure 3.1, the three different seeding techniques are compared in terms of 
scaffold initial cellularity (total number of cells attached per scaffold) at different 
fiber sizes and at an inoculation number of 2.5x105 cells. At fiber sizes of 20 and 35 
µm, oscillatory flow perfusion seeding (also called dynamic seeding) yielded the 
highest cellularity. In all cases, the shearing of statically seeded scaffolds yielded the 
lowest scaffold cellularity.  
 
 
Figure 3.1. Effect of seeding technique and fiber size on the number of cells attached per scaffold using 
an inoculation number of 2.5x105 cells. All scaffolds were oxygen plasma treated. (*) p<0.05 
 
The efficiency of seeding (percentage ratio of the initial scaffold cellularity to 
the number of cells suspended), is shown in Figure 3.2 for the different seeding 
techniques. As a general trend, it was observed that seeding efficiency decreased at 
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higher suspension cell numbers. Dynamic seeding yielded the highest efficiency in 
most cases, with a maximum value of about (56±5)%; nonetheless, differences among 
the different seeding techniques were not clearly appreciated on untreated fibers 
(Figure 3.2a). In oxygen-plasma treated fibrous scaffolds, the differences on 
efficiency among the different seeding techniques were more obvious (Figure 3.2b). 
The tendency of the dependence of seeding efficiency on inoculation number was 
preserved, with values of up to (87±6)%. In most cases, the plasma treatment 
significantly increased seeding efficiency when compared with untreated fibers 
(Figures 3.2, 3.3 and 3.4). 
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Figure 3.2. Effect of cell inoculation number on the seeding efficiency of (a) untreated scaffolds and 
(b) oxygen-plasma-treated scaffolds at different seeding techniques. All scaffolds had a fiber size of 20 
µm. Multiple pair-wise comparisons have been carried out using the Tukey-HSD methodology at a 
confidence level of 95%.The ampersand symbol (&) denotes the seeding technique that yielded the 
highest seeding efficiency at the same inoculation number. The plus symbol (+) represents the seeding 
technique that yielded the lowest seeding efficiency at the same inoculation cell number. (*) p<0.05 
 
The dependence of the scaffold cellularity on the inoculation cell number after 
dynamic seeding is presented in Figure 3.3. Similar trends were noticed for all fiber 
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sizes; cell attachment increased with the inoculation cell number, but it reached a 
plateau at an inoculation number of 5x105 cells. In untreated fibers, there was not a 
significant difference between fiber sizes of 20 and 35µm; however, fibrous matrices 
with 50 µm fibers had a significantly lower number of cells attached. Plasma-treated 
scaffolds presented a similar trend in terms of cellularity related to the inoculation cell 
number and fiber size (Figure 3.3b). However, at higher inoculation numbers (5x105 
and 1x106 cells in the inoculum), the number of cells attached to the plasma treated 
scaffolds dramatically changed, presenting a 2-fold increase for fiber diameters of 20 
and 35 µm, and a 5-fold increase for 50 µm, with respect to untreated scaffolds. 
73 
 
 
 
 
Figure 3.3. Dependence of the number of cells attached per scaffold (cellularity) on the cell inoculation 
number and fiber size of (a) untreated scaffolds, and (b) oxygen-plasma-treated scaffolds after flow 
perfusion seeding. Multiple pair-wise comparisons have been carried out using the Tukey-HSD 
methodology at a confidence level of 95%. The ampersand symbol (&) denotes the fiber size that 
presented the highest cellularity at the same inoculation number. The plus symbol (+) represents the 
fiber size that yielded the lowest cellularity at the same inoculation cell number. (*) p<0.05 
 
Scaffold cellularity was normalized with the surface area available for cell 
attachment (Figure 3.4). This normalization is referred to as cell surface density. 
74 
Scaffold surface areas were estimated to be (11.8 ± 2.1), (5.2 ± 0.8), and (4.2 ± 0.4) 
cm2 for fibers of 20, 35 and 50 µm respectively, and (18.7 ± 1.5) cm2 for porous 
foams. Cell surface density kept a similar dependence on the inoculation cell number 
to that obtained in Figure 3.3, reaching a plateau when the number of cells in the 
inoculum was 5x105. No clear trend on cell surface density was observed with respect 
to fiber sizes when untreated meshes were used, but, in plasma treated fibers, the 
surface density in the 20-µm fibers was significantly lower than those yielded by 
larger fiber sizes (35 and 50 µm).  
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Figure 3.4. Dependence of cell surface density on cell inoculation number and fiber size of (a) 
untreated scaffolds, and (b) oxygen-plasma-treated scaffolds after flow perfusion seeding. Multiple 
pair-wise comparisons have been carried out using the Tukey-HSD methodology at a confidence level 
of 95%. The ampersand symbol (&) denotes the fiber size that presented the highest cell surface 
density at the same inoculation number. The plus symbol (+) represents the fiber size that yielded the 
lowest cell surface density at the same inoculation cell number. (*) p<0.05 
 
The effect of scaffold architecture on cell surface density is shown in Figure 
3.5. Both kinds of scaffolds, fibrous matrices and porous foams, had the same 
dimensions, 8 mm in diameter by 3 mm in thickness, and a porosity of 95%. 
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Untreated, 20 µm fibers were compared to untreated foams prepared by salt leaching. 
In both architectures, cell surface density increased with the inoculation number but 
reached a plateau at an inoculation of 5x105 cells. The cell surface density of the 
foams was lower than that of the fibrous meshes at higher cell inoculation numbers 
(5x105 and 1x106 cells). 
 
 
 
Figure 3.5. Effect of scaffold morphology on cell surface density after seeding in a flow perfusion 
system. Both scaffolds had a diameter of 8 mm, thickness of 3 mm and a porosity of approximately 
95%. The symbol (*) denotes significantly higher cell surface density when comparing the different 
scaffold architectures at the same cell inoculation number. The symbol (#) represents cell inoculation 
number that yielded significantly lower cell surface densities than those yielded by inoculation cell 
numbers of 5x105 and 1x106 at the same scaffold morphology.  
 
Figure 3.6 shows the effect of the seeding technique on the seeding efficiency 
on porous foams. As observed with the fibrous matrices, the oscillatory flow 
perfusion seeding yielded the highest seeding efficiency, while the static followed by 
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shearing yielded the lowest (p<0.01). Approximately, 40% of the cells seeded 
statically were detached when unidirectional flow perfusion was applied. 
 
 
Figure 3.6. Effect of seeding technique on the cell seeding efficiency of prous scaffold scaffolds 
made by particulate leaching using an inoculation number of 5x105 cells. (*) denotes the seeding 
technique that yielded the highest efficiency. (#) denotes the seeding technique that yielded the lowest 
seeding efficiency. 
 
3.3.2. Cell detachment after seeding 
Perfusion seeding consists of three stages: oscillating flow, cell conditioning 
without flow, and unidirectional media recirculation at a specific flow rate. In the 
detachment studies, three different flow rates were tested in the recirculation phase, 
0.15, 0.5 and 1.0 ml/min.  Figure 3.7 shows the detachment curves in plasma-treated 
fibrous meshes with a fiber size of 20 µm, seeded using an inoculation of 2.5x105 
cells. Scaffold cellularity remained unchanged at different stages of the perfusion 
seeding, oscillating flow for 2h, cell conditioning for 2fh without flow, and 
unidirectional media recirculation for 8h, both at a flow rate of 0.15ml/min. 
Nonetheless, the number of cells attached to the scaffolds seeded dynamically 
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decreased when higher rates of media recirculation were tested. At 0.5 and 1.0 ml/min 
unidirectional flow, the cellularity of the mesh was respectively about 50 and 35% of 
that obtained at 0.15 ml/min.  
 
In the case of statically seeded scaffolds, the cellularity was decreased when 
unidirectional flow was incorporated, and lower cellularities were obtained compared 
to the dynamically seeded scaffolds experiencing the same unidirectional flow for the 
same period of time. Statically seeded scaffolds that were subjected to 0.15 ml/min 
presented about 70% of the initial cellularity, yielding the same cellularity as the 
dynamically seeded scaffolds exposed to 1.0 ml/min in the recirculation phase. After 
applying flow rates of 0.5 and 1 ml/min to statically seeded scaffolds, the total 
scaffold cellularity was between 38 and 31% of the initial cellularity, respectively.  
 
 
 
Figure 3.7. Detachment curve of cells seeded both statically and dynamically on oxygen plasma treated 
fibrous meshes with a fiber size of 20 µm. Inoculation cell number of 2.50x105 cells. (*) p<0.05 with 
respect to 0.5 ml/min; (+) p<0.05 with respect to 0 ml/min. Both curves were significantly different at 
every point of flow rate (p<0.05). 
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3.3.3. Assessment of cell spatial distribution 
Fluorescence microscopy was used to assess cell distribution. In Figure 3.8, 
the different seeding techniques for the fibrous matrices were compared by 
fluorescence microscopy. Scaffolds were separated in three general regions: top, 
middle and bottom, with the top being the surface on which the cell suspension was 
initially placed. In the statically seeded scaffolds, cells were clustered around the 
fibers at the top of the matrix, forming large cellular networks. Middle and bottom 
sections of these scaffolds showed significantly fewer cells, and no clusters were 
found. A closer look at the cells, using a higher magnification, revealed that a great 
number of single cells attached to the fibers had a rounded shape, while others were 
slightly stretched (Figure 3.9a). In the dynamically seeded fibers, the top surface also 
appeared to have more cells than the other regions of the scaffold, but the difference 
in depth was less pronounced than that observed under static conditions. Clusters 
were occasionally found in some areas of the upper scaffold section, but they were 
smaller than those seen in statically seeded scaffolds and localized. Unlike cells 
attached under static conditions, most of the dynamically seeded cells stretched along 
the surface of the fibers (Figure 3.9b).  
 
Cells seeded on porous foams were located along the edges of the pores at the 
outer scaffold surface, as shown in Figure 3.10. In both seeding techniques, the top 
presented an appreciable number of cells. The bottom, on the other hand, showed very 
few cells in dynamically seeded scaffolds and virtually no cells in those scaffolds 
seeded statically. 
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Figure 3.8. Fluorescent micrographs of the top, middle and bottom portions of fibrous matrices (20-µm 
fibers) seeded statically and dynamically in the flow perfusion bioreactor. Cells were tagged with 
BODIPY® FL phallacidin. Calibration bar: 200 µm. 
 
 
Figure 3.9. Cell stretching on fibrous matrices (20-µm fibers) seeded (a) statically, and (b) dynamically 
in the flow perfusion bioreactor. Calibration bar: 50 µm. 
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Static 
Dynamic 
Top Bottom 
 
Figure 3.10. Fluorescent micrographs of the top and bottom portions of polystyrene porous foams 
seeded statically, and dynamically, in the flow perfusion bioreactor. Cells appear as brighter dots. 
Calibration bar: 200 µm. 
 
Histology of porous poly(L-lactic acid) (PLLA) foams was used to assess cell 
distribution in the direction of the flow. Histological sections of statically seeded 
PLLA scaffolds (Figure 3.11) are in accordance with the fluorescence microscopy on 
polystyrene foams; most of the cells are observed close to the top surface, and very 
few cells are located in the bottom portions after static seeding. Under flow perfusion 
however, a greater number of cells was observed in all the sections of the scaffold. 
We also compared scaffold cellularities of PLLA and polystyrene foams under flow 
perfusion seeding for identical inoculation densities but did not find a significant 
difference between the two values (data not shown). 
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Pore edge 
 
Figure 3.11. Axial histological sections of PLLA foams seeded statically and dynamically, in the flow 
perfusion bioreactor. Top and bottom portions of both scaffolds are represented. Cells were stained 
with toluidine blue. Arrows point the areas were cells were observed. Calibration bar: 195 µm. 
 
From the histology analyses, both of the foams and the fibers, it was possible 
to calculate the percent uniformity defined by equation 3.4. The percent uniformities 
for 20-µm fibers (plasma treated) seeded statically and dynamically are compared in 
Figure 3.12, in which a significant difference was observed among the two different 
techniques, with the dynamic seeding yielding higher uniformity. Moreover, Table 3.1 
shows that in dynamically seeded scaffolds cells showed increased homogeneity in 
the direction of the flow than in statically seeded scaffolds. This phenomenon was 
found in fibrous matrices and porous foams. In the foams, the percent uniformity after 
oscillatory seeding was (65 ± 4) %, while in the statically seeded scaffold it was (20 ± 
2) %. 
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Figure 3.12. Percent uniformity of scaffold dynamic and static seeding. Oxygen plasma-treated fibrous 
meshes were used with a fiber size of 20 µm. A cell suspension number of 1x106 was utilized. 
(*p<0.05) 
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Table 3.1. Cell coverage fractions of statically and dynamically seeded scaffolds. Oxygen plasma-
treated fibrous meshes were used with a fiber size of 20 µm. A cell suspension number of 1x106 was 
utilized. Histological sections were segmented in three zones along the direction of the flow: a top zone 
close to the surface on which the cell suspension was originally placed (0-1 mm), a middle zone (1-2 
mm), and a ottom zone (2-3 mm).  
 
Cell Coverage Fraction 
                        Technique 
Zone Static Seeding Dynamic Seeding 
0-1 mm (0.56 ± 0.01) (0.37 ± 0.02) 
1-2 mm (0.28 ± 0.01) (0.39 ± 0.02) 
2-3 mm (0.16 ± 0.01) (0.25 ± 0.01) 
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3.4. Discussion 
 
The purpose of this study was to use oscillatory flow in a flow perfusion 
system suitable for long term cultures as an alternative technique for scaffold seeding. 
We also aimed to evaluate the effects of this seeding technique on seeding efficiency 
and cell spatial distribution on scaffolds with different architectures and materials. We 
compared the results obtained from this technique with those found when scaffolds 
were seeded statically, and when statically seeded scaffolds were submitted to 
unidirectional flow in the perfusion bioreactor.  
 
Most experiments performed in flow perfusion systems utilized for long term 
cell culture have used static seeding and later incorporated these cell-scaffold 
constructs into the bioreactor 36,53-59. However, static seeding is not an ideal method 
due to low efficiencies and poor cell distribution throughout the scaffold’s porous 
network 30,34,37. Consequently, it was important to evaluate the effects of flow 
perfusion in the seeding of polymeric scaffolds for tissue engineering. Performing the 
seeding in the flow perfusion system provided an obvious advantage since scaffold 
handling would be minimized. Seeding scaffolds statically and transporting them into 
the bioreactor poses great risks of contamination due to excessive manipulation.  
 
The effects of the incorporation of flow perfusion in scaffold seeding can be 
examined by considering: 1) the influence of different seeding techniques (static, 
static followed by flow shearing, and oscillating flow perfusion) on seeding 
efficiency; 2) the relation between cell attachment and scaffold architecture, with two 
different kinds of scaffolds, fibrous meshes and porous foams, as well as, the effect of 
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fiber size, and 3) the influence of the seeding technique on the initial cell spatial 
distribution throughout the entire scaffold surface.  
 
3.4.1. Influence of the seeding technique on seeding efficiency. 
Previous studies have used systems similar to the flow perfusion bioreactor 
that we have employed. Li et. al., used a depth filtration system to seed poly (ethylene 
terephthalate) (PET) matrices at a rate of 1ml/min. The cell suspension was recycled 
to increase the yield. Cell density increased along with the suspension cell number, 
with an efficiency of about 65%, while the static seeding yielded lower efficiencies 30. 
Similarly, Kim et. al. seeded hepatocytes on polymeric matrices using a flow 
perfusion system. A suspension of rat hepatocytes at a density of 5x106 cells/ml was 
pumped through decellularized bone matrices at a flow rate of 1.5 ml/min for 4 h. A 
total of approximately 4.4x106 cells were attached to the matrix, and a uniform 
distribution of the hepatocytes throughout the scaffold surface was achieved 27. These 
studies are in agreement with our findings. Higher efficiencies were achieved using 
oscillating flow perfusion compared to static seeding. Furthermore, the seeding 
efficiencies yielded in our study by the oscillating flow perfusion reached values close 
to 100% in some instances.  
 
Wendt et. al. monitored seeding efficiency and uniformity within static, 
spinner flask and perfusion systems. There was no difference among the efficiencies 
of the static and perfusion techniques, both producing a larger yield than the spinner 
flask. Uniformity, however, was optimized by the perfusion apparatus, while the static 
and the spinner flask generated cell-scaffold constructs with low spatial uniformity 34. 
Zhao et. al. used a flow perfusion system to seed PET fibers by continuously 
87 
recirculating a cell suspension through the system confirming the results from other 
studies 37. We have also demonstrated that dynamic seeding, in this case, oscillatory 
flow perfusion seeding improves cell spatial distribution when compared to static 
techniques.  
 
In this study, not only did we compare dynamic and static seeding, but we also 
considered the effects of exposing statically seeded scaffolds to unidirectional flow. 
Efficiencies yielded by static seeding were in some instances comparable to those 
encountered dynamically, with values reaching 50% sometimes. Despite these 
efficiency values, there were poor cell matrix interactions since many of the cells 
attached under static conditions were washed away when subjected to shear forces in 
the flow perfusion system. A reason for this behavior can be found in Figures 3.8 and 
3.9, in which large clusters are shown around the statically seeded fibers. These 
clusters were either attached to the scaffold in multiple locations or bonded through a 
single cell with the rest floating in the surrounding media. The latter type of clusters is 
expected to be more prone to detachment from the matrix in the presence of shear 
forces.  
 
Under dynamic conditions of seeding, we were able to maintain higher 
efficiencies; an effect that can be attributed to several factors. The oscillation 
provided during the first stage of the perfusion seeding gives more chances for cells to 
attach. Furthermore, it is possible that, by applying these different cycles in the 
oscillation, the cells could attach to places that were more energetically favorable for 
them to interact with, thereby resulting in stronger cell-matrix interactions. 
Microscopy results corroborate this hypothesis by showing an absence of large cell 
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clusters and higher spreading of the cells attached to the fibers. In spite of these 
advantages, it was interesting to observe a decrease in the efficiency when larger 
numbers of cells were present in the suspension. This decrease can be explained by a 
possible saturation of the surface with cells (see the cell attachment curve in Figures 
3.2 and 3.3). Thus, the trend of cell attachment with respect to the inoculation number 
presents a behavior that resembles a protein adsorption isotherm.  
 
Changing the conditions of flow, depicted in the detachment curve, gives us an 
insight into the cell attachment behavior. The fact that the cellularity of dynamically 
seeded scaffolds remained unchanged when recirculation at 0.15 ml/min was applied, 
combined with the fact that the cellularity of statically seeded scaffolds significantly 
declined after applying flow, implies that flow perfusion induced stronger cell 
attachment. A sign of the strength of attachment was the spreading of the cells, shown 
in Figure 8. The incorporation of unidirectional flow at higher rates, which resulted in 
stronger shear forces, showed that the profile of cell detachment for dynamically and 
statically seeded scaffolds is very similar. Even though the profile for cell detachment 
for dynamically and statically seeded scaffolds was very similar, dynamically seeded 
scaffolds retained a significantly greater number of cells even at 1.0 ml/min. Shear 
stresses under the different conditions of cell detachment were estimated by using 
Stokes-Oseen equation (see Apendix II) 60. This equation assumes creeping, 
transversal flow around a single cylinder, based on the determination of the drag 
coefficient. For our estimations, we have used the corrected Stokes-Oseen equation 
for a parallel array of cylinders 61,62. The calculated values of shear stress were 
between 0.04 and 0.4 dyn/cm2 for the range of flow rates utilized. 
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3.4.2. Relation between cell attachment and scaffold architecture 
3.4.2.a. Dependence on fiber size 
When the total number of cells attached was compared at different fiber sizes, 
it was noted that meshes with larger fibers displayed lower cellularity. This behavior 
further elucidated when the cell attachment was normalized by the available surface 
area per scaffold. In the latter case, scaffolds with smaller fibers had the smaller cell 
surface density. MC3T3-E1 pre-osteoblastic cells have a comparable size to the 
smaller fibers used in this study, which enables them to attach more easily to larger 
fibers; such is the case of 35 and 50-µm fibers. 
 
3.4.2.b. Dependence of scaffold morphology on initial cell surface density 
Scaffold morphology varies greatly in different tissue engineering 
applications. Our results demonstrate that cell attachment, among other factors, is 
affected by the architecture of the cell carrier matrix. Parameters such as scaffold 
diameter, thickness and porosity were kept constant for both architectures, but it was 
not possible to maintain the surface area available for cell attachment and the 
distribution of the void spaces constant as well. Inside the fibrous matrices, the flow is 
relatively undisturbed compared to the tortuous paths encountered in the foams. This 
difference may have played a role in the fluid dynamic environment the cells 
encountered within the scaffolds. In the case of the foams, sudden changes in pore 
diameter are capable of generating eddies followed by localized areas of significantly 
higher shear which can detach the cells.   
 
 
90 
3.4.3. Influence on the initial cell spatial distribution throughout the entire 
scaffold surface 
Other groups have reported poor uniformity in cell spatial distribution 
throughout tissue engineering scaffolds when they are seeded under static conditions. 
Dynamic systems such as spinner flask bioreactors and rotating wall vessels have 
been implemented to create convection and, thereby, hydrodynamic forces that could 
increase mass transport to the interior of the scaffold. However, a higher cell density 
is still observed close to the outer surfaces of the construct but very few cells at its 
center 63. Our findings, as well as previous experiments, confirm that flow perfusion 
guarantees fluid flow to the interior of the scaffold and a more uniform cell 
distribution 30,34,53-55,64. 
 
It is implied from these findings that, in the absence of flow, the cells cannot 
easily penetrate the scaffold (especially ones with high tortuosity), and thereby the 
majority of them stay at the upper surface. Capillary forces may also generate barriers 
for the migration of the cells to the inner sections of scaffolds. Additionally, being 
anchorage dependent, MC3T3-E1 will bind to the first surface available, and 
ultimately form large cell cluster networks. The incorporation of flow perfusion into 
the seeding seems to greatly abate part of these problems since it forces fluid flow 
throughout the porous network. Consequently, the cell suspension is forced into the 
scaffolds, giving cells the possibility to attach to the deeper regions of the void spaces. 
Possible cell clusters present in the suspension break down due to the shear forces. 
These features are common for both scaffold morphologies; nevertheless, the porous 
foams exhibited a very small amount of cells at the bottom of the constructs, as 
compared to the fibers. 
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The distribution of the void spaces in these two architectures is dramatically 
different. The void space in the non-woven fibrous matrices is less tortuous when 
compared with the foams, allowing the cell suspension to readily penetrate the porous 
network. Higher tortuosity and decreased pore interconnectivity in the foams prepared 
by particulate leaching 65 obstruct the efficient penetration of the cell suspension into 
interior sections of the foam.   
 
Morphology was not the only factor that was important for us to evaluate in 
this study. Polystyrene is one of many available biomaterials. To confirm the 
applicability of oscillating perfusion seeding beyond polystyrene, we have tested 
PLLA foams prepared in an almost identical way as the polystyrene foams used in 
this study.  Therefore, we also explored whether the behavior observed in cell spatial 
distribution was maintained on PLLA foams. This fact is demonstrated by the 
histological analysis, which showed that flow perfusion yielded more homogeneous 
cell distributions than static seeding in PLLA foams.  
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3.5. Conclusions 
 
In the present study, we have evaluated the effect of different seeding 
techniques on the initial scaffold cellularity and cell distribution, as well as the effects 
of scaffold morphology and the nature of their surface on cell attachment under 
different conditions of seeding. Flow perfusion yields higher seeding efficiencies and 
more homogeneous cell spatial distribution than static seeding. At the same time, 
oscillatory flow perfusion seeding results in stronger cell attachment. Moreover, 
scaffold architecture and the nature of the scaffold surface affect cell-matrix 
interactions. In general, flow perfusion seeding is more convenient for many tissue 
engineering applications, especially if a long term culture is to be carried out in a 
similar system. 
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Chapter 4 
 
Preparation of a functionally flexible, three-dimensional, 
biomimetic poly (L-lactic acid) scaffold with improved cell 
adhesion 
 
Chapter Abstract 
Poly(L-lactic acid) (PLLA) is widely used in tissue engineering applications 
due to its degradation characteristics and mechanical properties but possesses an inert 
nature, affecting cell-matrix interactions. It is desirable to modify the surface of PLLA 
to create biomimetic scaffolds that will enhance tissue regeneration. We prepared a 
functionally flexible, biomimetic scaffold by derivatizing the surface of PLLA foams 
into primary amines, activated pyridylthiols, or sulfhydryl groups, allowing a wide 
variety of modifications. Poly (L-lysine) (PolyK) was physically entrapped uniformly 
throughout the scaffold surface and in a controllable fashion by soaking the foams in 
an acetone-water mixture and later in a polyK solution in dimethylsulfoxide. RGDC 
adhesion peptide was linked to the polyK via creating disulfide bonds introduced 
through the use of the linker N-succinimidyl-3-(2-pyridylthiol)-propionate (SPDP). 
Presence of RGDC on the surface of PLLA 2-D disks and 3-D scaffolds increased the 
number of adherent mesenchymal stem cells. We have proposed a methodology for 
creating biomimetic scaffolds that is easy to execute, flexible, and nondestructive. 
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4.1. Introduction 
 
In most tissue engineering applications, the biochemical and physical 
interactions of the cells with the scaffolding material are of crucial importance. The 
deposition of extracellular matrix by specific functional or progenitor cells (e.g., 
mesenchymal stem cells) on the surface of the scaffolds provides a tissue-inductive 
nature to the construct that can enhance the regeneration of the damaged or lost tissue. 
Thus, strong cell-matrix interactions will benefit the expression of extracellular matrix 
proteins 1,2. The scaffold has to thereby support the adhesion of the cells, as well as 
their growth, migration and differentiation toward a specific phenotype 3-5. 
 
The scaffold needs to possess certain mechanical and morphological 
characteristics so as to achieve a more efficient regeneration process 6-9. The material 
must have mechanical properties that can meet the demands of the defect site, 
especially when the injury occurs in a mechanically demanding zone. Sufficient 
porosity, an optimum pore size and pore interconnectivity are necessary for the 
nutrition of the cells, the formation of new tissue and the establishment of a vascular 
network that will guarantee the survival of the de novo tissue. Ideally, the scaffold 
should be biodegradable and permit progressive tissue formation without 
compromising the fulfillment of the mechanical requirements at the site of 
implantation 8,10-12.  
 
Scaffolds for tissue engineering have been created using a wide variety of 
techniques and materials, both synthetic and natural 13-27.  Collagen, ceramics, and 
biodegradable polymers are among the most popular choices in different approaches 
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21,28,29
. Poly(α-hydroxy esters) represent the most common biodegradable polymers 
for this purpose due to their well known degradation mechanisms, and good 
mechanical properties, particularly poly(lactic acid), poly(glycolic acid) and their 
copolymers are widely employed. Nevertheless, these polymers can only support cell 
adhesion and growth to a certain extent 30,31. These polymers can be modified with 
active biomolecules to create scaffolds that enhance cell-matrix interactions or elicit 
other specific cellular responses according to the application 29,32.  
 
The development of these biomimetic scaffolds involves the bulk or surface 
modification of a base biomaterial with growth and differentiation factors that can 
improve cell attachment, proliferation, and migration, as well as eliciting other 
specific cellular responses both in vitro and in vivo 2,6,32. The most common way to 
modify the bulk of biodegradable polymers is by chemically cross-linking polymer 
chains with a bioactive molecule; this technique is popular in the preparation of 
hydrogels for cartilage repair 32-39. A challenge encountered with the current bulk 
modification techniques, when applied to a porous preformed scaffold, is the 
modification of its mechanical properties and degradation characteristics.  
 
Surface modification can also be carried out both physically and chemically. 
Physical adsorption, a common and easy way to modify materials, consists of simply 
incubating the surface of the polymer in a solution with the modifying biomolecule 
and letting it adsorb onto the surface; however, this methodology poses the risk of 
desorbing the incorporated modifying agent during their utilization 38,40,41. The surface 
of the polymer can also be functionalized by hydrolysis or aminolysis by soaking the 
scaffold in reactive solutions. Nonetheless, the extent of modification with this 
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methodology is limited since the intrinsic inert nature of the polymer restricts the 
creation of active sites; in addition to that, the degradation properties of the polymer 
close to the surface could also be changed 42. Physical entrapment of the bioactive 
molecule near the surface of the scaffold is an alternative that could overcome the 
restrictions regarding the generation of active sites as well as desorption of the 
modifying agent. Cui et al. entrapped gelatin in the surface of poly(L-lactic acid) 
(PLLA) films and enhanced the attachment of chondrocytes 43. Furthermore, the 
degradation characteristics are preserved because the chemical structure and bulk 
composition of the polymer are not altered. In our studies, we have used a similar 
modification methodology to that used by Cui et al to create a functionally flexible, 
biomimetic scaffold that can be further functionalized for specific applications in 
tissue engineering. 
 
The aim of this study was to modify the surface of PLLA foams using physical 
entrapment of poly(L-lysine) (PolyK) into their surface. This amine functionalized 
scaffold can be further modified by linking different molecules chosen accordingly in 
different tissue engineering applications through the use of amine coupling 
chemistries. Linking different bioactive molecules makes the scaffold functionally 
flexible since, through its appropriate modification, specific cellular responses can be 
attained depending on the desired application. The possibility of entrapping PolyK in 
a controllable fashion was considered. Moreover, we strived to estimate the amount of 
polyK available in the surface at different levels of entrapment. The stability of the 
modified surface and the effects of the modification technique on scaffold 
morphology were also studied. Further functionalization of the surface was 
demonstrated by improving cell adhesion. Arg-Gly-Asp (RGD), an adhesion peptide 
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found in fibronectin and other bioactive molecules that promote cell adhesion, was 
linked to the entrapped polyK, and the capacity for mesenchymal stem cell attachment 
at different levels of RGD modification was assessed on two-dimensional discs and 
three-dimensional tissue engineering scaffolds .  
 
  
4.2. Materials and Methods 
 
4.2.1 Materials 
Poly(L-lactic acid) (PLLA, average MW 100,000) was purchased from 
Birmingham Polymers. Poly(L-lysine) (PolyK, MW 1000-4000) and dimethyl 
sulfoxide (DMSO) were purchased from Sigma-Aldrich. Periodate-activated 
horseradish peroxidase (HRP) (E-Z link activated peroxidase), N-succinimidyl 3-(2-
pyridylthiol) propionate (SPDP), dithiothreitol (DTT), and fluorescein-5-maleimide, 
were obtained from Pierce. Chloroform and acetone were purchased from Fisher 
Scientific. Sodium chloride, Triton X-100, and hydrogen peroxide (H2O2) were 
obtained from VWR. An ABTS kit for the detection of HRP activity, containing the 
ABTS reagent (2,2'-azino-di(3-ethylbenzthiazoline-6-sulfonate)), citrate buffer and 
hydrogen peroxide (H2O2),  was purchased from Zymed Laboratories. An AMPLEX® 
Red kit, BODIPY® FL phalloidin, cell-loading pinocytic reagent and a PicoGreen® 
DNA quantification kit were purchased from Invitrogen. Phosphate buffered saline 
(PBS) and fetal bovine serum (FBS) from selected lots were purchased from Atlanta 
Biologicals. Alpha minimum essential medium (α-MEM) and trypsin-EDTA were 
obtained from Gibco. Arginine-glycine-aspartic acid-cysteine (RGDC) was purchased 
from American Peptide. 
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4.2.2 Determination of the optimal entrapment technique 
PolyK has been incorporated in different biomaterial surfaces to enhance the 
adhesion of osteoblasts and other cells. PolyK molecules have shown great 
improvement on cell spreading and, in many cases, cell growth, demonstrating 
compatibility of the biomaterial with the cells 44-49. The degree of adhesion has been 
shown to be directly proportional to the polyK molecular weight 50,51. A small-size 
polyK (MW 1000-4000) was utilized in order to minimize its effect on cell adhesion 
and assess the effect of RGD only. 
 
To determine the most efficient entrapment technique, two-dimensional PLLA 
films were created. PLLA was dissolved in chloroform at a concentration of 0.1g/ml 
and poured on glass Petri dishes, and the chloroform was allowed to evaporate 
overnight. Discs with 8 mm in diameter and 200 µm in thickness were punched. The 
following modification techniques were tested: 
(a) Bulk modification. In this technique, the Poly(L-lysine) (polyK) was dispersed in 
the chloroform- PLLA solution at a concentration of 0.1mg polyK/ml, before pouring 
it on the Petri dishes.  
(b) Acetone-polyK soaking. Prefabricated PLLA discs were incubated in 600µl of a 
suspension of polyK in acetone (0.1mg/ml) for 12 h. 
(c) Acetone/DMSO soaking. Prefabricated PLLA discs were soaked in a 7:3 acetone-
water mixture for 1h. They were then soaked in 600µl of a solution of polyK in 
dimethyl sulfoxide (DMSO) (0.1mg/ml) for 12 h.  
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Four discs were used to test each modification technique. To assess polyK 
incorporation, modified discs were reacted in 600 µl of 10-8 M periodate-activated 
horseradish peroxidase (Periodate-HRP) (pH 8) for 2 h. An ABTS kit was used to 
detect the presence of HRP. Briefly, equal amounts of the ABTS reagent and H2O2 
were diluted in a citrate buffer, as specified by the manufacturer. Modified discs were 
incubated in 600µl of the ABTS/ H2O2 solution. HRP activity was measured by 
reading absorbance in a Synergy HT plate reader (Bio-Tek®) at 405nm. Levels of 
polyK entrapment were directly related to the absorbance signal; the higher the signal, 
the greater the amount of polyK entrapped.  
 
PolyK surface distribution after entrapment: Fluorescence tagging of the 
polyK also allows for the evaluation of its distribution throughout the disc surface. 
Modified discs were incubated in 600µl of 1mM N-Succinimidyl 3-(2-pyridyldithio) 
propionate (SPDP) in HEPES buffer (pH 8.3) for 30 min., followed by rinsing and the 
unmasking of the thiol group in 600µl of 1mM dithiothreitol (DTT). The discs were 
then rinsed and incubated in 0.1mM fluorescein-5-maleimide in HEPES buffer (pH 
8.3) for 2 hrs. Every rinsing step after modification consisted of one wash with 0.1% 
Triton X-100 and three washes with deionized water. Fluorescence microscopy of 
modified and unmodified discs was performed using a Nikon Epifluorescence 
microscope with excitation at 495nm and emission at 518 nm. Images were captured 
with MetaMorph 6.2 (Universal Imaging Corporation). 
 
The presence of SPDP linked to the entrapped polyK was corroborated by 
measuring the absorbance generated by the release of pyridine-2-thione at a 
wavelength of 343 nm, after the reaction of SPDP with DTT. A standard curve was 
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generated by preparing SPDP solutions of known concentrations and incubating them 
with DTT for 30 min. Moles of reactive SPDP linked to the polyK in 2-D surfaces 
were estimated with this curve. The number of discs used in these quantifications was 
four. 
 
4.2.3 Modification of 3-D PLLA scaffolds 
Scaffold fabrication. PLLA foams were prepared by particulate leaching using 
sodium chloride (NaCl) as the porogen, with a grain size between 300-450µm 
2,52,53. Briefly, PLLA was dissolved in chloroform at a concentration of 5% w/v. 
The solution was then poured on a sodium chloride bed, and the solvent was allowed 
to evaporate for 24 h. The solid salt-polymer composite, which was 95 wt% in NaCl, 
was pressed in a cylindrical mold with an inner diameter of 8 mm at 500 psig, using a 
hydraulic press, with simultaneous heating at 130oC for 30 min. The resulting pellet 
was cut into discs of 3 mm in thickness using a low speed diamond wheel saw (Model 
650, South Bay Technology, Inc). Salt leaching was carried out using deionized water 
for 3 days while the water was changed at least twice a day. Scaffold porosity was 
determined as the percentage ratio of the weight of the porous scaffold to the weight 
of a solid PLLA disc with the same dimensions.  
 
Entrapment of polyK in 3-D scaffolds. Results from the modification of 2D 
discs indicated that the most efficient entrapment technique was Acetone\DMSO 
soaking (section 4.2.2.c); thus, this technique was used to modify three dimensional 
scaffolds. Foams were soaked in a 1:3 acetone-water mixture for 1 h. Then, they were 
placed in 1 ml of a solution of PolyK in dimethyl sulfoxide (DMSO) at 0.1 mg/ml for 
12 h. Rinsing was carried out after that with 0.1% Triton X-100, followed by three 
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washes with deionized water. All the stages were carried out under vacuum and 
vigorous shaking so as to allow the penetration of the different solutions throughout 
the porous network of the scaffold. 
 
Detection of entrapped PolyK. Modified foams were incubated in 600µl of 
1mM SPDP in HEPES buffer (pH 8.3) for 30 min., followed by rinsing and 
unmasking of the thiol group of the SPDP in 600µl of 1mM DTT. Scaffolds were then 
incubated in 0.1mM fluorescein-5-maleimide for 2 hrs. All steps were carried out 
under vacuum and sufficient rinsing followed each incubation step as previously 
explained. Scaffolds were placed in 1-ml centrifuge tubes with deionized water and 
frozen in liquid nitrogen for later longitudinal sectioning using a low speed diamond 
wheel saw. The sections had a thickness of 1 mm. Fluorescence microscopy was 
performed on the transversal sections in a Nikon Epifluorescence microscope with 
excitation at 495nm and emission at 518 nm. Images were captured with MetaMorph 
6.2. Controls included modification of the scaffolds in the following combinations: 
polyK-no SPDP, no polyK-SPDP, or plain. All scaffolds were treated with DTT and 
fluorescein-5-maleimide as explained above. 
 
4.2.4 Varying the amount of entrapped polyK in PLLA foams 
PLLA scaffolds were modified at polyK incubation concentrations of 1x10-8, 
1x10-7, 1x10-6, 1x10-4, and 0.1 mg/ml. PolyK- modified scaffolds were incubated in 1 
ml of 10-7 M periodate-HRP under vacuum for 2 hrs. After HRP linkage, they were 
rinsed in 0.1% Triton X-100 under vacuum, followed by three washes with deionized 
water. Each rinsing step was carried out for 15 min, and the vacuum was applied by 
covering the container with a sleeve stopper and suctioning the air with a syringe. 
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Estimation of the amount of entrapped polyK was achieved by using an AMPLEX® 
Red kit (Molecular Probes). Briefly, equal parts of 20mM H2O2 in reaction buffer 
(0.05 M sodium phosphate in Tris buffer, pH 7.4) and 100µM AMPLEX® Red (10-
acetyl-3,7-dihydroxyphenoxazine) in DMSO were mixed. In a 96-well plate, the 
remaining activated HRP incubation solutions and washes were arranged in aliquots 
of 10 µl, along with 90 µl of PBS and 50µl of the working solution (AMPLEX® 
Red/H2O2) and incubated for 5 min. A standard curve was generated by reading the 
fluorescence of HRP solutions of known concentrations. Fluorescence was measured 
at an excitation of 530 nm and emission of 590 nm in a Synergy HT plate reader (Bio-
Tek®). Fluorescence signals were converted to concentrations through the use of the 
standard curve. The moles of entrapped polyK were determined as the difference 
between the moles of HRP present in the original soaking solution and the moles 
measured in the remaining soaking solutions and washes. Amounts of entrapped 
polyK were calculated by subtracting the background signal emitted by the plain 
scaffolds. The number of scaffolds used in each group was four.  
 
4.2.5. Stability of the modified surface  
Modified 2-D discs were soaked in PBS for 10 days, at room temperature, 
under gentle shaking. After thorough rinsing, entrapped polyK was quantified at days 
0, 4 and 10 with periodate-HRP linkage and AMPLEX® Red, as previously described 
(n = 4).  
 
4.2.6. Effect of the acetone treatment on the porous architecture of 3-D foams 
Micro-computed tomography was carried out by scanning the scaffold (treated 
with acetone) using the ultra-high-resolution tomography system with a 200-kV 
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microfocal X-ray source (Bio-Imaging Research, Inc.) at the University of Texas 
Computed Tomography Facility (UTCT, Austin, TX), using X-ray settings of 180 kV 
and 0.088 mA. The slice thickness and inter-slice spacing was 0.0193 mm.  An 8.15 
mm field of view was reconstructed on a 512x512 pixel field, resulting in a pixel 
spacing of 0.0162 mm. The data was analyzed using the software Blob3D developed 
at the UTCT facility. Values of scaffold porosity and interconnectivity of the void 
spaces were obtained from these analyses 54. (n=1) 
 
4.2.7. Incorporation of RGDC peptides to the polyK modified surface  
After entrapping polyK in the surface of PLLA discs and foams, RGDC was 
linked via a disulfide bond through the SPDP attached to the amine groups. PolyK-
modified surfaces were incubated in 600µl of 1mM SPDP in HEPES buffer (pH 8.3) 
for 30 min. One cycle of rinsing with 0.1% Triton X-100 and three cycles with PBS 
were performed succeeding the reaction. Surfaces were incubated in 100µM RGDC 
for one hour and rinsed. When modifying the 3-D foams, vacuum was utilized at each 
stage of modification to mitigate mass transport limitations to the interior of the 
scaffold.  
 
RGDC linkage to SPDP was corroborated on 2D discs by measuring the 
absorbance at 343nm corresponding to the release of pyridine-2-thione group during 
the reaction of the sulfhydryl group from the cysteine with the SPDP (see Apendix I). 
A standard curve was generated by preparing SPDP solutions of known 
concentrations and incubating them with RGDC for one hour. Moles of reactive 
SPDP linked to the polyK in 2-D surfaces were estimated with this curve (n = 4). 
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X-ray photoemission spectroscopy (XPS). XPS was also performed on the 
surface of RGDC-linked and unmodified disks to confirm the presence of the 
adhesion peptide on the surface. Another control also included polyK-treated disks 
incubated in RGDC, in the absence of SPDP. XPS data were recorded on a Physical 
Electronics PHI 5800 ESCA System with a background pressure of approximately 
3.0X 10-9 Torr. The electron takeoff angle was 45o with respect to the sample surface. 
A spot size of 800-µm and 23 eV pass energy were used for the analysis. The number 
of discs was used was four, and ten spots were taken on each sample. The binding 
energies were corrected by reference to the C1s line at 284.8 eV for hydrocarbon. 
Quantification of the surface composition was carried out by integrating the peaks 
corresponding to each element with aid of the Shirley background subtraction 
algorithm, and then converting these peak areas to atomic composition by using the 
sensitivity factors provided for the each element by the PHI 5800 system software. 
 
4.2.8 Cell seeding on RGDC-modified surfaces 
Adult mesenchymal stem cells (MSCs) were isolated from the bone marrow of 
eight-week-old male Wistar® rats (Harland Laboratories) using well established 
methods 38-40. Briefly, rats were euthanized, and the tibiae and femura were extracted. 
The epiphyses were cut off, and the bone marrow was flushed and suspended in α-
MEM supplemented with 10% fetal bovine serum (FBS). The suspension was then 
distributed in polystyrene culture flasks (75 cm2). Cells were cultured at 37oC and 5% 
CO2. Non-adherent cells were discarded after two days of culture. MSCs were 
detached using trypsin, centrifuged at 400g for 5 min, resuspended in α-MEM and 
replated until the 4th passage. 
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Cell area measurements on 2D discs: Cells from the 4th passage (total of 
5x104 cells at a density of 2x105 cells/ml) were seeded on the surface of polyK-SPDP-
RGDC modified discs (at different levels of modification) and allowed to attach for 6 
hours. Discs were then rinsed in PBS and fixated in 3.7% formalin for 10 min, and 
rinsed with 0.1% Triton-X-100 and PBS. Cells were labeled with 2 units of 
BODIPY® FL phalloidin, a high affinity probe for F-actin, for 10 min. After rinsing, 
fluorescence microscopy was performed using a Nikon Epifluorescence microscope. 
Image processing and measurements of cell area were carried out with MetaMorph 
6.2 (Universal Imaging Corporation). The excitation and emission wavelengths were 
558nm and 569 nm, respectively. Fifteen cells from four different samples were used 
in cell area measurements. Controls in this study included plain discs and plain discs 
incubated in an RGDC solution to assess the effect of RGDC physisorption. 
 
Cell attachment on 3D scaffolds: MSCs from the 4th passage were also seeded 
on three-dimensional foams that were either unmodified or modified with RGDC at 
different levels of polyK-SPDP-RGDC modification (four scaffolds for each 
modification level). Scaffolds were press-fitted in cartridges designed for static 
seeding, and a cell suspension containing 5x105 MSCs (at a density of 2x106 cells/ml) 
was poured on top of the scaffolds. Cells were allowed to attach for 6 hours. 
Furthermore, cells seeded on RGDC-modified scaffolds were cultured for 24 and 48 h 
in order to assess any cytotoxic effects.  After attachment, the seeded scaffolds were 
quickly rinsed in PBS, suspended in 3 ml of deionized water, and broken down into 
small pieces. Samples were later submitted to three cycles of freeze/thaw to lyse the 
cells. A picogreen® DNA quantification assay was performed to obtain the number of 
cells attached to the scaffolds. A standard curve was made using known-concentration 
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solutions of lambda virus DNA. Sample and standard aliquots of 43 µl were 
accommodated in a 96-well plate, along with 107 µl of reaction buffer (20mM Tris-
HCl, 1 mM EDTA, pH 7.5) and 150 µl of the Picogreen® dye. Fluorescence was 
measured  (490 nm excitation and 520 nm emission) using a Synergy HT plate reader. 
The number of cells was calculated using the total amount of DNA determined in the 
sample divided by the amount of DNA contained in one cell. 
 
4.2.9 Statistical analysis 
For most experiments, four samples were used (n = 4), unless otherwise 
specified. Values were reported as the average ± the standard error of the mean. The 
data were analyzed by using ANOVA, and multiple pair-wise comparisons were 
carried out using the Tukey-HSD method at a confidence level of 95%.  
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4.3. Results 
 
4.3.1 Determination of the optimal polyK entrapment technique  
Two dimensional discs were used to determine the most efficient surface 
modification protocol due to their regular morphology and ease of preparation and 
handling. The optimal technique characterized in the 2-dimensional surfaces was later 
utilized in the modification of 3-D foams. After entrapment, it was possible to attach 
HRP to the polyK, and quantitative absorbance or fluorescent assays involving the 
enzymatic reaction with hydrogen peroxide could be carried out.  
 
Detection of entrapped polyK on the surface of PLLA discs using different 
entrapping techniques is shown in Figure 4.1. Bulk modification and acetone-polyK 
soaking yielded no significantly different absorbance signals from the unmodified 
surfaces (0.38 ± 0.06). The acetone/DMSO soaking, on the other hand, gave the 
significantly highest absorbance (1.16 ± 0.11). Thus, acetone soaking of the discs 
followed by incubation (room temperature) in a polyK/DMSO solution resulted in the 
most efficient method to entrap PolyK in the surface of the polymer and would be 
later used to modify three-dimensional scaffolds.  
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Figure 4.1. Detection of poly(L-lysine) entrapped in poly(L-lactic acid) discs with different techniques. 
Horse radish peroxidase was linked to the polyK and reacted with H2O2 in the presence of ABTS, 
developing a green color whose absorbance can be read at 405nm.The (*) represents the technique that 
yielded the significantly highest absorbance signal. (n = 4) 
 
The reaction of SPDP with DTT results in the release of pyridine-2-thione, a 
group responsible for the generation of absorbance at 343 nm (Figure 4.2). The 
detection of this group can also provide an insight into the amount of reactive SPDP 
incorporated to the surface by using a standard curve prepared with SPDP solutions of 
known concentrations unmasked with excess DTT. The estimated amount of SPDP 
linked to disks modified with a polyK incubation concentration of 0.1 mg/ml was 
(36.0 ± 6) nmoles. The unmodified surface yielded a negligible absorbance signal 
(p<0.05). 
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Figure 4.2. Physical entrapment of Poly(L-lysine) (PolyK) on the surface of poly (L-lactic acid) and 
further incorporation of SPDP, and the release of pyridine-2-thione due to the action of DTT 
 
The distribution of the entrapped PolyK was assessed by linking Fluorescein-
5-Maleimide to the sulfhydryl groups provided by the SPDP after DTT treatment. The 
distribution of the PolyK can be seen in Figure 4.3, where both modified and 
unmodified discs are shown. The modified disc exhibited greater fluorescence than 
the plain disc, and a uniform labeling pattern was observed throughout the modified 
surface. 
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Figure 4.3. Fluorescent micrographs of the surface of (a) polyK-modified (using the acetone/DMSO 
procedure), SPDP-derivatized and (b) unmodified discs. Both discs were treated with Fluorescein-5-
Maleimide.  
 
4.3.2 Modification of 3-D porous foams 
Acetone/DMSO soaking resulted in the most efficient polyK entrapment 
technique in PLLA discs; therefore, it was employed to modify three-dimensional 
porous foams. Fluorescein-5-Maleimide was used once again to evaluate the 
distribution of the PolyK throughout the porous network. In Figure 4.4, fluorescence 
micrographs of longitudinal transversal sections of three-dimensional foams prepared 
using different modification methodologies are shown. PolyK/SPDP modified foams 
presented a stronger fluorescence than the controls, which included scaffolds treated 
with polyK/no SPDP, no polyK/SPDP and plain discs; all scaffolds were treated with 
DTT and fluorescein-5-maleimide. A homogeneous intensity was observed 
throughout the transversal sections of polyK/SPDP-scaffold.  
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Figure 4.4. Demonstration of the presence of polyK on the surface of 3-D scaffolds modified with the 
acetone/DMSO procedure. Transversal sections of scaffolds treated differently are shown: (a) 
polyK/SPDP (b) polyK/no SPDP (c) no polyK/SPDP (d) plain. All scaffolds were treated with DTT 
followed by fluorescein-5-maleimide 
 
4.3.3 Varying the amount of the entrapped polyK 
To vary the amount of entrapped polypeptide added to the scaffolds, different 
concentrations of PolyK were incubated with the scaffolds during the period of 
entrapment. The quantification of the amount of entrapped polyK using periodate-
HRP is presented in Figure 4.5. The amount of entrapped polyK directly depended on 
the polyK incubation concentration up to an incubation concentration of 1x10-4 
mg/ml, after which the amount of polyK entrapped did not significantly change. A 
statistically significant lower amount was entrapped at an incubation concentration of 
1x10-6 mg/ml (58.5 ± 0.5 pg). Low polyK incubation concentrations of 1x10-7 and 
1x10-8 mg/ml yielded significant levels of entrapment, with amounts of entrapped 
polyK of (22.8 ± 1.4) and (12.6 ± 0.7) pg, respectively.  
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Figure 4.5. Quantification of the amount of entrapped polyK in the surface of PLLA foams at different 
concentrations of polypeptide in the stage of incubation after the soaking with acetone. (* p<0.05) (n = 
4) 
 
4.3.4. Effect of the acetone treatment on the porous architecture of 3-D foams. 
Micro-computed tomography images (Figure 4.6) revealed that, after 
treatment, the scaffold presented a clear porous network, with a level of 
interconnectivity of 99.9% as reported by the microCT data analysis. This analysis 
also reported a porosity of 90% after treatment, which was in agreement with our 
estimations prior and after treatment, in which cases the porosity was calculated as the 
ratio of the scaffold weight to the weight of a solid PLLA disc with the same 
dimensions, resulting in 90% in both cases.  
 
 
Figure 4.6. Micro-computed tomography scan of a PLLA foam after 
being treated with a mixture of acetone and water (7:3) for 1 hr. 
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4.3.5 Stability of the modified surface  
The initial amount of entrapped polyK in 2-D discs, using the AMPLEX 
RED® quantification procedure, was estimated to be (1.1 ± 0.1) ng. After 10 days of 
incubation in PBS under gentle shaking, the estimated amount of polyK on the surface 
was (1.1 ± 0.2) ng, which was not statistically different from freshly modified 
surfaces.  
 
4.3.6 Incorporation of RGDC peptides to the poly-modified surfaces 
When RGDC is linked to polyK-SDPD-modified surfaces, the sulfhydryl 
group from the cysteine causes the release of the pyridine-2-thione group from the 
SPDP molecule (see Figure 4.7). The amount of released pyridine-2-thione, which is 
equivalent to the amount of SPDP that reacts with the RGDC, was estimated using a 
standard curve, as previously explained. PolyK/SPDP/RGDC-modified 2-D discs 
using a polyK incubation concentration of 0.1 mg/ml yielded (25 ± 8) nmoles.  
 
When using an incubation concentration of 0.01mg/ml, there was no 
statistically significant difference with the higher polyK incubation concentration in 
the estimated amount of reactive SPDP (24 ± 8) nmoles. However, at an incubation 
concentration of 1x10-4 mg/ml, the amount of reactive SPDP was estimated to be (18 
± 6) nmoles, which was significantly lower than those obtained at higher incubation 
concentrations (p<0.05). The release of the pyridine-2-thione at polyK incubation 
concentrations lower than 1x10-4 mg/ml was below the lowest detection limit of the 
dose response curve, and no measurement could be done. 
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The presence of the RGDC peptide on the surface was confirmed by X-ray 
photoemission spectroscopy (XPS). Sulfur was chosen as the marker for comparison 
in this analysis since the sulfhydryl group from the cysteine is responsible for the 
reaction with the SPDP. Sulfur concentration on the polyK/SPDP/RGDC-modified 
surface (0.67 ± 0.25)% was significantly higher than in the polyK/RGDC-modified 
(without SPDP) and unmodified surfaces, (0.22 ± 0.05)% and (0.11 ± 0.01)% 
respectively.  
 
With the quantification of the moles of SPDP present on the surface of the 
polyK-modified PLLA surface by the release of the pyridine-2-thion, it is now 
possible to estimate the area covered by the entrapped poly (L-lysine). In the same 
way, an estimation can be made based on the amount of HRP quantified through the 
AmplexRed procedure. The molecular coverage of the surface, Acov, can be calculated 
through equation 4.1: 
 
molAanNA =cov                   (4.1) 
 
Where n is the number of moles, NA is Avogadro’s number (6.022x1023), and 
amol is the area occupied by a single molecule, which was estimated assuming a circle 
with the molecular hydrodynamic radius. In the case of HRP, the radius was 30 Å. 
When using the SPDP data, amol was based on the spacer length of SPDP (6.8 Å) 
added to the size of a single lysine (10.2 Å). The available surface area for entrapment 
for a PLLA disc was 106 mm2.  
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With the AmplexRed quantification done at a polyK incubation concentration 
of 0.1 mg/ml (the highest used in our studies), 2.8x10-12 moles of HRP/cm2 were 
estimated on the surface of 2D discs. In this case, the area of coverage resulted in 123 
mm
2
. This value was obtained for the coverage of HRP on the PLLA surface. It needs 
to be noted that HRP is much larger than either polyK or SPDP, and under each HRP 
molecule, multiple polyK molecules can be found. Thus, in essence, we are just 
calculating the HRP coverage, which appears to cover the entire available area of the 
2D surface. Clearly, a one to one stoichiometry of HRP to polyK would provide a 
lower limit on the polyK coverage (2.8x10-12 moles/cm2), while the actual value may 
be higher. This procedure will provide a more accurate estimate of polyK coverage 
when the HRP coverave is very sparce (less than 5% of the value observed here). 
 
For the SPDP calculations, it was assumed that polyK had an average MW of 
2500 (the manufacturer stated that the MW ranged from 1000 to 4000), and that 50% 
of the molecule was entrapped in the PLLA, leaving approximately 12 lysines active 
for reaction. If we assume that all the available lysines react with SPDP, the coverage 
obtained is 56 mm2, implying 53% coverage of the PLLA surface with polyK. 
Clearly, this is a conservative estimate since the presence of unreacted lysines with 
SPDP could result in higher than 53% coverage. If the number of reactive lysines is 
decreased, we can achieve 100% coverage when 6 out of 12 lysines per polyK are 
reacted. Therefore, our surface coverage ranges between 50 and 100%, depending on 
the assumptions made, and the number of reacted lysines is at least 50% of the 
assumed 12 available reactive lysines per polyK molecule.   
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For a lower polyK incubation concentration (1x10-4 mg/ml), and with the same 
assumptions stated in the previous paragraph (avg MW of polyK of 2500, and 12 
lysines available for reaction), it was found that if all lysines react the surface 
coverage is 38%. Moreover, if the number of reactive lysines is decreased to 5, we get 
100% coverage. Again, the lowest limit of polyK coverage can be established to be on 
the order of 35 to 100%, with a similar level of reactive lysines as in the highest 
polyK level.  
 
4.3.7. Cell seeding on RGDC-modified surfaces 
The RGDC incorporation steps can be seen in Figure 4.7. Figure 4.8 shows 
fluorescence micrographs of fluorescently tagged MSCs that were seeded on plain 
and modified discs. In polyK/SPDP/RGDC-modified discs, at polyK incubation 
concentrations of 0.1 and 1x10-4 mg/ml, cells greatly stretched once attached to the 
surface after six hours, with elongated extensions of the cell membrane and a uniform 
distribution throughout the disc surface, while at a polyK incubation concentration of 
1x10-6 some cells started to display a rounded appearance, a behavior that was more 
pronounced on unmodified discs. Cell surface areas at different levels of surface 
modification are shown in Figure 4.9.  
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Figure 4.7. Incorporation of RGDC to the Poly-modified PLLA surface 
 
 
 
Figure 4.8. Cell adhesion test on RGDC-modified PLLA discs. The RGDC was linked to polyK 
through the creation of a disulfide bond using SPDP. Mesenchymal stem cells were seeded on the 
surface of disks modified with polyK at: (a) 0.1 mg/ml, (b) 10-4 mg/ml, (c) 10-6 mg/ml, or (d) plain 
surface.  
 
Greater cell spreading area was obtained at polyK incubation concentrations of 
0.1 and 1x10-2 mg/ml, without any significant difference between the two. Significant 
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declines were observed at polyK incubation concentrations of 1x10-4 and 1x10-6 
mg/ml, but there was not a significant decrement when the incubation concentration 
was reduced to 1x10-7 mg/ml. Furthermore, polyK/SPDP/RGDC-modified surfaces 
provided greater cell surface areas than polyK-modified or polyK/RGDC-modified 
discs. Cell surface area was the lowest when cells were seeded on plain discs and 
plain discs incubated in an RGDC solution.  
 
 
Figure 4.9. Effect of the extent of polyK entrapment on cell surface area after linkage of RGDC 
peptides to polyK entrapped in PLLA discs. Controls included polyK-modified and polyK/RGDC-
modified surfaces, as well as plain discs and plain discs incubated in an RGDC solution. The (*) 
denotes statistical significance between two groups (p<0.05). The (&) denotes the modification 
sequence that yielded the highest cell surface area at a given polyK incubation concentration. The (+) 
denotes the modification sequence that yielded the lowest cell surface area at a given polyK incubation 
concentration. The (#) denotes significant difference (p<0.05) with respect to polyK-SPDP-RGDC at 
every polyK incubation concentration. (n=15 cells)  
 
In the three-dimensional PLLA foams, the incorporation of small amounts of 
RGDC onto the surface (polyK incubation concentration of 1x10-7 mg/ml) increased 
cell attachment after 6 h (2.7 ± 0.1x105 cells) (Figure 4.10), which was about three 
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times higher than that obtained in the unmodified scaffolds, (0.9 ± 0.2x105 cells). 
However, no significant difference in cell attachment was observed when scaffolds 
were modified with RGDC at a polyK incubation concentration of 0.1 mg/ml when 
compared to the lower polyK incubation concentrations. Cellularity of scaffolds 
modified at a polyK concentration of 0.1 mg/ml did not significantly change after 24 
h (2.9 ± 0.1x105 cells), but there was a significant increase after 48 h (3.4 ± 0.1x105 
cells) (p<0.05). At a polyK concentration of 1x10-7 mg/ml, scaffold cellularity was 
(3.0 ± 0.2x105) after 24 h, and a significantly higher cellularity of (3.4 ± 0.2x105) was 
found after 48 h (p<0.05). 
 
 
Figure 4.10. Effect of the extent of modification on the adhesion of cells to three-dimensional, porous 
PLLA foams. Two different extents of modification are represented by polyK incubation 
concentrations of 1x10-7 and 0.1 mg/ml; both scaffolds were treated with SPDP and RGDC. A plain 
scaffold was used a control. The (*) denotes the significantly lowest scaffold cellularity (number of 
cells attached per scaffold). (n = 4) 
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4.4. Discussion  
Aiming to create a functionally flexible construct that can be utilized in 
different tissue engineering applications, we have physically entrapped poly(L-lysine) 
(polyK) in the surface of 3-D, poly(L-lactic acid) (PLLA) tissue engineering 
scaffolds. Thus, the main goal of this study was to demonstrate that 1) the entrapment 
could be done easily, efficiently and in a controllable fashion, 2) the modification 
procedure of three dimensional scaffolds, which consisted of soaking the scaffold in 
an acetone-water mixture and later incubating in a polyK solution in DMSO, was 
nondestructive, and the modified surface was stable, 3) the surface could be further 
functionalized (e.g. with pyridyl thiols, free thiols, or bioactive molecules) to induce 
particular responses from the cells, specially cell adhesion by the incorporation of 
RGDC peptides. 
 
The quality and effectiveness of the final, biomimetically modified scaffold 
will greatly depend on the polyK entrapment technique. Therefore, the optimal 
entrapment methodology would be the one that not only yields the most suitable 
amounts of the entrapped polyK but is also easy to carry out and preserves the 
morphologic structure of the scaffold. In this study, we initially determined the 
optimal entrapment technique on two dimensional discs due to the ease of preparation 
and handling of the discs, and then confirmed its feasibility on three-dimensional 
scaffolds. In the latter, the additional application of vacuum to the scaffolds to 
thoroughly penetrate the porous structure was found to be critical because it mitigates 
any problems pose by transport limitations. The criteria used to determine the most 
efficient procedure included the highest amount of entrapped polyK, the homogeneity 
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of polyK distribution throughout the surface, and the preservation of the structure of 
the three-dimensional porous foams. 
 
The total amount of polyK present in the incubation steps of all the assayed 
entrapment procedures was maintained constant so as to be able to make a fair 
comparison among those listed in section 4.2.2. In case a, when the polyK was 
suspended into the solution of PLLA in chloroform prior to making the disks (bulk 
modification), the presence of polyK on the disc’s surface was minimal, as observed 
in Figure 1. In case b (acetone-polyK soaking), where the surface was incubated in a 
suspension of polyK in acetone, the amount of polyK available on the surface was not 
significantly different from that of the bulk modification. Case c (acetone/polyK in 
DMSO soaking), where the disc is soaked in acetone and later incubated in a solution 
of polyK in DMSO, resulted in the highest polyK entrapment. 
 
The main improvement in technique c is the introduction of an intermediate 
stage, before rinsing, where the polyK is dissolved in DMSO. It is important to point 
out that polyK is not soluble in either acetone or chloroform; therefore, it is only 
possible to make polyK suspensions in these systems, and during the experimental 
trials, clusters of the polypeptide could be observed. This phenomenon poses great 
limitations in the efficiency of entrapment and the ability to achieve reproducible 
uniform distributions throughout the surface because not every site is exposed to 
polyK molecules that could be potentially entrapped. DMSO, on the other hand, is a 
solvent for polyK; as a result, every site on the surface of the disc is exposed to polyK 
molecules. Furthermore, the DMSO is responsible for slowing down the dissolution 
of the PLLA, simultaneously hardening the polymer surface and entrapping, at the 
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same time, some of the polyK in solution. A similar softening technique was 
implemented by Cui et al where two-dimensional PLLA surfaces were soaked in an 
acetone/water mixture (7:3) and later in a gelatinous solution, where the water is 
responsible for the unswelling or hardening of the polymer surface 43.  
 
Even though case a (bulk modification) was less efficient than case c, 
quantities of entrapped polyK comparable to those obtained in case c can be reached 
by increasing the amount of polyK incorporated in the PLLA-chloroform solution. 
However, due to the distribution of the polyK throughout the polymer volume in the 
solid phase, some of the characteristics of the material, such as degradation and 
mechanical properties, could be altered, ultimately resulting in a potential limitation 
in the range of applications of the scaffold in tissue engineering, especially when 
mechanical strength is an important factor.  
 
PolyK detection assays with periodate-HRP corroborated the availability of 
active polypeptide on the surface for further linkage of other molecules. The coupling 
of fluorescein-5-maleimide also supported these observations. By observing similar 
fluorescence intensities generated by the fluorescein-5-maleimide in different parts of 
the surface of the discs modified by acetone/DMSO soaking (technique c), we were 
able to infer that a competent level of homogeneity in the distribution of polyK on the 
disc surface had been achieved. The absorbance generated by the release of the group 
pyridine-2-thionee, when SPDP was deprotected with DTT, not only corroborated the 
availability of polyK on the surface of the disks but also demonstrated its reactivity 
and that of the SPDP linked to the polyK. 
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Once the optimal entrapment technique had been determined (technique c), we 
proceeded with the modification of 3-D PLLA porous foams, which posed a challenge 
in terms of achieving homogeneity throughout porous network. The existence of 
capillary forces, the intricacy of the porous network, and the presence of tortuous 
paths inside the scaffold give rise to limitations in the penetration of the solutions into 
deeper sections of the scaffold. This problem was overcome by the application of 
vacuum in the different incubation steps.  A similar vacuum methodology has been 
used in other studies to infiltrate porous constructs prior to cell seeding 30,55,56.  
 
SPDP can be used to deliver either an activated thiol reactive group or a free 
sulfhydryl moiety and thus acts as a linker to attach specific bioactive molecules to 
the polyK surface, expanding the repertoire of molecules that may be attached to 
prepare biomimetic surfaces. Controls in Figure 4.4 eliminate the possible hypothesis 
of labeling of the PLLA surface due to physical absorption of the different reagents 
(polyK, SPDP or fluorescein-5-maleimide). Fluorescein-5-maleimide is only attached 
to the SPDP-linked polyK since no fluorescence was observed in the absence of 
SPDP and presence of polyK. The attachment of the periodate-activated HRP and 
SPDP to the surface demonstrates that the reactivity of the polyK is not dramatically 
changed by the physical interactions with the polymer. At this point, we had 
established a clear and easy protocol for the modification of 3-D porous PLLA 
scaffolds. It was then important to evaluate whether the entrapment could be perform 
in a controllable fashion. 
 
A change in the polyK incubation concentration when modifying 3-D foams 
resulted in different amounts of entrapment, as observed in Figure 4.5, where lower 
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polyK incubation concentrations yielded decreased fluorescence signals. 
Nevertheless, the surface is saturated at higher polyK concentrations (above 1x10-4 
mg/ml). Furthermore, it was demonstrated that at lower polyK incubation 
concentrations (as low as 1x10-8 mg/ml) there was measurable entrapment.  
 
One of the concerns when the surface was prepared was the retainment of the 
polypeptide molecules in the surface; even more important was the preservation of its 
activity for a certain period of time after modification. The results indicate that the 
level of polyK was maintained, and, at the same time, that the reactivity of the polyK 
was not changed during the 10 days of incubation. The time of soaking in PBS was 
chosen based on the account that, by 10 days, cell population and the deposition of a 
collagenous matrix by the cells would have started to dominate cell adhesion 
properties. 
 
After showing that the polyK-derivatized surface was stable, we examined the 
effects of the acetone treatment on the scaffold architecture. The scaffold morphology 
is a key component in tissue engineering approaches because it affects the way cells 
attach to the scaffold and migrate along its surface. Pore structure and 
interconnectivity influence the transportation of nutrients, tissue regeneration and the 
formation of a vascular network when the construct is implanted 4,5,10,11,57. Micro 
computed tomography analysis performed after acetone/DMSO soaking demonstrated 
that scaffold porosity was preserved; moreover, a porous network with high levels of 
pore interconnectivity was found after the treatment, making the modified scaffold 
morphologically suitable for tissue engineering. 
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After being characterized, the surface was further modified to improve cell 
adhesion and thereby illustrate the functional capabilities that will allow it to be 
biomimetic. RGDC peptides were linked to the entrapped polyK by forming a 
disulfide bond with the SPDP. XPS analysis, detection of the release of pyridine-2-
thionee and cell attachment assays demonstrated the presence of RGDC peptides on 
the polymer surface and their linkage to the polyK/SPDP-modified scaffolds. The 
amount of SPDP estimated when reacted with the RGDC was similar to the value 
estimated when unmasked with DTT.  
 
RGD peptides have been demonstrated to enhance cell adhesion and 
deposition of a bone-like matrix on different substrates through the interactions with 
integrin receptors 58-62. Rezania et al. reported that the presence of RGD peptides on 
two dimensional quartz surfaces affected osteoblastic differentiation of mesenchymal 
stem cells by boosting alkaline phosphatase activity and improving the deposition of 
calcium. At the same time a higher surface peptide concentration resulted in an 
increment in these parameters 40. Thus, the incorporation of this peptide into the 
surface is a valuable asset due to its multi-functionality.  
 
In the presence of RGDC peptides cells appeared more stretched, which is a 
sign of a stronger attachment. The rounded appearance of the cells in the unmodified 
discs and at lower extents of modification translates into weaker attachment. Higher 
surface concentrations of RGDC caused larger stretching of the cells seeded on two 
dimensional surfaces, and lower concentrations also seemed to have a significant 
effect when compared to plain surfaces, polyK-modified and polyK-RGDC modified 
surfaces.  
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These results demonstrate that the greatest effect on cell stretching was 
exerted by the whole modification, polyK-SPDP-RGDC, and not by possible 
adsorption of RGDC on the surface of the material or the charges presented by the 
polyK. Incubation of the plain disc in a solution of RGDC seemed to have no 
enhancing effect when compared to the plain polymer, implying minimal adsorption 
of RGDC on the PLLA surface or that the adsorbed RGDC was inactive. The 
improvement on the 3-D scaffold initial cellularity after incorporating small amounts 
of the adhesion peptide on the surface imply that cell-matrix interactions were greatly 
improved, but a higher RGDC surface concentration, represented by a higher amount 
of entrapped polyK, did not further increase scaffold cellularity. Although no 
significant difference was observed on scaffold cellularity when high and low RGDC 
surface concentrations were used, our results from the 2-D studies imply that the 
strength of cell attachment may have increased at higher levels of surface 
modification. The effect of the presence of the peptide on cell attachment observed in 
this study complies with the findings of other researchers in different studies 
12,24,34,40,63-69
. Furthermore, the results from the extended cell culture, which show cell 
growth after 48 h, demonstrate that the modified scaffolds are able to support cell 
proliferation and do not have any appreciable cytotoxic effects. 
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4.5. Conclusions 
 
Poly (L-lactic acid), three-dimensional, tissue engineering scaffolds were 
modified by physically entrapping poly (L-lysine) in their surface in order to create a 
functionally flexible construct that can be utilized for different applications. PolyK, a 
source of amino groups, was homogenously entrapped throughout the surface of 3-D 
foams and in a controllable fashion. The modified surface was stable and the 
modification technique was non-destructive. Further functionalization of the scaffold 
was demonstrated by the incorporation of sulfhydryl compounds and RGDC peptides. 
Cell stretching was greatly affected by the RGDC surface concentration on two 
dimensional disks but did not affect the cellularity of three dimensional scaffolds.  
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Chapter 5 
 
Improved Mesenchymal Stem Cell Seeding on RGD-Modified 
Poly (L-lactic acid) Scaffolds using Flow Perfusion 
 
Chapter Abstract 
Arg-Gly-Asp (RGD) has been widely utilized to increase cell adhesion on 
three dimensional scaffolds for tissue engineering. However, cell seeding on these 
scaffolds has only been carried out statically, yielding low cell seeding efficiencies. 
We have characterized, for the first time, the seeding of rat mesenchymal stem cells 
on RGD-modified poly (L-lactic acid) (PLLA) foams using oscillatory flow 
perfusion. Incorporation of RGD on the PLLA foams improved scaffold cellularity in 
a dose dependent manner under oscillatory flow perfusion seeding. When compared 
to static seeding, oscillatory flow perfusion was the most efficient seeding technique. 
Cell detachment studies showed that cell adhesion depended on the applied flow rate, 
and that cell attachment strengthened at higher levels of RGD modification.  
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5.1 Introduction 
 
Tissue engineering seeks to replace lost or damaged tissue through the use of 
different bioactive factors that can induce regeneration.  Common tissue engineering 
strategies involve the culture of a specific type of cells in a three dimensional scaffold 
that has been appropriately chosen for the desired application.  The cell-seeded 
scaffold is then implanted in the affected area for a complete in vivo regeneration and 
formation of new tissue 1-3. 
 
The scaffold must support cell adhesion, migration and proliferation, as well 
as allow the transport of nutrients to its interior by having sufficient porosity, an 
optimum pore size, and pore interconnectivity.  Ideally, the scaffold should be 
biodegradable and permit progressive tissue formation without compromising the 
mechanical needs at the site of implantation 4-10. A wide variety of techniques and 
materials, both synthetic and natural, have been used to make scaffolds 11-17.  Poly(α-
hydroxy esters) are biodegradable polymers that have been frequently used in tissue 
engineering applications, particularly poly(lactic acid), poly(glycolic acid) and their 
copolymers.  Nevertheless, these polymers can only support cell adhesion and growth 
to a certain extent since they lack functional groups that the cells could interact with 
18
.  The creation of a scaffold that enhances cell-matrix interactions is thus necessary 
in the creation of efficient tissue engineering constructs 17,19. 
 
The development of functionalized scaffolds involves the bulk or surface 
modification of a base biomaterial with growth and differentiation factors 19,20. 
Common modification techniques include chemical modification such as cross-
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linking polymer chains with a bioactive molecule and surface activation through 
hydrolysis, aminolysis or plasma treatment 19,21-27.  Physical modification can also be 
carried out by physisorption of the molecule onto the surface, or by entrapment 27-29.  
Cui et al. entrapped gelatin in the surface of poly(L-lactic acid) (PLLA) films and 
enhanced the attachment of chondrocytes 30.  In this technique, the material is 
incubated in a partial solvent in order to swell the surface and later placed in a 
solution of the modifying agent that can stop the partial dissolution of the base 
material, namely PLLA, so that some of the molecules of the modifying agent are 
entrapped in the surface. A similar modification methodology has been recently 
proposed involving the creation of an amine-functionalized, three-dimensional 
scaffold by entrapping poly (L-lysine) 31.  
 
In this study, we have linked Arg-Gly-Asp (RGD) peptides to the amine 
functionalized scaffold in order to improve cell seeding efficiency on three 
dimensional PLLA foams.  Different two-dimensional surfaces have been modified 
with the adhesion sequence by physical and chemical means, displaying an 
improvement on cells attachment and morphology 32-40. In three dimensional 
scaffolds, RGD peptides have been incorporated mainly by chemically cross-linking 
them with other molecules and materials that demonstrate poor cell adhesion 
characteristics 10,41-49. Some of these studies have shown that the presence of RGD on 
these materials not only improves cell adhesion, but it also supports MSC osteoblastic 
differentiation in a dose dependent manner 41,46,48. However, the effect of RGD on cell 
adhesion has been only studied using static seeding techniques in which a cell 
suspension is added on top of the scaffold in a drop-wise manner.  
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Static seeding has been shown to yield low seeding efficiencies and poor cell 
distributions. Most of the cells stay close to the upper surface of the scaffold, on 
which the suspension was placed 5,50. One way to overcome these limitations is by 
utilizing flow perfusion during the seeding phase 50-54. In flow perfusion systems, the 
construct is press fitted into a chamber, and the cell suspension is perfused through it, 
being forced to flow throughout the scaffold’s porous network. Different systems that 
operate based on the concept of flow perfusion have been utilized to seed polymeric 
scaffolds and shown increases in seeding efficiency and yielded more homogeneous 
cell distributions throughout the scaffolds, compared with static and other dynamic 
systems such as spinner flasks and rotating wall vessels that can only  provide 
convective forces on the exterior area of the scaffold 54-57. 
 
In this study, we have characterized, for the first time, the seeding of MSC on 
RGD-modified PLLA foams using oscillatory flow perfusion. Flow perfusion was 
chosen as the seeding technique since it enhances cell penetration into the scaffold, 
and yields high efficiencies and homogeneous cell distributions 55. Different levels of 
RGD modification were used to evaluate its effect on the number of cells attached to 
the scaffold (scaffold cellularity) at different cell suspension numbers.  Static seeding 
and static seeding followed by the application of unidirectional flow perfusion were 
used as seeding controls.  The different seeding techniques were compared based on 
seeding efficiency, and cell morphology.  Furthermore, the strength of cell attachment 
after the completion of the seeding phase was evaluated by applying unidirectional 
flow at rates larger than the ones used during the seeding phase. 
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5.2 Materials and Methods  
 
5.2.1. Scaffold Preparation  
Poly (L-lactic acid) (Birmingham Polymers, average MW 100,000) foams 
were prepared by particulate leaching, using sodium chloride (NaCl) as the porogen 
20,58
. The grain size of the NaCl was between 300-450µm. Briefly, PLLA was 
dissolved in chloroform at a concentration of 5% w/v. The solution was then poured 
on a sodium chloride bed, and the solvent was allowed to evaporate for 24 h. The 
solid salt-polymer composite, which was 95 wt% NaCl, was pressed in a cylindrical 
mold with an inner diameter of 8 mm at 500 psig, using a hydraulic press, with 
simultaneous heating at 130oC for 30 min. The resulting pellet was cut into discs of 3 
mm in thickness using a low speed diamond wheel saw (Model 650, South Bay 
Technology, Inc). Salt leaching was carried out using deionized water for 3 days, and 
the water was changed at least twice a day. The scaffolds had a porosity of 90% 
determined as the percentage ratio of the weight of the scaffold to the weight of a 
solid PLLA disc with the same dimensions. 
 
5.2.2. Surface Modification 
A technique has been developed and characterized for the surface modification 
of PLLA three-dimensional scaffolds 31. Briefly, this technique consists on the 
physical entrapment of poly (L-lysine) (PolyK, 4000 MW, Pierce) on the surface of 
the polymer, and generates a homogeneous distribution of the polyK throughout the 
entire scaffold surface. The polyK entrapment can be done in a controllable fashion 31. 
The surface can then be further functionalized by linking bioactive molecules of 
interest to the entrapped polyK using amine coupling chemistries. In this study, 
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RGDC peptides were linked to the polyK by creating a disulfide bond using N-
Succinimidyl 3-(2-pyridyldithio) propionate (SPDP). Briefly, foams were soaked in a 
1:3 acetone-water mixture for 1 h. Then, they were placed in 1 ml of a solution of 
PolyK in dimethyl sulfoxide (DMSO) at 0.1, 1x10-4, or 1x10-7 mg/ml for 12 h. 
Rinsing was carried out after that with 0.1% Triton X-100, followed by three washes 
with deionized water. PolyK-modified surfaces were incubated in 600µl of 1mM 
SPDP in HEPES buffer (pH 8.3) for 30 min. One cycle of rinsing with 0.1% Triton X-
100 and three cycles with phosphate buffered saline (PBS) were performed 
succeeding the reaction. Surfaces were incubated in 100µM RGDC for one hour and 
rinsed. All the modification stages were carried out under vacuum and vigorous 
shaking. Controls in this study included scaffolds modified with polyK only and plain 
scaffolds incubated in the RGDC solution. All control scaffolds were rinsed with 
0.1% Triton X-100, followed by three washes with PBS.  
 
5.2.3. Cell Culture 
Adult mesenchymal stem cells (MSC) were isolated from the bone marrow of 
eight-week-old male Wistar® rats (Harland Laboratories) using well established 
methods 59,60. Briefly, rats were euthanized, and the tibiae and femura were extracted. 
The epiphyses were cut off, and the bone marrow was flushed and suspended in α-
modified essential media (α-MEM, Atltanta Biological) supplemented with 10% fetal 
bovine serum (Atlanta Biological). The suspension was then distributed in 
polystyrene culture flasks (75 cm2). Cells were cultured at 37oC and 5% CO2. Non-
adherent cells were discarded after two days of culture. At 70% confluency, MSC 
were detached using trypsin (Invitrogen), centrifuged at 400g for 5 min, re-suspended 
in α-MEM and re-plated until the 3rd passage. Cells from the 3rd passage were 
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detached and resuspended in fresh α-MEM. Seeding densities were 5x105 and 1x106 
cells in 250µl of α-MEM.  
 
5.2.4. Scaffold Seeding 
An oscillatory flow perfusion seeding technique that improves seeding 
efficiency, cell spatial distribution and strength of cell adhesion was developed and 
characterized in our laboratory [55]. This flow perfusion system was also utilized in 
long term culture studies of MSC seeded in three dimensional scaffolds 51,61,62. 
Briefly, scaffolds were confined in cassettes so as to force the flow throughout the 
porous network and restrict it from going around the scaffold. The cassettes were 
placed into the perfusion chambers of the main body of the bioreactor, which consists 
of a total of six chambers. Culture media was pumped to the top of the chambers 
using a peristaltic pump (Cole-Parmer) from a media reservoir and returned to a 
second reservoir, allowing recirculation. 
 
Prior to seeding, the flow system was cured with α-MEM for 2 h. Scaffolds 
were press-fitted into cassettes and placed in the flow perfusion chambers of the 
bioreactor. Cell suspensions were poured on top of the scaffolds, and the chambers 
were filled up with fresh media to avoid the presence of air bubbles. Oscillating flow 
was then applied for 2 h at 0.15 ml/min by manually changing the direction of the 
pump every 5 min. This cycle time was previously demonstrated to be sufficient for 
all the cells to go through the scaffold before changing the direction of the flow 55. 
Cell conditioning, without flow, was allowed for an additional period of 2h, after 
which unidirectional flow was incorporated at 0.15 ml/min for 8h. Static seeding was 
used as a seeding control. In this technique, the scaffolds are placed in cassettes 
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similar to those of the bioreactor system, and the cell suspension is added drop-wise 
on top of the scaffold. Cells were allowed to attach for 12h. In most flow perfusion 
studies, the scaffolds are seeded statically and then placed in the perfusion system for 
application of unidirectional flow 51,53,55,61-63. Thus, a combination of dynamic and 
static seeding that emulates the initial stages of previous flow perfusion studies was 
also carried out by drop-wise adding the suspension on top of the scaffolds, allowing 
the cells to attach for 4h in the absence of flow, and then applying unidirectional flow 
in the flow perfusion system at 0.15 ml/min for 8h to mimic the last phase of the 
oscillatory seeding and measure any potential cell detachment from the statically 
seeded scaffolds due the presence of unidirectional flow.  
 
5.2.5. Detachment Studies 
All RGD-modified scaffolds were seeded dynamically as previously explained 
by applying oscillatory flow for 2h, letting the cells condition for 2 h without flow, 
and finally applying unidirectional flow perfusion for 8h at 0.15, 0.5 and 1 ml/min. 
The shear stress (dyn/cm2) experienced by the cells under the different rates of flow 
perfusion can be estimated by using a model for parabolic flow through cylindrical 
pores: 
 
2
πdD
Q  32
τ
φ
µ
=                    (5.1) 
 
Where µ is the medium viscosity (0.01 g/cm.s), φ is the scaffold porosity, d is the pore 
diameter, and D is the scaffold diameter 53. 
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4.2.6. Evaluation of cell morphology on RGD-modified scaffolds 
RGD-modified scaffolds at polyK concentrations of 1x10-7 and 0.1 mg/ml 
seeded statically or dynamically were fixed in 3.7% buffered formalin for 10 min. 
They were then rinsed with 0.1% Triton-X-100 and PBS. Cells were labeled with 2 
units of BODIPY® FL phalloidin (Invitrogen), a high affinity probe for F-actin, for 20 
min. After rinsing, fluorescence microscopy was performed using a Nikon 
Epifluorescence microscope, and image analysis was carried out with MetaMorph 6.2 
(Universal Imaging Corporation). The excitation and emission wavelengths were 
558nm and 569 nm, respectively. Images were captured at the top surface on which 
the cell suspension was placed and at the bottom surface. 
 
5.3.7. Determination of the number of cells attached to the scaffolds (Scaffold 
Cellularity) 
After seeding, scaffolds were quickly rinsed in PBS, suspended in 3 ml of 
deionized water, and broken down into small pieces. Samples were later submitted to 
three cycles of freeze/thaw to lyse the cells. A picogreen® DNA quantification assay 
(Invitrogen) was performed to obtain the number of cells attached to the scaffolds. A 
standard curve was made using known-concentration solutions of λDNA. Sample and 
standard aliquots of 43 µl were accommodated in a 96-well plate, along with 107 µl 
of reaction buffer (20mM Tris-HCl, 1 mM EDTA, pH 7.5) and 150 µl of the 
Picogreen® dye. Fluorescence was measured (490 nm excitation and 520 nm 
emission) using a Synergy HT plate reader (Biotek). The number of cells was 
calculated using the total amount of DNA determined in the sample divided by the 
amount of DNA contained in one cell. Based on the number of cells attached to the 
scaffold, we were able to determine the seeding efficiency, which is defined as the 
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percentage ratio of the number of cells attached to the scaffold to the initial number of 
cells in suspension. 
 
5.2.8. Statistical analysis 
For all the experiments, three to five samples were used (n = 3-5), unless 
otherwise specified. Values were reported as the average of all the samples, and the 
error was reported as the standard error of the mean. The data were analyzed by using 
ANOVA, and multiple pair-wise comparisons were carried out using the Tukey-HSD 
method at a confidence level of 95%. 
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5.3 Results  
 
5.3.1. Effect of RGD modification on scaffold cellularity after oscillatory flow 
perfusion seeding 
Scaffold cellularity for all RGD-modified scaffolds seeded under oscillatory 
flow perfusion is shown in Figure 5.1. The level of RGD modification is reported as 
the concentration of polyK in the incubation stage of the modification procedure 
before linking the SDPD and RGDC. Higher polyK concentration translates into a 
larger amount of RGDC present on the surface. Under oscillatory flow perfusion 
seeding, the lowest level of RGD modification (polyK-SPDP-RGDC), represented by 
a polyK incubation concentration of 1x10-7 mg/ml, yielded a scaffold cellularity 
significantly higher than those yielded by the controls (plain scaffold, polyK-modified 
scaffold without RGDC, and plain scaffold incubated in an RGDC solution). Further 
increases in the polyK incubation concentration resulted in significantly higher 
scaffold cellularities. 
 
Figure 5.2 shows the dependence of scaffold cellularity with the initial number 
of cells in suspension for all levels of modification. It can be seen that the scaffold 
cellularity increased with the initial number of cells in suspension for all RGD 
modification levels. A cell suspension number of 1x106 nearly doubled scaffold 
cellularity at all polyK incubation concentrations. At any cell suspension number 
scaffold cellularity significantly increased along with the RGD modification level. 
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Figure 5.1. Scaffold cellularity at different levels of RGD modification after oscillatory flow perfusion 
seeding at 0.15 ml/min. Number of cells in suspension was 5x105. The x-axis shows the levels of RGD 
modification represented by polyK incubation concentrations during the polyK entrapment phase, with 
the pattern of modification used (±polyK/±RGDC). Controls for this set of experiments included plain 
scaffold, scaffolds modified with polyK only at 0.1 mg/ml (no RGDC), and plain scaffolds incubated in 
an RGDC solution. (* p< 0.05). 
 
 
Figure 5.2. Dependence of scaffold cellularity on the cell suspension number at different levels of 
modification. Scaffolds were seeded under oscillatory flow perfusion at 0.15 ml/min. (#) and (&) 
represent respectively the highest and the lowest scaffold cellularity at a given cell suspension number. 
(* p< 0.05). 
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5.3.2. Effect of oscillatory flow perfusion on seeding efficiency of RGD-modified 
scaffolds 
In Figure 5.3, oscillatory flow perfusion seeding of RGD-modified scaffolds is 
compared to static seeding, and static seeding followed by unidirectional flow 
perfusion. The comparison is made in terms of seeding efficiency. For plain scaffolds 
and at a polyK incubation concentration of 0.1 mg/ml, oscillatory flow perfusion 
seeding yielded the highest seeding efficiency when compared to static seeding, 
achieving values of (22±2%) and (64±2%), respectively. In all cases, the static 
seeding followed by unidirectional flow perfusion yielded the lowest efficiency, 
reaching values as low as (10±1%) for plain scaffolds and as high as (34±4%) at a 
polyK concentration of 0.1 mg/ml. A polyK incubation concentration of 0.1 mg/ml 
yielded the highest seeding efficiency for flow perfusion seeding and static seeding 
followed by unidirectional flow perfusion (34±4%), while plain scaffolds yielded the 
lowest efficiency when compared to the other modification levels at flow perfusion 
seeding, static seeding (17±2%), and static followed by unidirectional flow perfusion 
(10±1%). Under static seeding, there were no statistical differences on seeding 
efficiency between the different levels of modification. 
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Figure 5.3. Dependence of seeding efficiency on the different techniques used to seed RGD-modified 
scaffolds at different modification levels. Flow rate applied in the flow perfusion system was 0.15 
ml/min. Number of cells in suspension was 5x105. (&) and (#) represent the seeding technique that 
yielded the highest and the lowest cellularity at a given polyK incubation concentration. (* p< 0.05). 
 
Figure 5.4 shows the effect of seeding technique on cell morphology on RGD-
modified scaffolds at polyK incubation concentrations of 1x10-7 and 0.1 mg/ml. On 
scaffolds seeded statically, cells appeared rounded in shape and were mostly clustered 
at the top surface, where the cell suspension was placed (Figure 5.4 c and g). Some of 
these clusters seemed to be attached to the pore walls only through a single cell. Cell 
density was higher at the edges of the scaffolds. These observations were found at 
both the lowest and highest RGD-modification levels. There were no cells found at 
the bottom surface on statically seeded scaffolds (Figure 5.4 d and h). On scaffolds 
seeded under oscillatory flow perfusion, a lower cell density was found at the top 
(Figure 5.4 a and e) compared to statically seeded foams, but a significant number of 
cells was found on the bottom surface of the scaffold (Figure 5.4 b and f).Fewer and 
smaller cell clusters were found at the top, specially at the lower modification lever, 
where cells still looked rounded with only some of them showing significant 
stretching (Figure 5.4e). At the highest modification level, cells looked clearly 
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stretched along the edges of the pore, and virtually no clusters were visible (Figure 
5.4a). A uniform cell density was observed throughout the upper and lower surfaces. 
 
Figure 5.4. Fluorescence microscopy of 
the top and bottom surfaces of RGD-
modified scaffolds seeded statically or 
under flow perfusion. The top surface is 
where the initial cell suspension was 
placed. Number of cells in suspension 
was 5x105. Images of scaffolds 
modified at a polyK incubation 
concentration of 0.1 mg/ml: (a) 
oscillatory flow perfusion, top (b) 
oscillatory flow perfusion, bottom (C) 
static, top (d) static, bottom. Images of 
scaffolds modified at a polyK 
incubation concentration of 1x10-7 
mg/ml: (e) oscillatory flow perfusion, 
top (f) oscillatory flow perfusion, 
bottom (g) static, top (h) static, bottom. 
Calibration bar: 195 µm. 
 
 
5.3.3. Cell detachment on dynamically seeded RGD-modified scaffolds 
The percentage of cells seeded statically that detached when submitted to 
unidirectional flow perfusion decreased at higher levels of RGD modification. At 
polyK incubation concentrations of 1x10-4 and 1x10-7 mg/ml the percent of 
detachment was 50% and 67% respectively.  While only 38% of the cells seeded 
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statically were detached when flow was applied to scaffolds modified with a polyK 
incubation concentration of 0.1 mg/ml. 
 
Figure 5.5. Detachment profile of cells seeded under oscillatory flow perfusion on RGD-modified 
scaffolds. Unidirectional flow rate refers to the phase of flow shearing applied after the 2 h of 
oscillatory flow and 2 h of cell conditioning without flow. Number of cells in suspension was 5x105. 
(&) represents the flow rate that yielded the highest scaffold cellularity at a given polyK incubation 
concentration. (*) represents the flow rate that yielded the lowest scaffold cellularity at a given polyK 
incubation concentration. (#) represents the level of modification that yielded the highest cellularity at a 
given flow rate. (+) represents the level of modification that yielded the lowest cellularity at a given 
flow rate. 
 
Results for the cell detachment studies on scaffolds seeded under oscillatory 
flow perfusion are shown in Figure 5.5. In these studies, we varied the flow rate at the 
unidirectional flow perfusion phase of the dynamic seeding in order to evaluate how 
well the cells attached to the scaffold. The shear stress experienced by the cells under 
the conditions of detachment was estimated, through equation 5.1, to be in the range 
of 0.02 to 0.15 dyn/cm2. These values of shear stress are lower than that experienced 
by osteocytes under physiological interstitial shear (8-30 dyn/cm2) or by endothelial 
cells in a superficial femoral artery (2.7 dyn/cm2) (refs). Cellularity of RGD-modified 
scaffolds decreased at higher flow rates for all modification levels. At all flow rates, 
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scaffold cellularity was directly dependant on the RGD modification level. However, 
detachment was more pronounced at lower RGD modification levels. At polyK 
incubation concentrations of 1x10-7 and 1x10-4 mg/ml, 43% of the cells that adhered 
originally were detached after applying a flow rate of 1.0 ml/min, while at 0.1 mg /ml 
the percentage of detachment significantly decreased to 39%. 
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5.4. Discussion 
 
The objective of this study was to evaluate the effect of the presence of RGD, 
at different modification levels, on cell adhesion when seeding MSC on PLLA 
scaffolds under oscillatory flow perfusion conditions. Specifically: a) we assessed the 
effect of the RGD modification level on the cellularity of PLLA foams seeded under 
static or oscillatory flow perfusion conditions, b) we compared the oscillatory flow 
perfusion with static seeding in terms of cell seeding efficiency and cell morphology 
on RGD-modified PLLA scaffolds, and c) we examined the levels of cell detachment 
in statically and oscillatory flow perfusion seeded RGD-modified scaffolds after their 
exposure for 8 h to different unidirectional fluid flow perfusion rates.  
 
5.4.1. Effect of RGD modification on scaffold cellularity after oscillatory flow 
perfusion and static seeding 
Cell adhesion on modified PLLA foams under oscillatory flow perfusion 
seeding was enhanced by the presence of RGDC in a dose dependent manner. MSC 
adhesion was improved mostly due to the presence of the RGDC linked to entrapped 
polyK. Scaffolds modified with polyK only (no RGDC) or plain scaffolds incubated 
in RGDC (no polyK) displayed small improvement on scaffold cellularity when 
compared to all the levels of RGD modification (polyK-SPDP-RGDC) (Figure 5.1). 
This is corroborated by the increased cellularity at increased modification levels. This 
pattern persisted when different cell suspension densities were used (Figure 5.2). 
Previous studies have also shown that cell attachment is dose dependent on RGD 
modification levels. However, these studies have only used static seeding 46,48,59. In 
this study, RGD modification improved cell seeding efficiency under any seeding 
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technique. Unlike the dose dependent behavior of cell seeding efficiency under 
oscillatory flow perfusion, static seeding conditions resulted in comparable scaffold 
cellularities at every level of RGD modification. However, the pattern of increased 
cellularity at increased RGD modification levels reappears after submitting statically 
seeded scaffolds to unidirectional flow perfusion at the lowest flow rate utilized in our 
experiments (Figure 5.3). A potential reason for this behavior could be that weakly 
adherent cell clusters that appear predominantly on statically seeded scaffolds (Figure 
5.4) are detached easier from scaffolds containing low RGD modification levels in the 
presence of fluid flow. Among all the seeding techniques, oscillatory flow perfusion 
not only demonstrated the strongest influence of RGD modification level on scaffold 
cellularity, but it also significantly improved cell seeding for the same level of RGD 
modification when compared to the traditional static seeding technique.  
 
It is important to note that after using that after increasing the polyK 
incubation concentration by six orders of magnitude, scaffold cellularity increased in 
only about 80-90%. It was expected a larger increase in scaffold cellularity; however, 
a previous study carried out in our group made estimations on the amount of 
entrapped polyK at different incubation concentrations. A merely three-fold increase 
in the amount of polyK entrapped, from about 23 to 64 pg, was observed when the 
incubation concentration was increased from 1x10-7 to 0.1 mg/ml (six orders of 
magnitude) 31. 
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5.4.2. Comparison of oscillatory flow perfusion and static seeding of RGD-
modified scaffolds 
Long term cultures performed in flow perfusion systems are often preceded by 
static seeding outside the bioreactor 51,53,60-65. Nevertheless, static seeding is not an 
ideal method because it yields low seeding efficiencies and poor cell distribution 
throughout the scaffold’s porous network 54,56,57. Oscillatory flow perfusion, on the 
other hand, ensures flow throughout the porous network and thereby allows more 
cells to reach the interior of the scaffold. Thus, more of the surface area available for 
adhesion can be utilized by the cells. Oscillatory flow perfusion seeding inherently 
allows the cells to penetrate the scaffold multiple times from the top and the bottom, 
thus increasing the probabilities for cell attachment and consequently leading to 
increased seeding efficiency. Oscillatory flow perfusion seeding has been shown to 
improve cell seeding efficiency in unmodified polymeric scaffolds containing no 
adhesion molecules when compared to static seeding 55.This observation was 
supported by our findings where in plain scaffolds, oscillatory flow perfusion yielded 
the highest seeding efficiency (Figure 5.3).  
 
Although oscillatory flow perfusion seeding was expected to improve cell 
seeding efficiency when compared to static techniques, the combined effect of this 
seeding technique with the presence of RGD peptides on the scaffold surface was not 
obvious. Even though static seeding in some cases yielded seeding efficiencies higher 
than (polyK, 1x10-7 mg/ml) or equal (polyK, 1x10-4 mg/ml) to those yielded by the 
oscillatory flow perfusion (contrary to the behavior observed in plain scaffolds), the 
significant decrease on scaffold cellularity when statically seeded scaffolds are 
submitted to unidirectional flow perfusion indicates that oscillatory flow perfusion is 
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preferable over static seeding. Performing the seeding in the flow perfusion system 
provides an additional advantage when long term culture under flow perfusion is 
attempted since scaffold handling would be minimized by performing the seeding in 
the same environment as the long term culture. Seeding scaffolds statically and 
transporting them into the bioreactor poses an increased risk of contamination due to 
excessive manipulation.  
 
This conclusion is also supported by the microscopy results where it was 
found that under conditions of flow perfusion cells appeared to stretch along the pore 
edges of the top surface (Figure 5.4), demonstrating improved cell-matrix interactions 
when compared to the static seeding. Furthermore, microscopy also demonstrated a 
greater degree of penetration of the cells under dynamic seeding than under the static 
technique evident from the abundant presence of cells at the bottom surface of the 
scaffold (Figure 5.4), implying improved cell distribution.  
 
5.4.3. Cell detachment on oscillatory flow perfusion seeded RGD-modified 
scaffolds 
Cell detachment under different flow conditions has been studied on two-
dimensional surfaces containing adhesion peptides. It has been reported that the extent 
of cell detachment increases with the shear forces caused by the flow rate applied on 
the surface 66-69. Our studies demonstrate that this behavior extrapolates to cells 
seeded on a three dimensional porous network. Increased flow rates, which translate 
into higher shear forces, result in greater cells detachment from the scaffold at all 
RGD modification levels. However, the highest level of RGD modification resulted in 
the lowest cell detachment (reported as the ratio of the remaining cells on the scaffold 
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to the number of cells originally attached) after applying a flow rate of 1 ml/min. 
Thus, the highest level of RGD modification not only generates scaffolds with the 
highest cellularity after oscillatory flow perfusion seeding (compared to the lower 
RGD modification levels), but it also retains the largest portion of these cells in the 
presence of increased shear forces.   
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5.5. Conclusions 
 
 
For the first time, the oscillatory flow perfusion seeding of rat MSC on RGD-
modified PLLA foams has been characterized. Scaffold cellularity was improved by 
the incorporation of RGDC peptides in a dose-dependent manner. Furthermore, it was 
demonstrated that oscillatory flow perfusion was the most efficient seeding technique 
when compared to the more traditional static seeding. Cell detachment increased at 
higher unidirectional flow rates, and the extent of cell detachment was also dependent 
on the level of RGD modification. The use of oscillatory flow perfusion seeding of 
RGD-modified foams will allow the efficient preparation of uniformly seeded 
scaffolds with MSC or mature osteoblastic cells prior to implantation, and in addition 
the design of long term culture studies of MSCs seeded uniformly on three 
dimensional scaffolds in the absence of clustered cells that do not sense the signaling 
moieties attached to the scaffold’s surface. 
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Chapter 6 
 
RGD Peptides Affect the Osteoblastic Differentiation of Rat 
Mesenchymal Stem Cells under Flow Perfusion in a Dose 
Dependent Manner 
 
Chapter Abstract 
Arg-Gly-Asp (RGD) peptides incorporated into different biomaterials have 
been shown to up-regulate the osteoblastic differentiation of mesenchymal stem cells 
(MSC). However, the effect of RGD on MSC osteoblastic differentiation has been 
carried out mostly statically. It has been reported that flow perfusion also has an 
enhancing effect on MSC osteoblastic differentiation. Nonetheless, there is a lack of 
studies that combine RGD surface modification of biomaterials with the mechanical 
stimulation of MSCs due to flow perfusion. In the present study, the effect of the 
RGD modification level of poly(L-lactic acid) scaffolds on osteoblastic differentiation 
under conditions of flow perfusion was evaluated for the first time. It was found that 
there is an enhanced effect on the combination of flow perfusion and the presence of 
RGD on the surface of PLLA foams when compared to their individual effects. 
Furthermore, under conditions of flow perfusion, there exists a critical RGD surface 
concentration that is flow rate dependant. 
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6.1 Introduction 
 
Bioreactors have been widely used in emerging tissue engineering approaches 
to impart certain forces that imitate different mechanical stimuli occurring in the body 
1,2
. These stimuli enhance the proper formation of in vitro generated extracellular 
matrix (ECM) that, to a certain extent, mimic the physiological morphology of the 
desired tissue 3-5. However, these devices are not limited to the sole application of 
mechanical stimuli; they must meet other requirements in order to create grafts that, 
when implanted, will lead to the regeneration of damaged organs. A bioreactor must 
efficiently transport nutrients and oxygen to the construct, maintaining an appropriate 
concentration in solution 6. In most tissue engineering applications, a scaffold is 
seeded with cells and supports the formation of ECM 7. Consequently, the bioreactor 
has to induce a homogeneous cell distribution throughout these structures in order to 
generate a uniformly distributed ECM 2. 
 
The scaffolding material must support cell adhesion, migration and 
proliferation.  It must also allow the transport of nutrients to its interior by having 
sufficient porosity, an optimum pore size, and pore interconnectivity.  These 
parameters not only affect the nutrient transport into the scaffold but also the 
formation of new tissue and the establishment of a vascular network that will 
guarantee the survival of the de novo tissue.  Ideally, the scaffold should be 
biodegradable and permit progressive tissue formation without compromising the 
fulfillment of the mechanical requirements at the site of implantation 8-14. 
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Different materials, both natural and synthetic, have been used to create a wide 
array of scaffolds for different tissue engineering applications using numerous 
techniques15-21. Poly(α-hydroxy esters), which include poly(lactic acid), poly(glycolic 
acid) and their copolymers,  are biodegradable polymers that have been widely used 
in tissue engineering applications. Nevertheless, these polymers can only support cell 
adhesion and growth to a certain extent since they lack functional groups that the cells 
could interact with 22.  The creation of a scaffold that enhances cell-matrix 
interactions is thus imperative in the creation of efficient tissue engineering constructs 
21,23
. 
 
The development of functionalized, biomimetic scaffolds involves the bulk or 
surface modification of a base biomaterial using growth and differentiation factors 
23,24
. Common modification techniques include chemical modification such as cross-
linking polymer chains with a bioactive molecule and surface activation through 
hydrolysis, aminolysis or plasma treatment 23,25-31.  Physical modification can also be 
carried out by physisorption of the molecule onto the surface, or by entrapment 31-33.  
Cui et al. entrapped gelatin in the surface of poly(L-lactic acid) (PLLA) films and 
enhanced the attachment of chondrocytes 34.  A similar modification methodology has 
been recently proposed involving the creation of an amine-functionalized, three-
dimensional scaffold by entrapping poly (L-lysine) 35. Different bioactive molecules 
appropriate for specific tissue engineering applications can be further linked to the 
amine groups present on the surface. 
 
In this study, we have linked Arg-Gly-Asp (RGD) peptides to the amine 
functionalized scaffold in order to improve cell seeding efficiency on three 
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dimensional PLLA foams and assess its effect on the osteoblastic differentiation of 
MSCs.  This amino acid sequence has been demonstrated to improve cell adhesion to 
different materials 26,32,36-40. The RGD sequence is encountered in different 
extracellular matrix components such as fibronectin, osteopontin and bone 
sialoprotein, and cells interact with this sequence through integrin receptors 41. 
Improvement on the adhesion of different types of cells via RGD incorporation has 
been carried out on 2D and 3D surfaces 6,38-60. Ceramic, glass, hydroxyapatite and 
polymeric two-dimensional surfaces have been modified with the adhesion sequence 
by physical and chemical means, displaying an improvement on cells attachment and 
morphology 38,39,41,45-48,51,57.  
 
In three dimensional scaffolds, RGD peptides have been incorporated mainly 
by chemically cross-linking them with other molecules such as collagen, chitosan and 
poly(ethylene glycol) and materials that demonstrate poor cell adhesion 
characteristics 6,14,40,43,49,50,58-61. Some of these studies have shown that the presence of 
RGD on these materials not only improves cell adhesion, but it also supports MSC 
osteoblastic differentiation in a dose dependent manner 6,40,58. However, the effect of 
RGD on the osteoblastic differentiation of MSCs in three dimensional environments 
has been mostly studied statically.  
 
Static culture of cells in three dimensional scaffolds posses limitations on the 
transport of nutrients to the interior of the scaffolds, and thereby cell and matrix 
distributions throughout the scaffold’s surface lack a sufficient level of homogeneity. 
One way to overcome these limitations is by utilizing flow perfusion during the 
seeding phase 62-66. In flow perfusion systems, the construct is press fitted into a 
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chamber, and the culture medium is perfused through it, being forced to flow 
throughout the scaffold’s porous network. Different systems that operate based on the 
concept of flow perfusion have been utilized to culture cell-seeded polymeric 
scaffolds, not only showing more homogeneous cell and matrix spatial distribution 
when compared to the static cultures but also improved osteogenic MSC 
differentiation by yielding higher levels of secreted calcium, alkaline phosphatase 
activity and other osteogenic markers. These improvements have been found with 
respect to static cultures and other dynamic systems such as spinner flasks and 
rotating wall vessels that can only  provide convective forces on the exterior area of 
the scaffold 66-69. A previous study have shown that the incorporation of RGD, 
through physisorption, improves MSC adhesion and their osteoblastic differentiation 
under conditions of flow perfusion 70. 
 
In the present study, we evaluate the effect of different extents of RGD 
incorporation into PLLA foams on the osteogenic differentiation of MSCs under 
conditions of flow perfusion at different flow rates. Static culture controls without 
flow but seeded the same way have been used as controls. Additionally, we have 
utilized an oscillatory flow perfusion seeding technique which has been shown to 
yield higher seeding efficiencies and more homogeneous cell distributions when 
compared to static seeding.  
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6.2. Materials and Methods 
 
6.2.1. Scaffold Preparation  
Poly (L-lactic acid) (Birmingham Polymers, average MW 100,000) foams 
were prepared by particulate leaching, using sodium chloride (NaCl) as the porogen 
24,71
. The grain size of the NaCl was between 200-350µm. Briefly, PLLA was 
dissolved in chloroform at a concentration of 5% w/v. The solution was then poured 
on a sodium chloride bed, and the solvent was allowed to evaporate for 24 h. The 
solid salt-polymer composite, which was 95 wt% NaCl, was pressed in a cylindrical 
mold with an inner diameter of 8 mm at 500 psig, using a hydraulic press, with 
simultaneous heating at 130oC for 30 min. The resulting pellet was cut into discs of 3 
mm in thickness using a low speed diamond wheel saw (Model 650, South Bay 
Technology, Inc). Salt leaching was carried out using deionized water for 3 days, and 
the water was changed at least twice a day. The scaffolds had a porosity of 90% 
determined as the percentage ratio of the weight of the scaffold to the weight of a 
solid PLLA disc with the same dimensions. 
 
6.2.2. Surface Modification 
A technique has been developed and characterized for the surface modification 
of PLLA three-dimensional scaffolds 35. Briefly, this technique consists on the 
physical entrapment of poly (L-lysine) (PolyK, 4000 MW, Pierce) on the surface of 
the polymer, and generates a homogeneous distribution of the polyK throughout the 
entire scaffold surface. The polyK entrapment can be done in a controllable fashion 35. 
The surface can then be further functionalized by linking bioactive molecules of 
interest to the entrapped polyK using amine coupling chemistries. In this study, 
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RGDC peptides were linked to the polyK by creating a disulfide bond using N-
Succinimidyl 3-(2-pyridyldithio) propionate (SPDP). Briefly, foams were soaked in a 
1:3 acetone-water mixture for 1 h. Then, they were placed in 1 ml of a solution of 
PolyK in dimethyl sulfoxide (DMSO) at 0.1, 1x10-4, or 1x10-7 mg/ml for 12 h. 
Rinsing was carried out after that with 0.1% Triton X-100, followed by three washes 
with deionized water. PolyK-modified surfaces were incubated in 600µl of 1mM 
SPDP in HEPES buffer (pH 8.3) for 30 min. One cycle of rinsing with 0.1% Triton X-
100 and three cycles with phosphate buffered saline (PBS) were performed 
succeeding the reaction. Surfaces were incubated in 100µM RGDC for one hour and 
rinsed. All the modification stages were carried out under vacuum and vigorous 
shaking. Controls in this study included scaffolds modified with polyK only and plain 
scaffolds incubated in the RGDC solution. All control scaffolds were rinsed with 
0.1% Triton X-100, followed by three washes with PBS.  
. 
6.2.3. Cell Culture 
Adult mesenchymal stem cells (MSC) were isolated from the bone marrow of 
eight-week-old male Wistar® rats (Harland Laboratories) using well established 
methods 70,72. Briefly, rats were euthanized, and the tibiae and femura were extracted. 
The epiphyses were cut off, and the bone marrow was flushed and suspended in α-
modified essential media (α-MEM, Atltanta Biological) supplemented with 10% fetal 
bovine serum (Atlanta Biological). The suspension was then distributed in 
polystyrene culture flasks (75 cm2). Cells were cultured at 37oC and 5% CO2. Non-
adherent cells were discarded after two days of culture. At 70% confluency, MSC 
were detached using trypsin (Invitrogen), centrifuged at 400g for 5 min, re-suspended 
in α-MEM and re-plated until the 3rd passage. Cells from the 3rd passage were 
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detached and resuspended in fresh α-MEM. Seeding densities were 5x105 and 1x106 
cells in 250µl of α-MEM.  
 
6.2.4. Scaffold Seeding 
An oscillatory flow perfusion seeding technique that improves seeding 
efficiency, cell spatial distribution and strength of cell adhesion was developed and 
characterized in our laboratory 67. This flow perfusion system was also utilized in long 
term culture studies of MSC seeded in three dimensional scaffolds 62,73,74. Briefly, 
scaffolds were confined in cassettes so as to force the flow throughout the porous 
network and restrict it from going around the scaffold. The cassettes were placed into 
the perfusion chambers of the main body of the bioreactor, which consists of a total of 
six chambers. Culture media was pumped to the top of the chambers using a 
peristaltic pump (Cole-Parmer) from a media reservoir and returned to a second 
reservoir, allowing recirculation.  
 
Prior to seeding, the flow system was cured with α-MEM for 2 h. Scaffolds 
were press-fitted into cassettes and placed in the flow perfusion chambers of the 
bioreactor. Cell suspensions were poured on top of the scaffolds, and the chambers 
were filled up with fresh media to avoid the presence of air bubbles. Oscillating flow 
was then applied for 2 h at 0.15 ml/min by manually changing the direction of the 
pump every 5 min. This cycle time was previously demonstrated to be sufficient for 
all the cells to go through the scaffold before changing the direction of the flow 67. 
Cell conditioning, without flow, was allowed for an additional period of 2h, after 
which unidirectional flow was incorporated at 0.15 ml/min for 8h.  
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6.2.5. Long term cultures 
After oscillatory perfusion seeding, the scaffolds were cultured statically or in the 
bioreactor. In the static culture, the seeded scaffolds were placed in 6-well Petri 
dishes. The wells were filled with fresh a-MEM, and the cultures were carried out for 
4, 8 and 16 days. Culture medium was changed every three days. In the flow 
perfusion culture (also called dynamic culture), after scaffold seeding, unidirectional 
flow perfusion was applied for 3, 8 and 16 days at flow rates of 0.1 and 1.0 ml/min. 
Total changes of medium in the flow perfusion system were carried out every three 
days.  
 
6.2.6. Determination of the number of cells attached to the scaffolds (Scaffold 
Cellularity) 
After every culture time point, scaffolds were quickly rinsed in PBS, 
suspended in 3 ml of deionized water, and broken down into small pieces. Samples 
were later submitted to three cycles of freeze/thaw to lyse the cells. A picogreen® 
DNA quantification assay (Invitrogen) was performed to obtain the number of cells 
attached to the scaffolds. A standard curve was made using known-concentration 
solutions of λDNA. Sample and standard aliquots of 43 µl were accommodated in a 
96-well plate, along with 107 µl of reaction buffer (20mM Tris-HCl, 1 mM EDTA, 
pH 7.5) and 150 µl of the Picogreen® dye. Fluorescence was measured (490 nm 
excitation and 520 nm emission) using a Synergy HT plate reader (Biotek). The 
number of cells was calculated using the total amount of DNA determined in the 
sample divided by the amount of DNA contained in one cell. Based on the number of 
cells attached to the scaffold, we were able to determine the seeding efficiency, which 
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is defined as the percentage ratio of the number of cells attached to the scaffold to the 
initial number of cells in suspension. 
 
6.2.7. Alkaline phosphatase (ALP) activity 
Lysates obtained for the DNA quantification assay were used for the 
determination of ALP activity. This parameter was determined by using a fluorimetric 
assay using p-nitrophenol as standards. Samples and standards aliquots of 80ml were 
arranged in a transparent 96-well plate with 20 µl of a buffer solution (5 mM MgCl2, 
0.5 M 2-amino-2methyl-1-propanol), and 100 µl of substrate solution (5 mM 
paranitrophenylphosphate). After 30 min, the reaction was stopped by adding 100 µl 
of 0.1M NaOH. Absorbance was read at 405 nm in a Synergy HT plate reader 
(Biotek).  
 
6.2.8. Calcium deposition 
Calcium deposition in each scaffold was determined by using the ortho-
cresolphtalein method. Lysates were mixed with an equal volume of 1N acetic acid. 
The assay working solution was prepares by mixing equal volumes of the calcium 
binding reagent (0.024% ortho-cresolphtalein complexone and 0.25% 8-
hydroxyquinoline) and buffer (500 mmol/l 2-amino-2-methyl-1,3 propanediol and 
other nonreactive stabilizers). Standards were prepared with CaCl2. Sample and 
standard aliquots of 10ml were arranged in a transparent 96-well plate along with 
200ml of the working solution, and absorbance was read at 575nm. 
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6.2.9. Statistical analysis 
For all the experiments, six samples were used (n = 6). Values were reported 
as the average of all the samples, and the error was reported as the standard error of 
the mean. The data were analyzed by using ANOVA, and multiple pair-wise 
comparisons were carried out using the Tukey-HSD method at a confidence level of 
95%. 
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6.3. Results and Discussion 
 
6.3.1. Scaffold Cellularity 
Scaffold cellularity is defined as the number of cells attached to the scaffold at 
a given time point. This parameter was determined through the use of the PicoGreen 
DNA quantification assay, and the results are shown in Figure 6.1 for static condition 
(1a) and under flow perfusion at 0.1 ml/min (1b) and 1.0 ml/min (1c). PolyK-
modified scaffolds at an incubation concentration of 1x10-7 mg/ml were included, and 
a plain scaffold incubated in an RGDC solution was used as a control. In general, 
scaffold cellularity increased during the first days of culture, reaching a peak at day 8, 
after which the cellularity decreased considerably by day 16. At all culture conditions, 
scaffolds that were modified with the complete pattern (polyK-SPDP-RGDC) yielded 
higher cellularities than the controls. There was not a clear difference between the 
number of cells among the different culture conditions at days 4 and 16. Nevertheless, 
scaffold cellularity at day 8 significantly increased with the flow rate (p<0.05), with 
the static culture yielding the lowest value.  
Under static conditions, the highest extent of modification (0.1mg polyK/ml) 
yielded the highest scaffold cellularity at every time point. Under flow perfusion the 
difference between the different extents of modification could only be observed at day 
8. Scaffolds modified with a polyK incubation concentration of 1x10-4mg/ml 
presented the highest number of cells, both at 0.1 and 1.0 ml/min, (5.74±0.38)x105 
cells and (6.45 0.34)x105 cells respectively. Cellularity of the scaffolds at the highest 
and the lowest modification extent did not present significant differences at any time 
point when cultured under flow perfusion at 0.1 ml/min. However, the higher flow 
rate (1.0 ml/min) made the differences among these extents of modification more 
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pronounced. At this flow rate, scaffolds at the lowest modification level (1x10-7 mg 
polyK/ml) presented significantly higher number of cells than those at the highest 
level (0.1 mg polyK/ml) at days 4 and 8.  
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Figure 6.1. Effect of the RGD 
modification level (expressed 
as the concentration of polyK 
in the incubation phase of the 
modification) on the growth of 
cells cultured under (a) static 
conditions, and under flow 
perfusion at flow rates of (b) 
0.1 ml/min and (c) 1.0 ml/min. 
Controls included a plain 
PLLA scaffold incubated in an 
RGDC solution (RGDC) and a 
scaffold modified with polyK 
only at an incubation 
concentration of 1x10-7 
mg/min (polyK only). @ 
denotes the modification level 
that yields the highest 
cellularity at a specific day. + 
represents the controls having 
significant lower cellularity 
than the polyK-SPDP-RGDC 
modified scaffolds. # and & 
represent the days with the 
highest and lowest cellularity 
at a specific modification 
level. (*) signifies p< 0.05. 
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6.3.2.. Alkaline Phosphatase Activity 
Alkaline phosphatase (ALP) activity was reported as pg of ALP per cell per 
hour, and it is depicted in Figure 6.2 for scaffolds at all levels of modification and 
controls cultured under static conditions (2a) and flow perfusion at 0.1 ml/min (2b) 
and 1.0 ml/min (2c). As observed with the scaffold cellularity, ALP activity presented 
a peak after eight days of culture under most culture conditions, and modification 
levels and patterns. Under static culture, the activity was statistically equal for all the 
polyK concentrations on polyK-SPDP-RGDC scaffolds; however, the controls 
presented a significantly lower activity at day 8. The values of ALP activity under 
static conditions reached values as high as (4.26±0.55) pmol/hr/cell. Under flow 
perfusion ALP activity was enhanced to values as high as (20.91±3.50) pmol/hr/cell 
after 16 days for a polyK incubation concentration of 1x10-4 mg/ml at a flow rate of 
0.1 ml/min; and (22.28±2.18) pmol/hr/cell after 8 days for a polyK incubation 
concentration of 1x10-7 mg/ml at 1.0 ml/min. At the lowest flow rate, there were no 
significant differences between the different modification levels at days 4 and 8. 
However, ALP activity continued to grow after 16 days for the middle level of 
modification (1x10-4 mg polyK/ml), while declining at the highest and lowest 
modification levels.  At 1.0 ml/min on the other hand, cells cultured at the lowest 
modification level presented the highest ALP activity after 4, 8 and 16 days when 
compared to the other two levels, which did not present significant differences among 
them.  
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Figure 6.2. Effect of the 
RGD modification level 
(expressed as the concentration 
of polyK in the incubation 
phase of the modification) on 
Alkaline Phosphatase Activity 
of cells cultured under (a) static 
conditions, and under flow 
perfusion at flow rates of (b) 
0.1 ml/min and (c) 1.0 ml/min. 
Controls included a plain 
PLLA scaffold incubated in an 
RGDC solution (RGDC) and a 
scaffold modified with polyK 
only at an incubation 
concentration of 1x10-7 mg/min 
(polyK only). @ denotes the 
modification level that yields 
the highest cellularity at a 
specific day. + represents the 
controls having significant 
lower cellularity than the 
polyK-SPDP-RGDC modified 
scaffolds. # and & represent the 
days with the highest and 
lowest cellularity at a specific 
modification level. (*) signifies 
p< 0.05. 
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6.3.3. Calcium Deposition 
Mineralization of the scaffolds is reported as mg of calcium, and it is shown in 
Figure 6.3 for all culture conditions at every extent of modification. At all culturing 
conditions, the calcium deposition significantly increased with time, and the control 
scaffolds presented significantly lower calcium levels. Under static conditions, the 
control scaffolds presented significantly lower calcium deposition after 16 days, but 
there was no difference between the different modification levels. At day 8there were 
no difference between the controls and the modified scaffolds. The amount of 
deposited calcium reached values as high as (195±30mg). Under flow perfusion the 
calcium deposition was greatly improved when compared to that found under static 
conditions. At a flow rate of 0.1 ml/min, scaffolds modified at polyK incubation 
concentration of 1x10-4 mg/ml yielded the highest calcium levels at all time points, 
reaching a maximum of (473±55mg). At 1.0 ml/min, the highest calcium deposition 
was encountered at the lowest RGDC level (1x10-7 mg polyK/ml) at all time points, 
reaching a maximum of (786±120mg). There are no significant differences between 
the other modification levels at this flow rate. 
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Figure 6.3. Effect of the RGD 
modification level (expressed as the 
concentration of polyK in the 
incubation phase of the 
modification) on the deposition of 
calcium by cells cultured under (a) 
static conditions, and under flow 
perfusion at flow rates of (b) 0.1 
ml/min and (c) 1.0 ml/min. Controls 
included a plain PLLA scaffold 
incubated in an RGDC solution 
(RGDC) and a scaffold modified 
with polyK only at an incubation 
concentration of 1x10-7 mg/min 
(polyK only). @ denotes the 
modification level that yields the 
highest cellularity at a specific day. 
+ represents the controls having 
significant lower cellularity than the 
polyK-SPDP-RGDC modified 
scaffolds. # and & represent the 
days with the highest and lowest 
cellularity at a specific modification 
evel. (*) signifies p< 0.05. 
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6.4. Discussion 
 
The objective of the present study was to evaluate the effect of the extent of 
RGD-modification of PLLA foams on the osteoblastic differentiation of rat 
mesenchymal stem cells under conditions of flow perfusion. Thus, we aimed to study 
the effect of mechanical stimulation (represented by flow perfusion) and chemical 
stimulation (represented by the incorporation of RGDC) individually, and ultimately 
their combined effect on MSC osteoblastic differentiation. It has been demonstrated in 
this study that there is an enhanced effect on MSC osteoblastic differentiation due to 
combination of the aforementioned means of stimulation. 
 
The estimation of the degree of differentiation is based on different 
osteoblastic markers. In this study common markers were used: cell growth, alkaline 
phosphatase activity, and mineral deposition represented by the amount of calcium 
deposited by the cells. The levels of RGD modification were represented by the initial 
polyK incubation concentration after the acetone soaking of the PLLA foams (se 
section 6.2.2). Control scaffolds included plain foams soaked in an RGDC solution, 
represented as RGDC in the figures, and polyK-modified PLLA foams without 
RGDC, represented as polyK only. Cultures were carried out in a flow perfusion 
bioreactor at two different flow rates: 0.1 and 1.0 ml/min. Static cultures served as 
controls. 
 
In the present study, MSCs underwent changes typical of the osteogenesis 
process reported in previous studies. An early stage was marked by a high 
proliferation rate. This phase was followed by a period where the proliferation was 
down-regulated and ALP activity was up-regulated, indicating early osteoblastic 
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differentiation. Once ALP activity reached a maximum (day 8), a mineralization stage 
followed with a characteristid down-regulation of ALP activity, continued decrease 
on the proliferation rate and the up-regulation of calcium deposition.  Scaffold 
cellularity also presented a peak around day 8, indicating that at later time points cell 
death occurred possibly due to the achievement of the last stage of osteoblastic 
differentiation. The high levels of calcium and the decrease of ALP activity at day 16 
support this hypothesis. 
 
The effect of flow perfusion on the osteoblastic differentiation of MSCs has 
been previously reported in the literature. The exposure of MSCs to the shear forces 
exerted by the flow throughout the porous network of the scaffold induces higher 
levels of ALP activity and mineral deposition when compared to static cultures. The 
results obtained in the present study corroborate those findings. Not only were levels 
of ALP activity and calcium deposition encountered under flow perfusion 
significantly higher than those found under static conditions, but so was the scaffold 
cellularity. Furthermore, these makers were generally further up-regulated at a higher 
flow rate, agreeing with the results previously reported by Bancroft et al and other 
authors62,70,73,74. In addition to the improvement of MSC osteoblastic differentiation 
due to mechanical stimulation, a similar effect was induced by the presence of RGDC 
on the scaffold surface.  
 
An amine-amine functionalized scaffold was previously developed in our 
laboratory through the controlled physical entrapment of poly-L-lysine (polyK) in the 
surface of PLLA foams. Further incorporation of RGD peptides was possible by 
forming a disulfide bond with SPDP linked to the amine group of the polyK. Thus, 
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the different amounts of entrapped polyK allow us to study the effect of different 
RGD surface concentrations on certain cellular responses, most specifically, the 
differentiation of MSCs towards an osteoblastic phenotype. An up-regulation of ALP 
activity, scaffold cellularity and mineral deposition on polyK-SPDP-RGDC modified 
scaffold when compared to the controls elucidates stronger cell-matrix interactions 
that result into greater differentiation. These results are in agreement with previous 
publications that report the effect of RGD on the osteoblastic differentiation of MSCs 
in a dose dependent manner 40,75,76. In the present study, this behavior was observed at 
both static and flow perfusion cultures. Nonetheless, it is clear that, under flow 
perfusion, the extent of RGD modification has a definite effect on the differentiation. 
 
Holtorf et have reported that the combination of shear forces due to flow 
perfusion combined with the presence of RGD peptides on the surface of titanium 
fiber meshes increases MSC osteogenesis when compared to their individual effects70. 
The results found in this study are in agreement with that finding, but they also show 
there is a critical level of RGD modification, and this level is dependent on the flow 
rate. A lower flow rate (0.1 ml/min) seemed to favor the middle modification level 
represented by a polyK incubation concentration of 1x10-4 mg/ml while the highest 
flow rate (1 ml/min) favored the lowest modification level (polyK incubation 
concentration of 1x10-7 mg/ml). Comisar et al found a similar behavior when 
culturing MC3T3 preosteoblastic cells on RGD nanopatterned hydrogels. They 
changed the spacing of RGD clusters and found that at lower levels of spacing, which 
translates in higher RGD surface density, there was decreased differentiation 75. It is 
proposed that the integrin receptor primarily responsible for osteoblastic cell 
adhesion, αvβ3, also inhibits osteoblastic differentiation 75,77-79.  It is then possible that 
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this inhibitory effect is downplayed at lower RGD surface densities due to greater 
spacing of the RGD peptides. This would explain why there is a critical modification 
level, but the question on the shift of this critical level at different flow rates remains. 
 
This may be explained by the enhanced cell-matrix interactions induced by the 
shear forces. When characterizing the seeding of RGD-modified scaffolds, we noticed 
that under static conditions few cells attached to the walls, and the rest formed 
clusters within the pores. At higher modification levels, some of the cells presented 
some stretching, indicating an improvement in cell matrix interactions. However, 
when seeded under oscillatory flow perfusion, the cells were clearly stretched along 
the edges of the pores, thus displaying a dramatic improvement on cell-matrix 
interactions 80. The results of the present study suggest that the interactions found 
under static conditions of culture might be strong enough to show a difference in cell 
numbers at different modification levels but not strong enough to affect the other 
markers. Under flow perfusion, since these interactions are dramatically increased, the 
differences arouse and a behavior similar to that reported by Comisar et al. is 
observed 75. It is possible that at higher flow rates, only strongly bound cells remain, 
and cell-matrix interactions are further strengthened, increasing the inhibitory effect 
of the αvβ3 receptor activation. The osteoblastic differentiation would then be down-
regulated when compared to the lower flow rates. Consequently, the critical 
modification level would shift to a lower RGD surface concentration. 
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6.5. Conclusions 
 
RGDC surface modification combined with flow perfusion conditions of 
culture improved MSC osteoblastic differentiation with respect to the influence of 
modification or flow perfusion individually. The presence of RGD peptides on the 
surface of PLLA foams up-regulated the ALP activity and calcium deposition, and 
this effect was more pronounced under conditions of flow perfusion. From our 
findings we conclude that there exists a critical RGD surface concentration that is 
different for every culture condition in a flow perfusion system. A balance must be 
reached so that this RGD surface concentration is high enough to improve cell-matrix 
interaction and avoid cell detachment due to the shear forces and, at the same time, 
low enough to avoid a strong inhibitory effect on the differentiation of mesenchymal 
stem cells towards an osteoblastic lineage. 
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Chapter 7 
Project Conclusions and Future Directions 
 
In this chapter, conclusions directed towards the fulfillment of the specific 
aims established in Chapter 1 are stated. Ideas for future projects and complements of 
the ideas presented during the discussions to the results presented in Chapters 3 
through 6 are also recommended. 
 
7.1. Project Conclusions 
 
Specific Aim 1: To develop a dynamic scaffold seeding technique based on 
oscillatory flow perfusion and evaluate its effects on seeding efficiency, initial cellular 
distributions throughout the scaffold surface, and cell-matrix interactions. 
 
As mentioned in Chapter 2, a traditional and probably the most common 
seeding technique used in many long-term culture studies, including these involving 
flow perfusion, is the static seeding. In this technique, a cell suspension is added to 
the top of the scaffold in a drop-wise fashion, and the cells are allowed to attach for a 
certain period of time after which they are transferred into the desired culture 
environment. There major limitations with this seeding technique. Firstly, it yields 
low seeding efficiencies because the cell suspension goes through the scaffold 
thickness only once, and this is the only chance the cells have to attach to its surface. 
Secondly, due to transport limitations and capillary forces, the cellular distributions 
achieved by static seeding present poor homogeneity. Thus, it was important to design 
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a culture technique that allowed the penetration of the cells suspension throughout the 
entire scaffold porous network and give the cells more possibilities of attachment.  
 
The oscillatory flow perfusion proposed in Chapter 3 meets these 
requirements. Due to the design of the flow perfusion system, the cell suspension is 
forced into the pores of the scaffold. Additionally, the stage of oscillatory flow allows 
the cells to go through the scaffold’s thickness several times thereby giving them a 
greater chance to attach to the surface. Consequently, it was not only found that, by 
using this technique, homogeneous cell distributions and high seeding efficiencies 
were achieved as compared to static culture but also a stronger extent of cell 
attachment, as demonstrated by detachment experiments. In general, flow perfusion 
seeding is more convenient for many tissue engineering applications, especially if a 
long term culture is to be carried out in a similar system. 
 
Specific Aim 2: To create a biomimetic poly(L-lactic acid scaffold) with improved 
cell adhesion using RGD peptides that can additionally allow the evaluation of the 
effect of different modification levels on cell adhesion, proliferation and 
differentiation.  
 
To complete this aim, a poly(L-lactic acid) foam prepare by particulate 
leaching was used. Amine groups were incorporated on to the surface by physically 
entrapping poly-L-lysine. Due to the process of entrapment, the amount of polyK 
entrapped could be controlled by varying its concentration in the incubation solution. 
It is mentioned in Chapter 4 that this scaffold is functionally flexible because by 
having these amine groups on the surface, different moieties can be further 
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incorporated on the surface to elicit different cell functions. In this project, RGDC 
peptides were linked by creating a disulfide bond with a molecule of SPDP attached 
to the amine group on the surface. This scaffold supported increased cell adhesion 
when compared to unmodified scaffolds and other controls. Furthermore, it supported 
proliferation. The ability to control the extent of polyK entrapment also allowed for 
the preparation of biomimetic scaffolds with different degrees of RGD modification. 
This feature would later support the evaluation of different RGD surface modification 
levels on MSC attachment, proliferation and osteoblastic differentiation, as shown in 
Chapters 5 and 6. 
 
Specific Aim 3: To characterize the newly developed oscillatory flow perfusion 
seeding of mesenchymal stem cells on the modified scaffolds based on cell spatial 
distribution, seeding efficiency and strength of cell attachment at different 
modification levels and flow conditions. 
 
For the first time, the oscillatory flow perfusion seeding of rat MSC on RGD-
modified PLLA foams was characterized, and the results of this characterization are 
shown in Chapter 5. Scaffold cellularity was improved by the incorporation of RGDC 
peptides in a dose-dependent manner. Cell spatial distribution and cell-matrix 
interactions were greater on dynamically seeded scaffolds than on those seeded 
statically. Cell detachment increased at higher unidirectional flow rates, and the extent 
of cell detachment was also dependent on the level of RGD modification. The use of 
oscillatory flow perfusion seeding of RGD-modified foams would allow the design of 
long term culture studies of MSCs seeded uniformly on three dimensional scaffolds, 
as shown in Chapter 6. 
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Specific Aim 4: To evaluate the effect of the extent scaffold modification on the 
osteoblastic differentiation of mesenchymal stem cells under conditions of flow 
perfusion.  
 
It is shown in Chapter 6 that RGDC surface modification combined with flow 
perfusion conditions of culture improved MSC osteoblastic differentiation with 
respect to the influence of modification or flow perfusion individually. The presence 
of RGD peptides on the surface of PLLA foams up-regulated the ALP activity and 
calcium deposition, and this effect was more pronounced under conditions of flow 
perfusion. Moreover, there exists a critical RGD surface concentration that is different 
for every culture condition in a flow perfusion system. A balance must be reached so 
that this RGD surface concentration is high enough to improve cell-matrix interaction 
and avoid cell detachment due to the shear forces and, at the same time, low enough 
to avoid a strong inhibitory effect on the differentiation of mesenchymal stem cells 
towards an osteoblastic phenotype. 
 
Through the fulfillment of these four specific aims, the main objective of the 
proposed research project has been achieved. An integral approach for bone tissue 
engineering has been proposed that uses the scaffolding, cellular and molecular 
components of traditional approaches. What makes this approach unique is the 
combination of mechanical and chemical stimulation of mesenchymal stem cells to 
direct them towards an osteoblastic path. This combinatorial approach resulted more 
successful than those based on chemical or mechanical stimulation alone. 
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7.2. Future Directions 
 
Even though the main objective of this PhD research project have been 
reached, there are still ideas that can be used to look into the suggested hypotheses 
stated to explain some of the observed results. Regarding the preparation of the 
biomimetic scaffolds with different levels of RGD modification, it is recommended to 
quantify more accurately the amounts of RGD present on the surface. The 
fluorimetric technique explained in Chapter 4, based on the AmplexRed dye, only 
gives us rough estimates of these amounts and is only useful to corroborate that there 
are changes on the amount of polyK being entrapped. A more accurate technique that 
works directly on the RGDC peptides would be more desirable. Radioactive assays 
would provide this level of accuracy. Thus, radioactive RGDC peptides can be linked 
to the polyK modified scaffolds following a similar procedure to that explained in 
chapter 4. The quantification can be done by reading the RGDC solution after the 
reaction and each of the washes and subtracting that amount from the initial quantity 
of RGDC in solution. Another alternative is breaking down the RGD-modified 
scaffold manually, followed by sonication, and reading the resulting suspension. 
Actual RGDC amounts can be determined by the use of a standard curve. Once the 
amounts of RGD on the surface of the scaffold are established for every level of 
modification, the reported results can be compared with previous studies that report 
actual RGD surface density and its effect on specific cellular responses.  
 
In Chapter 6, it was mentioned that the integrin receptor αvβ3 may have played 
an effect on MSC osteblastic differentiation; furthermore, it may explain the existence 
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of a critical RGD surface concentration and its shift at different flow rates. It is well 
known that fibronectin increases improves cell adhesion via activation of the α5β1 and 
αvβ3 receptors. In addition to that, previous studies have reported that integrin α5β1 
activation up-regulates osteogenesis. Lee et al coated surfaces with fibronectin or 
RGD peptide sequences at similar densities, and found that the effect of fibronectin of 
mineral deposition and ALP activity was greater in the presence of fibronectin. This 
approach could be used in the flow perfusion studies. Once, a clear protocol has been 
established to estimate the surface concentration of certain bioactive molecules, 
PLLA foams can be modified with fibronectin or units of fibronectin responsible for 
cell adhesion at surface concentrations similar to those used in Chapter 4 for the 
RGDC peptides. Further blocking of the αvβ3 receptors on the MSC membrane can 
further help on determining whether the observed behavior was due to an inhibitory 
effect via this receptor. 
 
With the preparation of the amine functionalized scaffold presented in Chapter 
4, there are many modification patterns that can be created for studies carried out both 
in vitro and in vivo applications that can even go beyond bone regeneration. Further 
incorporation of different glycosaminoglycans can be used to study the effect of the 
different surface concentrations on the osteogenic or chondrocytic potential of MSCs, 
statically or under flow perfusion. Angiogenic factors such as vascular endothelial 
growth factor (VEGF) can also be incorporated using a peptide link that is digested by 
metallo proteinases (MMPs) so as to have its controlled release in vivo. Consequently, 
it would be possible to determine what amount of entrapped polyK would yield the 
highest degree of formation of new blood vessels once the construct is implanted in an 
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animal model. Modifications using different bioactive molecules, such as RGD and 
VEGF, are also possible using this amine functionalized PLLA foam. 
 
Regarding oscillatory flow perfusion, it has been previously reported that cells 
cultured in flow chambers and subjected to changes in the direction of the flow 
presented higher motility and that this change in the direction of the flow up-regulated 
the secretion of certain bone ECM molecules. It would be interesting to carry out long 
term cultures on MSCs under flow perfusion with oscillatory flow at different 
sequences and periodicities and determine whether oscillatory flow further up-
regulates ALP activity, mineral deposition and cell proliferation on three-dimensional 
environments.  
 
